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ABSTRACT 
 
 The goal of this dissertation research was to characterize the spermatozoal 
transcript profile of bovine cryopreserved spermatozoa.   The main goal was to sequence 
the complete transcript profile from a population of sires across a wide fertility range 
utilizing RNA-Sequencing (RNA-Seq). Sequencing was then conducted to compare the 
spermatozoal transcript profiles of higher and lower fertility sires in an effort to 
determine the presence or absence of spermatozoal transcripts that may aid in improving 
fertility testing in sires.  In addition to RNA-Seq analysis, other semen parameters such as 
morphology, DNA fragmentation, and RNA amount were analyzed for relationships with 
fertility.     
 The first chapter of this dissertation is a literature review detailing the artificial 
insemination industry, male fertility, spermatogenesis, spermatozoal RNAs, and RNA-
Seq high-throughput sequencing.  The review details what is currently known about the 
spermatozoal RNA population as well as the potential application of RNA-Seq to 
advance the knowledge of this spermatozoal RNA population.  
 The second chapter is a manuscript that was published in the journal Biology of 
Reproduction in January 2013 and was co-first-authored by Elizabeth Anderson.  This 
manuscript was the first study to sequence the spermatozoal transcript profile using 
RNA-Seq for any species.  RNA-Seq analysis of pooled semen from multiple sires 
sequenced a bovine spermatozoal transcriptome consisting of 6,166 transcripts, including 
several previously identified and novel candidate transcripts for further functional study.  
The third chapter of this dissertation is a manuscript being prepared for submission to the 
Journal of Dairy Science.  In this manuscript, the spermatozoal transcript profiles of 
higher and lower fertile sires was sequenced.  Target fertility candidate transcripts were 
selected on the basis of expression differences between the two populations and then 
correlation of these spermatozoal transcripts with sire fertility was examined.  
 Appendix 1 consists of unpublished data examining the relationship of sperm 
RNA amount with semen parameters such as morphology, DNA fragmentation index, 
motility, and sperm RNA quantity.  Sperm morphology analysis was performed by the 
Parrish lab while DNA fragmentation index analysis was performed by the Evenson lab.  
This sperm RNA isolation method is the same procedure as described in Appendix One 
and therefore I was unable to validate this transcript population.   
 Appendix 2 reports an unpublished initial RNA-Seq study done with 
spermatozoal RNA isolated with a column based method and mRNA amplification that 
differs from these protocols reported in Chapter 2.  I was unable to validate the 
spermatozoal transcript profile generated with these RNA isolation and amplification 
methods leading to the development of a second RNA isolation procedure that is reported 
in Chapter 2.  
 Through this work it is evident that there was much we did not know about the 
bovine spermatozoal transcript profile but the use of RNA-Seq in this study has helped us 
understand the population more.  This new technology has allowed us to sequence the 
entire transcript profile while determining what 
transcripts are full-length.  Not only were we able to sequence a general population but 
we compared lower and higher fertility populations and found many differences between 
the two.  Utilizing all of our data we were able to identify four individual transcripts that 
have correlations with sire fertility that may prove useful as alternatives for in vitro 
fertility tests.   
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PREFACE 
 This dissertation is in manuscript format.  Chapters Two and Three of this 
dissertation are two manuscripts for publication in peer-reviewed journals.  Chapter Two 
titled, “Cryopreserved Bovine Spermatozoal Transcript Profile as Revealed by RNA-
Seq” was published in Biology of Reproduction in January 2013 with Elizabeth Anderson 
and myself as co-first authors.  My responsibilities in that manuscript include Figures 1, 
2, and 4, along with Tables 1, 2, and 4.  Liz was responsible for Figure 3 as well as 
Tables 3, 5, and 6.  Editing responsibilities were shared equally.  
 Chapter Three titled, “Spermatozoal Transcript Profiles differ between Lower and 
Higher Fertility Sires; ” is a second manuscript that is currently being edited for 
submission to the Journal of Dairy Science and is solely my work.    
 Appendix One involves data that I collected (RNA amount; motility) as well as 
data from two other labs, the Parrish (sperm morphology) and Evenson labs (DNA 
fragmentation).   
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CHAPTER 1 
 
 
LITERATURE REVIEW 
 
I. Livestock fertility 
A. Artificial insemination industry 
 Worldwide, artificial insemination (AI) has become standard practice for breeding 
in the dairy industry.  In 1944, there were approximately 25.6 million dairy cows that 
produced 53.1 billion kg of milk in contrast to 1997 when there were an estimated 9.2 
million dairy cows that produce an estimated 70.8 billion kg of milk (Dejarnette et al, 
2004).  This increase in milk production from fewer cows is due to the widespread use of 
AI to enhance genetic selection of desirable production traits, including increased milk 
production.  In addition to advances in cow nutrition and management practices, AI sires 
have been chosen for daughter milk production traits such as high milk yield, fat/protein 
yield, mastitis, non-return rate, and lameness, which have lead to significant overall 
increases in milk production (Cottle et al, 2013).  As producers seek to continue selecting 
sires that produce highly productive daughters, the AI industry has continued to expand 
annually.  Global semen sales have nearly doubled from 19.5 million units in 1994 to 38 
million units in 2012 as the demand for milk continues to grow (National Association of 
Animal Breeders, NAAB).  About 28 million units of semen are produced each year, with 
the exportation of approximately 9 million straws, totaling over $131 million in sales 
(NAAB).  
While AI has allowed for marked increases in milk production, sire selection has 
also improved other parameters related to animal health and production.  The selection of 
conformation traits beneficial to dairy herd production and health include sturdy feet and 
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leg conformation, udder development and overall body condition scores (Cottle et al, 
2013).  Other benefits of AI include a decreased incidence of venereal disease by 
eliminating animals or semen with diseases such as infectious bovine rhinotracheitis 
(IBR) and bovine viral diarrhea virus (BVDV; Eaglesome and Garcia, 1997).  The export 
of semen straws has also decreased the incidence of disease from shipping potentially 
sick animals into new herds.  Many dairy farms strictly use AI for their breeding 
programs, eliminating the need for farms to house their own bull, resulting in a safer 
environment for workers as well as reduction of production costs.  
 Despite these advances, currently only an average of 50% of inseminations (range 
30-75%) result in a full-term pregnancy, as cow fertility rates have been steadily 
declining over the past 50 years (Peddinti et al, 2008; Flowers, 2013). Sires are not 
chosen for fertility, as only the most sub-fertile bulls are culled, but are mainly chosen for 
production traits displayed in subsequent offspring, mainly milk production (Dejarnette et 
al, 2004; Colenbrander et al, 2003).  Milk production is negatively correlated with 
fertility, and milking frequency has been associated as a possible risk factor for the 
trending lower fertility rates (Dejarnette et al, 2004).  However, omitting fertility as a 
selection trait has lead to an increase in the number of days a cow is not pregnant (days 
open), thus decreasing fertility while increasing producer costs associated with managing 
these animals (Kuhn et al, 2008). 
 Improving fertility rates can alleviate costs associated with production.  For 
example, a 1% increase in the Estimated Relative Conception Rate (ERCR), one measure 
of cow fertility based on non-return to pregnancy rate (NRR), could lead to a $5.01 
increase in profit per animal (Pecsok et al, 1994).  By improving conception rates using 
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AI, producers avoid costs associated with repeat inseminations of the same cow and 
milking days lost. Although milk production has significantly increased with the use of 
AI, more accurate male fertility assays are needed to reverse declining cow fertility and 
to improve conception rates.   
 
B. Male fertility  
 Male fertility is one of the most important confounders of overall pregnancy rate 
in current dairy production (Funk, 2006).  Only a small number of sires are needed for AI 
breeding due to the ability of each mature sire to produce approximately 100,000 semen 
straws annually with the potential to inseminate thousands of cows each year.  The range 
of dairy sire fertility (23-96%) is larger than the average herd fertility (27-74%), 
suggesting that male fertility accounts for low and high herd conception rates (Flowers, 
2013).  Therefore, the selection of the most fertile sires has the potential to increase 
conception rates, while the selection and removal of sub-fertile sires could also reduce 
low fertility rates (Flowers, 2013).  Selection of sires for production traits as well as 
above average fertility is essential to economic stability and herd management of the 
dairy industry (Foote, 2003).  
 
C. Current sire fertility assays 
1. In vivo fertility assays 
 Direct assessment of semen fertilizing ability in the female reproductive tract (in 
vivo fertility) is the most accurate assay of sperm function and therefore the ideal fertility 
assay.  After insemination of a large number of cows with different sires, a number of 
 4 
fertility estimates, including non-return rate (NRR), estimated relative conception rate 
(ERCR), and sire conception rate (SCR), can be used to rank sires by in vivo fertility 
estimates.  The NRR fertility measurement determines how many cows return to estrus 
post-insemination, after either 55 or 70 days, and are therefore not pregnant (D’Amours 
et al, 2010).  To get an accurate NRR for each sire, at least 300 inseminations are 
necessary.  ERCR is a fertility ranking similar to NRR, where pregnancy is assumed but 
not known for all first services but ERCR scores are normalized to 0 for the average of 
the population.  The newer SCR fertility index improves upon previous fertility indices 
by confirming pregnancy status through ultrasound, palpation, or blood tests.  The SCR 
scoring system also includes including multiple services, a stud year effect, sire age, and 
inbreeding adjustments and does not round to the nearest whole number as is done in the  
ERCR estimate (Clay and McDaniel, 2001).  The addition of these variables with 
conception rates can improve the accuracy of sire in vivo fertility measurements by as 
much as 20% (Kuhn and Hutchinson, 2008).  In these fertility scoring systems, all data is 
averaged and normalized to a score of 0.  For example, a sire that is 2% above average in 
its fertility estimation would have a +2 SCR while a sire with 1% below average fertility 
would have an SCR of -1.  The average fertility range includes sires within the range of   
-2 to 2 SCR  (source: Semex).   
 In vivo measurements of sire fertility are time consuming, expensive, and require 
special resources, including large numbers of cows, AI technicians, in-depth record 
keeping, and cow heat detection equipment. The fertility estimates NRR, ERCR and SCR 
do not take into account variables such as reliable estrus control systems, season, 
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inseminator, breed, and parity (Al-Makhzoomi et al, 2008).  An optimal fertility assay 
would mirror in vivo sperm performance in a more efficient and economical manner.   
 
2. In vitro sire fertility assays 
Conventional in vitro fertility assays often can only detect the most sub-fertile 
individuals and are insufficient at accurately predicting in vivo fertility as normal semen 
parameters do not necessarily correlate to acceptable fertility (Petrunkina et al, 2007; 
Colengrander et al, 2003).  Despite a decline in sire fertility in the past 35 years, 
measures of scrotal circumference, sperm concentration, and sperm morphological traits 
have remained consistent, demonstrating the ineffectiveness of these parameters to 
determine fertility accurately (Dejarnette et al, 2004).  Examining sperm functional 
competence can give a better understanding of sperm quality than current assays for 
physical, and observable sperm traits (Petrunkina et al, 2007).   
Several sperm traits currently used to predict sire fertility include scrotal 
circumference, sperm concentration, motility, morphology, DNA fragmentation, sperm-
zona pellucida penetration and sperm-oocyte penetration (Foote, 2003). Sperm traits can 
be characterized as compensable or non-compensable. Compensable traits can be 
overcome, to an extent, by increasing sperm numbers during AI and include sperm 
concentration, motility, morphology, and sperm-zona pellucida penetration (Flowers, 
2013).  Noncompensable traits, or those traits for which increased sperm numbers cannot 
increase fertility, include sperm DNA fragmentation and in vitro oocyte penetration 
ability.  Sperm with defects in noncompensable traits can often reach the site of 
fertilization but fail to fertilize or cause embryonic or fetal death (Ostermeier et al, 2002).   
 6 
Noncompensable traits are more accurate fertility predictability measures (Flowers, 
2013).  Other noncompensable sperm traits that hold potential for more accurate fertility 
assays could include protein or gene expression that reflect sperm functional competence.    
It has become evident that the best way to predict in vivo fertility is by evaluating 
several semen parameters.  For example, analyzing percentage of sperm DNA 
fragmentation with conventional semen parameters including motility, morphology, and 
sperm concentration can better predict fertilization potential than analysis based solely on 
conventional semen parameters (Phillips et al, 2004; Omran et al, 2013).  The inclusion 
of DNA, RNA and protein expression level assays, and other semen parameters could 
develop an assay that could more accurately predict in vivo fertility. 
The identification of genes associated with fertility is a promising area for 
development of more accurate male fertility assays.  Select single-nucleotide 
polymorphisms (SNPs) are correlated to SCR score in AI sires (Penagaricio et al, 2012).  
Genomic testing can also select for production traits, as well as the prevalence of certain 
diseases (De Donato et al, 2013; Pryce et al, 2012).  With this approach, fertility assaying 
of associated DNA markers could potentially be conducted prior to puberty. This early 
sire testing would reduce costs associated with maintaining less fertile sires as they 
currently need to be housed, with associated costs, past maturity to determine if their 
semen is fertile (Foote et al, 2003).  
Transcriptome analysis studies have recently explored potential male germ cells 
mRNAs involved in spermatogenesis that may also be predictive of fertility.  SNP studies 
offer insight into the effects of slight changes in the DNA code but looking at the RNA 
profile could show differences in transcript presence/amount that may alter protein 
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production though no errors occur at the DNA level.  Many of these studies utilize 
microarray to determine the transcriptomes for testis, epididymis, and early stage 
developmental germ cells and identify transcripts that may be key to successful fertility 
(Chalmel et al, 2007; Dean et al, 2008; Guyonnet et al, 2009).  For example, comparison 
of testicular transcriptomes from infertile and fertile patients found a decrease in 
transcripts associated with testicular mRNA storage (Gatta et al, 2010).  Transcriptome 
differences in fertile and infertile patients have also shed light on gametogenesis-
associated genes could be critical for proper fertility (Chalmel et al, 2012).  Elucidation 
of gene expression that is responsible for sperm production, or the process of 
spermatogenesis, may provide more accurate fertility assays.   
II. Spermatogenesis 
 Spermatogenesis takes place in the seminiferous tubules of the testes where 
billions of sperm are produced per day.  Individual sperm are genetically unique to ensure 
genetic diversity of offspring.  A series of stages and events are necessary to produce 
fertile spermatozoa (Holt et al, 2004).  An overview of spermatogenesis is depicted in 
Figure 1.   
 At the onset of male germ cell development, undifferentiated spermatogonia 
initiate spermatogenesis at the basal membrane of the seminiferous tubules and undergo 
several mitotic divisions during the proliferation stage (Boerke et al, 2007).  
Undifferentiated spermatogonia differentiate into A1-A4, I, and B spermatogonia; A-
spermatogonia have the ability to revert to undifferentiated spermatogonia through the 
process of stem-cell renewal (Senger, 2003).  This self-renewal process ensures a 
constant supply of original cells to maintain spermatogenesis indefinitely, constantly 
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providing the male with a supply of mature spermatozoa.  The B-spermatogonia undergo 
one final mitotic division resulting in an abundance of primary spermatocytes, which then 
enter the second phase of spermatogenesis (Holstein et al, 2003).  
 
 
Figure 1. Cellular divisions of spermatogenesis.  The uncoupling of transcription 
and translation is highlighted. (www.springerimages.com) 
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 Two meiotic cell divisions occur during the primary and secondary spermatocyte 
stages of spermatogenesis (Holstein et al, 2003).  Homologous recombination occurs 
during the first meiotic division of primary spermatocytes to maintain genetic diversity. 
Spermatocytes then complete meiosis II to form haploid round spermatids (Holstein et al, 
2003).  The haploid round spermatids move into the third and final phase of 
spermatogenesis, the differentiation phase.   
 During the differentiation phase, the newly formed round spermatids undergo a 
series of morphological changes to produce a functional head and tail for a fully formed 
spermatozoon.  It is during this final morphological stage that the sperm head develops 
from the rearrangement of several vesicles from the Golgi apparatus fusing along the 
nucleus, forming the pro-acrosomic granules that eventually give rise to the acrosomal 
enzyme layer that is necessary for sperm-egg interaction. The head houses all of the 
genetic material with the acrosome spread across the anterior portion of the head.  The 
acrosome consists of various hydrolytic enzymes that help the sperm penetrate the zona 
pellucida of the oocyte during fertilization (Eddy, 2002).  The sperm tail, the motor of the 
sperm, develops from centriole elongation and localization of mitochondria along the 
sperm midpiece. Removal of excess cytoplasm during the final stages ensures that 
transcription and translation cease (Senger 2003).  After release of the sperm from the 
seminiferous tubules in the testes, sperm acquire motility and fertilizing potential while 
maturing in the epididymis (Senger 2003).   
 Transcription is halted during the late round spermatid stage/early elongated 
spermatid stage of spermatogenesis while translation continues until the late elongated 
spermatid stage (Braun, 2000; Eddy, 2002; Figure 1).   This uncoupling of transcription 
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and translation is necessary for protein production for formation of the late stage 
spermatids at the same time when the genomic DNA is being highly compacted, and 
therefore inactive, in the sperm head (Eddy, 2002).  Some transcripts can be stored in an 
inactive state in male germ cells for several days before they are translated and used as 
functional protein in the later stages of spermatogenesis, as ribosomal RNAs are still 
present in the elongating spermatids (Braun, 2000). Translation ceases as excess 
cytoplasm and ribosomes are removed in the fully formed spermatozoa.  If silenced 
transcripts are not translated as the elongated spermatid develops then a population of 
mRNAs, from the earlier stages of spermatogenesis can remain in the transcriptionally 
and translationally-inert spermatozoa (Miller et al, 2006; Boerke et al, 2007; Bissonnette 
et al, 2009).  This spermatozoal mRNA population has potential as a fertility assay based 
on the ability to reflect past events of gene expression during spermatogenesis.  
 
III.  Spermatozoal RNA 
A. Spermatozoal RNA 
 It has long been thought that the only function of spermatozoa was to deliver the 
paternal half of the genome to the egg for fertilization.  However, more recently, 
spermatozoa have been shown to also deliver other components to the oocyte at 
fertilization that are necessary for successful early embryogenesis, including a population 
of RNAs (as reviewed in Hamatani, 2012; Jodar et al., 2013). Spermatozoa contain lower 
amounts of RNA (5-400 fg/sperm depending on species) in contrast to oocytes (0.5-1.5 
ng) and other cell types (10-30 pg; Boerke et al, 2007; Das et al, 2010; Hamatani 2012). 
The sperm RNA population includes coding and non-coding RNAs, such as messenger 
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RNA (mRNA), microRNA (miRNA), small interfering RNA (siRNA), piwi-interacting 
RNA (piRNA), and long non-coding (lncRNA) (Jodar et al, 2013).  While the focus of 
this literature review is the spermatozoal mRNA population, the non-coding RNAs, long 
non-coding RNAs, chromatin-associated RNAs, and small-nuclear RNAs may aid 
processes critical for fertilization and early embryonic development demonstrating a 
functional role for sperm RNA (Jodar et al, 2013).  For example, in human spermatozoa, 
the microRNA miR-34C is critical for early zygotic cell division (Liu et al, 2012).  
piRNAs regulate stability of RNAs and protect the genome by binding to DNA and 
preventing the action of transposable elements (Kawano et al, 2012).  
 
B. Spermatozoal mRNA 
 In humans, 3,000-7,000 transcripts have been identified in sperm; while in the 
bovine over 6,000 transcripts have been identified (Boerke et al, 2007; Chapter 2 Card 
and Anderson et al, 2013).  As stated previously, because spermatozoa are 
transcriptionally-inactive, these mRNAs must originate from the stages of 
spermatogenesis when transcription occurs as all spermatozoal transcripts identified by 
microarray are expressed in round spermatids (Gilbert et al., 2007).  The spermatozoal 
mRNA population contains degraded as well as intact transcripts capable of translation 
into functional proteins (Gilbert et al, 2007; Chapter 2 Card and Anderson et al, 2013; 
Anderson et al., in prep) with potential functional and non-functional uses as a fertility 
assay.  
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C. Potential role of spermatozoal mRNAs in fertilization and embryonic development 
 A small portion of the spermatozoal mRNA population consists of full-length 
transcripts with poly-A tails, and therefore has the potential to be translated into protein 
post-fertilization (Gilbert et al, 2007; Chapter 2 Card and Anderson et al., 2013, 
Anderson et al, 2014 in prep). Spermatozoal mRNA is delivered to the oocyte during 
fertilization and therefore has been hypothesized to have a role in fertilization and early 
embryonic development such as the processes of morphogenesis and implantation 
(Ostermeier et al, 2004).  A significant amount of spermatozoal mRNA is rapidly 
degraded but some spermatozoal transcripts remain intact during early stages of 
embryogenesis (Boerke et al, 2007).  Not only have mRNAs been shown to persist in 
zygotes, but can also be found post-fertilization until the blastocyst stage, which has lead 
to speculation that they may function to aid early embryonic development (Hata et al, 
2007).  Spermatozoal transcripts delivered to the oocyte at fertilization and present at 24 
hours post-fertilization in the zygote include INTS1, PLCZ1, PRM1, PRM2, CLU, PSG-1, 
and HLA-E (Ostermeier et al, 2004; Kempisty et al, 2008; Avendano et al, 2009; Swann 
et al., 2006; Vassena et al, 2011).  The mouse spermatozoal transcript, Ints1, is 
transcribed in the round spermatid stage, selectively silenced and retained in sperm then 
and detected post-fertilization prior to activation of the embryonic genome.  The INTS1 
knockout embryos arrest at the blastocyst stage, thus demonstrating the importance of 
this sperm-borne transcript in early embryonic development (Vassena et al, 2011).  The 
sperm RNA PLCZ1 is translated in the oocyte and initiates oocyte activation at 
fertilization (Swann et al, 2006). These transcripts are examples of a function for sperm-
specific mRNA and may indicate that other spermatozoal mRNAs are necessary for 
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successful fertilization and embryogenesis.  It is evident that spermatozoal RNAs, once 
an afterthought, are likely critical for successful reproduction and could aid many 
processes necessary for fertility.  
 
D. Spermatozoal RNAs, sperm motility and DNA fragmentation 
The amount of individual spermatozoal RNAs is correlated with sperm functional 
parameters such as sperm concentration, motility, morphology and DNA fragmentation 
(Lambard et al, 2004; Aoki et al, 2005; Aoki et al, 2006; Bissonnette et al, 2009).  
Specifically, sperm motility levels are correlated with the ratio of protamine transcripts, 
Prm1/Prm2 ratios, in human sperm; high motility samples had a low ratio of Prm1/Prm2 
(Lambard et al, 2004).  Increased Prm1/Prm2 transcript levels and corresponding low 
protein levels in an individual could be an indicator of inefficient translation during 
spermatogenesis (Aoki et al, 2006).  The protamines (PRM1 and PRM2) have an 
essential role in spermatogenesis by replacing DNA histones, acquired during the early 
stages of spermatogenesis, to tightly compact the DNA (Braun, 2001).  Protamines are 
small, arginine-rich nuclear proteins with a strong positive charge, which allows them to 
bind tightly to the negatively charged DNA strands, protecting sperm genomic DNA 
before fertilization while also making the sperm nucleus more compact and 
hydrodynamic (Balhorn, 2007).  This new tight packaging of the chromatin via 
protamines also makes the DNA inaccessible to transcription factors, thus causing the 
cessation of transcription  (Kimmins et al, 2004; Aoki et al, 2005).  In human 
spermatozoa, 85% of chromatin is bound to protamines and 15% remains histone bound 
while in other mammalian species it is estimated that 98% of chromatin is bound to 
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protamines (Oliva, 2006).  Specific measurements of fertility, including in vitro 
fertilization, sperm concentration, motility, and morphology, are all negatively affected 
when the PRM1/PRM2 protein ratios are abnormally high or low (Aoki et al, 2006). 
DNA fragmentation, or the extent of damaged chromatin in the sperm nucleus, is 
significantly higher in sperm with low PRM1/PRM2 protein ratios (Aoki et al, 2005). 
Other transcripts that have been correlated with motility in bovine spermatozoa include 
TSSK6 and ADAM5P (Bissonnette et al, 2009). 
 
E.  Sperm mRNAs as a potential predictor of fertility  
 Due to the lack of transcription, the transcripts present in spermatozoa represent 
spermatogenic gene expression, potentially indicating efficiency of the process as a 
whole, possibly useful as a “fingerprint” of past events during spermatogenesis 
(Ostermeier et al., 2002; Lambard et al., 2004; Ostermeier et al., 2005; Platts et al., 2007; 
Lalancette et al., 2009).    Spermatogenic defects could potentially be represented by 
variation in transcript profiles between normal and abnormal spermatogenic samples 
while also predicting fertility (Jodar et al, 2013).  For example, spermatozoal transcripts 
associated with the ubiquitin-proteosome pathway, acrosome formation, and proper tail 
formation have different expression levels between normal semen and teratozoospermic 
(abnormal morophology) samples (Platts et al., 2007).  Spermatid and spermatocyte 
specific transcripts are also not present in teratozoospermatozic samples thus indicating 
errors in the later stages of spermatogenesis (Platts et al., 2007).   Both degraded and full-
length transcripts may be of importance as degraded transcripts may have been critical 
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during earlier stages of spermatogenesis while the full-length transcripts may be critical 
for the potential function during fertilization or early embryonic development.   
 
1. Global expression of sperm mRNAs in fertility 
 In order to identify the most useful candidate fertility spermatozoal transcripts, 
global comparison of spermatozoal transcript expression is needed by comparing 
complete transcript profiles of fertile with sub-fertile or infertile sires. To date, sperm 
transcript profile comparison studies have been conducted using hybridization-based 
methods, primarily microarrays that do not probe complete transcriptomes as described 
below.  Overall, microarray studies of spermatozoal transcript profiles for higher and 
lower fertility individuals have shown several common transcripts between populations 
and differences in the presence of some transcripts as well as transcript abundances.  In 
humans, fertile and infertile patients differ in transcript presence associated with cellular 
remodeling pathways (Platts et al, 2007; Ostermeier et al, 2005).  Over 1,700 transcripts 
are common in spermatozoal RNA populations amongst 23 fertile human subjects while 
96 and 37 transcripts are common between high and medium quality semen samples and 
medium and poor quality semen samples respectively (Lalancette et al., 2009; Ostermeier 
et al., 2005). Comparison of spermatozoal RNA from an individual with pooled 
spermatozoal RNA has shown conservation of transcripts across individuals, potentially 
stably regulated transcripts, while some individual variation is also present (Ostermeier et 
al, 2002).  
 Comparison of spermatozoal transcript profiles in bovine has also been conducted 
using microarrays.  Significant differences in transcript number and amount were 
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reported between high and low NRR fertility groups (high-NRR ≥71%; low-NRR ≤65%; 
Lalancette et al, 2008b).  The high-NRR group contained 17% transcripts that aligned to 
the bovine genome and 29% of these transcripts had a known function, while the low-
NRR group only 3% aligned to the bovine genome and 10% had a known function.  
Specifically, the PRM2 transcript was at higher levels in the low-NRR group (Lalancette 
et al, 2008b).  In a separate microarray study, the expression levels of 415 sperm 
transcripts differed between high and low fertility sires; 211 transcripts were detected at 
levels at least twice as high in the higher fertility population, while 204 transcripts were 
detected at least twice as high in the low fertility population (Feugang et al, 2010). It is 
apparent from global expression studies that there are marked expression differences of 
spermatozoal RNAs between individuals with different fertility.  These differential 
expression studies have shown a sub-population of transcripts that would be candidates 
for further study on an individual transcript basis.  Exploring individual transcripts to 
attempt to elucidate those that may have correlations could lead to the potential for 
transcripts being used as predictors of fertility.   
 
2. Individual spermatozoal transcripts as fertility markers 
 Individual spermatozoal transcripts that are candidate fertility markers have been 
identified in sires using microarrays.  Many transcripts, including, CRISP2, CCT8, IB5, 
TIMP2, are positively correlated with fertility while PEBP1 is negatively correlated with 
fertility (Table 1).  In humans, a number of additional transcripts have shown correlations 
with fertility including Prm1, Prm2, Bcl2, Psg1, and Hlae (Aoki et al, 2006; Steger et al, 
2008; Avendano et al, 2009).  A correlation of spermatozoal transcript level with sire 
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fertility may exist because amount of transcript remaining in the terminally-differentiated 
cells could be due to insufficient copies of a transcript synthesized due to transcriptional 
errors and inefficient translation of mRNAs, as discussed above for Prm1/Prm2 ratios and 
protein levels, resulting in inefficient spermatogenesis and subfertile spermatozoa.  
Additionally, a functional role for spermatozoal transcripts after fertilization, as discussed 
previously, may exist and contribute to sperm fertility.  
Table 1. Individual spermatozoal transcripts with correlations to bovine 
fertility. 
Transcripts Parameter 
mRNA 
Abundance Reference 
PEBP1, CRISP2 high SCR increase Arangasamy et al. 2011 
CCT8 high SCR decrease 
CD36, CENPA high fertility increase Feugang et al. 2010 
AK1, IB5, DOPPEL, NGF, 
TIMP2, LDC1, SNRPN, 
ODF2, PLCz1 
high SCR increase Kasimanickam et al. 2012 
ADIPONECTIN, 
ADIPOR1, ADIPOR2 high SCR increase Kasimanickam et al. 2013 
 
IV. RNA-Seq 
A. Comparison of microarray and RNA-Seq methods  
 Although microarrays have been powerful tools for comparative transcriptome 
studies, deficiencies in the complete transcriptome coverage and the reliance on 
hybridization methods make this data incomplete. The newer direct sequencing 
technology of RNA-Seq offers many benefits over previous hybridization-based 
techniques (Werner, 2011).  RNA-Seq, including the Illumina sequencing which was 
used for our studies, has the capability of directly sequencing the entire expressed 
transcript population by amplifying short cDNA and then fluorescently tagging a single 
base at a time generating tens of millions of short reads from 30-400 bp in length (Wang 
et al, 2009; www.illumina.com).  The sequencing reads can then be assembled de novo or 
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against a reference genome for a complete transcriptome (Wang et al, 2009).  Direct 
sequencing is an advantage over the short sequence of cDNA probes used for microarray 
chips that do not cover entire transcripts potentially resulting in misrepresentation of 
truncated transcripts and transcript isoforms.  Also, the lack of transcript coverage in 
microarrays compromises the ability to discriminate between fully-intact and degraded 
transcripts therefore RNA-Seq has the potential for novel discovery of transcripts, exons, 
and splicing junctions (Wang et al, 2009; Costa et al, 2010; Werner, 2011).  Another 
benefit of RNA-Seq is the ability to detect single nucleotide polymorphisms (SNPs) as 
well as exon-exon boundaries for all expressed transcripts in the sample (Costa et al, 
2010). Due to increased sensitivity with decreased background noise, accurate 
quantification of transcripts can also be obtained with RNA-Seq (Werner, 2011).  With 
great dynamic range of sequencing, this quantification can be accurate at both very low 
and high levels (Wang et al, 2009).  Using RNA-Seq will allow for more complete 
sequencing and comparison of transcriptomes for more accurate identification of the role 
of gene expression in mammalian reproduction and sire fertility. 
 
B. RNA-Seq in reproduction 
 In mammalian reproduction, RNA-Seq has been used recently to reveal new 
insights into the presence, function, and importance of transcripts at various reproductive 
stages with a primary focus on acquisition of reproductive function in adults and embryo 
quality.  In non-human primates, comparison of transcript profiles of juvenile and adult 
ovarian tissues revealed a population of up-regulated transcripts in adults that are targets 
for developmental studies (Babbitt et al, 2011).  Using high throughput sequencing, the 
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infant (6 day postnatal) testicular tissue expression profiles were found to differ between 
the juvenile (4 week) and adult (10 week) profiles, especially for transcripts associated 
with spermatogenesis, thus showing the onset of spermatogenesis for the juvenile stage 
(Wei et al, 2013).  These developmental studies have offered some insight into the timing 
of maturity as well as critical transcripts in mature animals.  At the adult level, the testis 
transcript profiles of two different pig breeds, Iberian and Large White, have been 
sequenced and differential expression between the two breeds was prevalent.  Many of 
these transcripts were associated with spermatogenesis and lipid metabolism (Esteve-
Codina et al, 2011).  
 RNA-Seq studies in embryos have shed light on important gene regulatory 
pathways.  Porcine embryonic germ cells have also been sequenced, identifying genes 
associated with pluripotency (Petkov et al, 2011).  In rhesus macaques, transcriptome 
comparisons of embryos resulting from fertilization of normal or reactive oxidative 
species (ROS) damaged sperm identified 40 transcripts that were differentially expressed 
between the two embryo types (Burruel et al, 2013).  Single cell blastomeres from mouse 
embryos have also been sequenced to examine allele specific gene expression patterns 
(Tang et al, 2011).  The high throughput sequencing of various placentation sites in rats 
showed differential gene expression based upon the different compartments (Shankar et 
al, 2012).   
 In the bovine, RNA-Seq has been recently used to investigate proper embryonic 
development.  In a single bovine blastocyst, RNA-Seq analysis uncovered 9,489 
transcripts and a high number of novel transcriptional units providing evidence of an 
incomplete bovine genome (Chitwood et al, 2013).  Unique transcript expression was 
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also reported when comparing the transcriptomes of normal and abnormal bovine 
blastocysts sequenced using RNA-Seq (Huang and Khatib, 2010).  One transcript was 
even found almost exclusively expressed in the degenerative embryo population, 
indicating potential for it to be used as a marker of abnormal embryo development 
(Huang and Khatib, 2010).  In vitro fertilization alters the transcriptome of embryos 
versus in vivo counterparts, as 793 genes were differentially expressed, though both pools 
of embryos were morphologically comparable (Driver et al, 2012). Y-chromosome 
specific reads have also been reported from RNA-Seq of testis tissue (Chang et al, 2013).   
RNA-Seq has just recently been applied to spermatozoal RNA populations as 
well.  To date, spermatozoa from two species, the human and horse have been sequenced 
utilizing this technology (Das et al, 2013; Sendler et al, 2013; Note: these manuscripts 
were published after the Chapter 2 Biology of Reproduction manuscript of this 
dissertation). The total human spermatozoal RNA population contains many coding 
RNAs as well as non-coding RNAs such as snRNAs, miRNAs, and pri-miRNAs.  The 
population was also found to include fully intact RNAs, as also reported in Chapter 2 of 
this dissertation, which is crucial for potential downstream significance (Sendler et al, 
2013).  In the horse, over 4,500 transcripts were detected in the spermatozoal population, 
including rRNAs and 82 miRNAs.  Gene ontology analysis elucidated that some 
processes such as chemoattractant-activated signal transduction and cellular components 
related to sperm functions at fertilization were prominent (Das et al, 2013).  To date, no 
RNA-seq studies have been conducted using bovine spermatozoa to characterize the 
spermatozoal transcript profile for this species.   
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V. Summary 
Without transcription occurring, mRNA in the spermatozoa must originate from 
earlier stages of spermatogenesis (Hamatani, 2012).  Consequently, spermatozoal mRNA 
could be considered a “fingerprint”, or indicator of the efficiency of spermatogenesis.  By 
examining the spermatozoal mRNA population and comparing levels of transcripts that 
are critical for sperm function, it may be possible to determine the success and efficiency 
of spermatogenic events. Specific transcripts that have roles during spermatogenesis 
could, in turn, become markers for sire fertility (Li et al, 2012).  Assaying spermatozoal 
transcripts has great potential as a new non-invasive measure of sire fertility, as testis 
biopsies to measure gene expression typically are not possible (Miller et al, 2006). While 
individual spermatozoal mRNAs have been identified, the complete bovine spermatozoal 
transcript profile has not been sequenced and the correlation of sperm mRNA levels with 
sperm functional assays including fertility, morphology and DNA fragmentation have not 
been explored.   
 
VI. Aims 
Aim 1:  Sequence and characterize the transcriptome of cryopreserved bull spermatozoa 
using next-generation RNA sequencing.    
Aim 2:  Compare transcriptomes of two pools of cryopreserved bull spermatozoa, low 
and high fertility, based on CR score.  
Aim 3:  Correlate total RNA/10 million spermatozoa from cryopreserved bull 
spermatozoa with DNA fragmentation, and sperm head morphology characteristics.  
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Timeline of Experiments 
 
1. Sperm RNA Isolation Method #1 (RNeasy; column based approach) 
 A. Correlation of sperm RNA amount with sperm morphology and DNA 
 Fragmentation (Appendix 1) 
  I. Non-amplified RNA 
   Although RNA isolation method #1 yielded RNA with   
   acceptable 260/280 ratios (1.85) and no detectable somatic cell  
   contamination, I was unable to consistently amplify known sperm  
   mRNA transcripts. RNA amounts from these experiments were  
   correlated with sperm head morphology and DNA fragmentation  
   measurements taken from bulls from the same batch.   
 
   
 
 B. RNA-Seq analysis of amplified spermatozoal mRNA 
      (Isolation method #1; Appendix 2)  
  I.  Amplified mRNA population 
   With the potential that transcripts from RNA isolation method (#1) 
   were present at very low levels, sperm RNA  was then linearly  
   amplified.  Amplified mRNA was devoid of somatic cell   
   contamination and ribosomal RNA.  The PRM1 transcript was  
   amplified successfully therefore this amplified sperm RNA was  
   submitted for RNA-Seq. 
 
  II.  RNA-Seq results 
   Several thousand transcripts were found to be expressed in the in  
   the amplified sperm RNA including many sperm-specific genes.   
   Though PRM1 was amplified in the sample via PCR before  
   sequencing, it was not expressed in the transcript profile.  There  
   were also inconsistencies when trying to amplify transcripts from  
   the transcript profile in similarly isolated bull sperm RNA.  From  
   here I decided troubleshoot the RNA isolation method. 
  
 
 
 
2. Sperm RNA Isolation #2 (TRIzol) 
 A. Characterization of bovine spermatozoal transcript profile; Biology of 
 Reproduction manuscript (Chapter 2) 
  I. TRIzol spermatozoal RNA isolation (RNA isolation method #2) 
   TRIzol spermatozoal RNA isolation resulted in lower 260/280  
   ratios (1.60).  After DNAse treatment, samples were ds-cDNA  
   amplified.  Spermatozoal RNA sample did not have genomic DNA 
   or somatic cell contamination and transcripts were consistently  
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   amplified via PCR.  A sample that contained spermatozoal RNA  
   from 9 bulls was submitted for Illumina RNA-Seq.   
 
  II. RNA-Seq via Illumna sequencing 
   Reads from RNA-Seq were analyzed with Tophat and Cufflinks  
   that found 6,166 expressed transcripts that were further categorized 
   via gene ontology analysis.  Nine transcripts were chosen as qPCR  
   candidates to validate expression levels from RNA-Seq data and a  
   high correlation was found between FPKM expression levels  
   (RNA-Seq) and copy number (qPCR).    
     
 B. Spermatozoal transcript profiles differ between high and low fertility  
 sires; Journal of Dairy Science in prep (Chapter 3) 
  I. RNA-Seq analysis of higher and lower fertility samples 
   With the spermatozoal RNA isolation method (#2) and sample  
   processing as Chapter 2, spermatozoal RNA from higher fertility (- 
   1.8 to 3.5 CR; 4 bulls) and lower fertility (-2.9 to -0.4 CR; 4 bulls)  
   was sequenced with RNA-Seq.  Cuffdiff analysis was conducted  
   and 36 transcripts were differentially expressed between the two  
   samples while over 100 and 400 transcripts were found to be  
   expressed at higher levels in higher and lower fertility populations  
   respectively when using differential ratio analysis.  Once again,  
   qPCR validation of FPKM expression levels was highly correlated.  
   A handful of transcripts were quantified on qPCR across 9   
   individual sires with varying fertility scores to investigate possible  
   correlations with fertility.  Some negative correlations with fertility 
   were found (COX7C, PRM2, and TNP1) while some transcripts  
   showed no correlation with fertility (PRM1 and PSMA6). 
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Abstract 
 Ejaculated bovine spermatozoa retain a pool of RNAs that may have a function in 
early embryogenesis and be used as predictors of male fertility.  The bovine spermatozoal 
transcript profile remains incomplete because previous studies have relied on 
hybridization-based techniques, which evaluate a limited pool of transcripts and cannot 
identify full-length transcripts. The goal of this study was to sequence the complete 
cryopreserved bovine spermatozoal transcript profile using Illumina RNA-Seq.  
Spermatozoal RNA was pooled from nine bulls with conception rate (CR) scores ranging 
from -2.9 to 3.5 and confirmed to exclude genomic DNA and somatic cell mRNA. After 
selective amplification of polyA+ RNA and high-throughput sequencing, 6,166 transcripts 
were identified via alignment to the bovine genome (UMD 3.1/bosTau6). RNA-Seq 
transcript levels (n=9) were highly correlated with qPCR copy number (r2=0.9747). The 
bovine spermatozoal transcript profile is a heterogeneous population of degraded and 
full-length predominantly nuclear-encoded mRNAs. Highly abundant spermatozoal 
transcripts included PRM1, HMGB4 and mitochondrial-encoded transcripts.  Full-length 
transcripts comprised 66% of the top 368 transcripts (FPKM>100) and amplification of 
the full-length transcript or 5’ and 3’ ends was confirmed for selected transcripts. In 
addition to the identification of transcripts not previously reported in spermatozoa, 
several known spermatozoal transcripts from various species were also found. Gene 
ontology analysis of the FPKM>100 spermatozoal transcripts revealed that translation 
was the most predominant biological process represented. This is the first report of the 
spermatozoal transcript profile in any species using high-throughput sequencing, 
supporting the presence of mRNA in spermatozoa for further studies. 
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Introduction 
 In addition to delivering the paternal genome to the oocyte at fertilization, 
ejaculated spermatozoa retain a pool of RNAs, containing mRNAs, rRNAs and short 
non-coding RNAs [1-4].  Spermatozoal antisense RNAs can epigenetically regulate early 
embryonic development and have a structural role in maintaining histone-bound 
spermatozoa chromosomal regions [3-6]. Although the complete spermatozoal mRNA 
profile is not known, spermatozoa contain at least 3,000-7,000 mRNAs with 
predominantly short fragments, probably indicative of a predominance of degraded RNA 
[7-9]. Individual spermatozoal transcripts that have been identified include mRNAs for 
ribosomal proteins, mitochondrial proteins, protamines, and proteins involved in signal 
transduction and cell proliferation [7-12]. The hypothesized function of the spermatozoal 
transcripts in transcriptionally-silent spermatozoa is currently unknown although 
spermatozoa-derived mRNAs, including PRM1, PRM2, PSG-1, CLU, HLA-E, DBY and 
PLCZ1, can be detected in embryos post-fertilization suggesting a role for spermatozoal 
mRNAs in the zygote [13-18].  However, only translation of PLCZ1 has been 
demonstrated in embryos and many of these spermatozoal transcripts are rapidly 
degraded in the embryo rendering them non-functional [15-18].  Some spermatozoal 
transcripts may be translated in the mitochondria during capacitation [19].  Additionally, 
the diagnostic potential of the total spermatozoal RNA population as a snapshot of 
spermatogenic gene expression is emerging [20]. For example, perturbation of the 
ubiquitin-proteosome pathway during spermatogenesis can be detected in spermatozoal 
RNA [21].   Individual transcripts are stably regulated within and between individual 
males making this a promising area for male fertility assay development [22, 23].  
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 The bovine spermatozoal transcript profile remains incomplete because previous 
studies have relied on hybridization-based techniques, which evaluate a limited pool of 
transcripts and do not provide information about full-length transcripts [7, 9, 10, 24, 25].  
In contrast, RNA-Sequencing (RNA-Seq), based on high-throughput sequencing 
technology, is revolutionizing our understanding of transcriptomics by enabling 
sequencing of the complete transcript profiles, including full-length mRNAs and 
identifying novel splicing junctions and exons [26, 27]. Also unique to this direct 
sequencing, absolute quantification of a broad range of expression levels across 
transcripts can be obtained.  High-throughput sequencing of the total RNA in human 
spermatozoa has focused on rRNA and small non-coding RNA populations but the 
complete mRNA profile has not been reported [2, 4].  
 We hypothesize that the transcript profile of cryopreserved bovine spermatozoa 
can be directly sequenced using RNA-Seq. Over 6000 spermatozoal transcripts were 
sequenced with this approach and a heterogeneous population of degraded and full-length 
mRNAs was identified.  Previously reported spermatozoal transcripts were confirmed 
while a number of transcripts not previously found in spermatozoa of any species have 
also been identified including HMGB4, GTSF1, and CKS2.   This is the first study to date 
to utilize RNA-Seq to sequence the spermatozoal mRNA population and report full-
length transcripts for any species.  
Materials and Methods 
Spermatozoa Samples 
 Cryopreserved spermatozoa was obtained from twenty-one Holstein bulls from 
Genex Cooperative Inc. (Shawano, WI).  Semen from 9 bulls (-2.9 to 3.5 CR) was used 
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for RNA-Seq, qPCR validation, and PCR amplification of the 5’ and 3’ exons.  For 
analysis of transcript variation among individual bulls, 9 different bulls were used.  
Sperm RNA from 3 additional bulls was pooled and used for PCR amplification of full-
length transcripts. Two straws per bull were thawed in a 37°C water bath for one minute 
and then washed twice in 4 mL PBS (10 minutes at 600 x g). The resulting spermatozoa 
pellet was subsequently used for RNA isolation.   
 
RNA Isolation 
 Bull testis RNA was isolated with TRIzol (Sigma-Aldrich; St. Louis, MO).  
Sperm RNA isolation was conducted using the TRIzol method reported by Das et al., 
2010 [8] with slight modifications.  Spermatozoa pellets were added to 1 mL TRIzol 
supplemented with glycogen (15 µg/ml).  Samples were then lysed through a 26 gauge 
needle 20 times and incubated for 30 minutes at room temperature.  Chloroform was 
added to the samples followed by a 10 minute incubation at room temperature.  For phase 
separation, samples were centrifuged at 12000 x g for 15 minutes at 4ºC.  The top layer 
(RNA) was removed and added to 500 µL ice cold isopropanol and incubated on ice for 
10 minutes followed by centrifugation 12000 x g for 10 minutes at 4ºC to precipitate the 
RNA. RNA pellets were washed with 1 mL 75% ethanol and air dried, followed by 
resuspension in nuclease free water.  RNA samples were treated with DNAse using the 
RNA Cleanup protocol from the RNeasy Mini Kit (Qiagen, Valencia, CA).  RNA 
concentrations were measured using the NanoDrop UV/Vis Spectrometer (Thermo 
Scientific; Wilmington, DE) and RNA samples stored at -80º C until used for subsequent 
analysis. 
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RT-PCR 
 For amplification of full-length transcripts, spermatozoal RNA (1 µg) was reverse 
transcribed using the Superscript III Reverse Transcriptase (Invitrogen, Carlsbad, CA) 
with 2.5 µM Oligo-dT primers, 0.5 mM dNTPs, 0.25 X First Strand Buffer, 0.005 mM 
DTT, 40 U RNaseOut, and 200 U Superscript III.  After the incubations at 50O C for 45 
minutes and 70O C for 15 minutes, 2 U RNase H was added followed by an additional 
incubation at 37O C for 20 minutes. For all primer pairs, cDNA was added to a PCR 
reaction mixture containing 1X reaction buffer, 1.5 mM MgCl2, 10 mM dNTPs, 2.5 µmol 
forward and reverse primers and 2.5 U Taq polymerase (NEB; Ipswich, MA).  To 
amplify the full-length transcript, forward primers were located in the first exon and 
reverse primers were located in the last exon (Table 1).   PCR conditions were 94°C for 5 
min, followed by 35 cycles of 94°C for 30 sec, primer dependent annealing temperature 
for 30 sec then 72°C for 2 min and a final extension at 72°C for 10 min. Negative 
controls containing no template cDNA and no enzyme were run in parallel to ensure gene 
specific amplification. The PCR products were separated by 2.0% agarose gel 
electrophoresis, gel purified (Qiagen Gel Extraction kit; Valencia, CA) and both strands 
sequenced (URI Genomics Center, Kingston, RI).  Amplicon sequence identity was 
confirmed with NCBI BLAST.  
 
Double-Stranded cDNA (ds-cDNA) Synthesis and Amplification 
 Due to low RNA yields typical of spermatozoal RNA isolations, the spermatozoal 
RNA was converted to ds-cDNA and amplified for RNA-Seq analysis and qPCR 
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validation (SMARTer Pico PCR cDNA Synthesis Kit; Clontech, Mountain View, CA). 
Due to the varying amounts of RNA extracted from each bull, the amount of RNA added 
for amplification was normalized to the sample with the lowest concentration to ensure 
equal representation of the nine bulls in the pooled sample. The amplification protocol 
enriches the full-length mRNA population with a modified oligo(dT) primer. 
Amplification cycles were optimized to 26 cycles following the protocol instructions to 
insure amplification the linear phase, maintaining gene representation of the original 
RNA pool. To verify the quality of ds-cDNA, an aliquot of the sample was run on the 
Agilent Bioanalyzer 2100 (Agilent Technologies; Santa Clara, CA).  Following ds-cDNA 
conversion and amplification, 5 µg of spermatozoal ds-cDNA was submitted for Illumina 
sequencing.   
 The remaining spermatozoal ds-cDNA was used for qPCR validation post-
sequencing, validating the lack of genomic DNA and somatic cell RNA in the 
spermatozoal RNA.  A separate pool of ds-cDNA was generated from three additional 
bulls to amplify the 5’ and 3’ ends of selected transcripts. Finally, spermatozoal RNA 
from individual bulls was individually amplified to assess transcript presence among 
individuals.  All PCR reactions were run with spermatozoal ds-cDNA except for the 
spermatozoal ds-cDNA sample that was spiked with genomic DNA (1 µg) isolated from 
the bull testis tissue (Lane G in Figure 1; Qiagen DNA Blood and Tissue kit; Valencia, 
CA).  All PCR reactions were conducted with intron spanning primers (Table 1) as 
described above. 
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RNA-Seq and Analysis 
 Paired-end 100 bp reads from spermatozoal ds-cDNA were generated using the 
Illumina HiSeq 2000 (Otogenetics; Norcross, GA).  Sequence analysis was conducted 
with Galaxy [28-30]. Trimming the adapter AGATCGGAAGAGC removed 14.29% 
(2,659,330 reads) from file 1 and 1.14% (211,176 reads) from file 2. Adaptor only reads, 
short sequence reads (15 nt minimum) and reads with unknown N bases were discarded 
during adapter trimming.  Concatamers formed from amplification of the SMARTer II A 
Oligonucleotide (AAGCAGTGGTATCAACGCAGAGTAA) were found in 41.48% 
(7,702,931 reads) for file 1 and 47.17% (8,760,365 reads) for file 2 and were removed 
prior to further analysis. Alignment to the reference genome (UMD 3.1/bosTau6) was 
conducted using Tophat, which uses Bowtie for alignment [31-32].  A maximum of two 
mismatches were allowed during alignment.  RSeQC was used to generate read and post-
alignment summary statistics [33]. Levels of individual transcripts are expressed in 
Fragments Per Kilobase of exon per Million fragments mapped (FPKM) and were 
obtained using Cufflinks [30].  Quantification of full-length transcripts was conducted by 
manually visualizing the read mapping for individual transcripts to the bovine genome 
(UMD 3.1/bosTau6) in the UCSC Genome Browser (http://genome.ucsc.edu/).  Reads 
were archived in the NCBI SRA055325 (http://www.ncbi.nlm.nih.gov/sra). 
 
qPCR 
 Quantitative PCR was used to validate RNA-Seq expression levels of the 
cryopreserved spermatozoal ds-cDNA.  Nine transcripts were chosen that represented a 
range of FPKM values (9.41 to 20,667). A standard curve was generated by diluting 
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DNA for each transcript into 7 concentrations ranging from 1x109 copies to 1x103 
copies/ul.  qPCR was performed with spermatozoal ds-cDNA and standard curves using 
the Brilliant II SYBR Green QPCR Master Mix Kit (Stratagene; Santa Clara, CA).  All 
qPCR samples included negative template controls and were run in duplicate on the 
Stratagene Mx3005 instrument at the Genome Sequencing Center at the University of 
Rhode Island.  Amplicon sequence identity was confirmed with NCBI BLAST.  
 
Gene Ontology Analysis 
 Gene ontology analysis was conducted with the DAVID Bioinformatic Database 
(http://david.abcc.ncifcrf.gov/) using the three Gene Ontology Term categories: 
Biological Process, Molecular Function, and Cellular Component.  Transcripts were 
analyzed in two different populations: FPKM>0 and FPKM>100.  
Results 
Bovine spermatozoal RNA purity 
 Using the Trizol method, the total amount of RNA isolated from two spermatozoa 
straws from an individual bull resulted in an average of 31 fg RNA per spermatozoa. 
Bioanalyzer analysis of the spermatozoa RNA population shows a peak of smaller RNAs 
and a lack of 18S and 28S ribosomal RNA peaks present in testis RNA (Figure 1A). 
Genomic DNA was also not detected in the isolated bovine spermatozoal RNA compared 
to a sample spiked with genomic DNA (Figure 1B).   The spermatozoal RNA was free of 
leukocytes, testicular germ cells and epithelial cells as demonstrated by the lack of C-
KIT, CD45, and CDH1 amplification respectively (Figure 1C). 
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Illumina Sequencing  
 High-throughput sequencing of the bovine spermatozoal RNA resulted in 
18,570,350 x 2 paired-end 100-bp reads.  After removal of concatamers, a total of 
2,538,688 reads (14.25%) of the total population mapped to the bovine genome with 
79.84% of the aligned reads being uniquely mapped to a single transcript.  Reads aligned 
specifically to coding exons (324,600 reads), 5’UTRs (39,758 reads), 3’UTRs (40,057 
reads), and 2,274 reads contained poly(A) sequences. Exon-exon junctions (157,717 
reads over 17,285 junctions) were covered and 100,929 of those reads (64.21%) mapped 
to 9,003 annotated junctions while 56,248 (35.79%) reads mapped to 8,282 novel/partial 
junctions.  All junctions were supported by at least two reads.  Also, 144,432 intronic 
reads were found, several of which may represent novel exons.  
 
Cryopreserved Bovine Spermatozoal Transcript Profile 
 A total of 6,166 transcripts were identified in spermatozoal RNA with a FPKM>0 
(Fragments Per Kilobase of transcript per Million reads mapped). The qPCR expression 
values showed a high correlation with FPKM values (r2 =0.9747; Figure 2). The bovine 
spermatozoal transcript profile contains predominantly nuclear-encoded mRNAs 
including 33 mitochondrial-encoded rRNAs and mRNAs representing 0.5% of the 
spermatozoal transcript profile.  Many of these mitochondrial transcripts were highly 
abundant, with 32 of 33 in the top 100 transcripts ranked by FPKM.  The top 10 
transcripts based on FPKM, excluding the mitochondrial RNAs, are listed in Table 2.  
 A heterogeneous population of degraded and full-length transcripts was identified. 
Degraded transcripts (lacking reads mapping to all exons) were more prevalent below 
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FPKM = 100.  Due to this observation, all transcripts with FPKM>100 (368 transcripts) 
were analyzed individually for reads mapping to each exon to be considered a full-length 
transcript.  In the FPKM>100 population, 66% of the transcripts had reads aligned to all 
exons, including amplification of the 5’ and 3’ exons, potentially indicating the presence 
of full-length transcripts in the spermatozoal RNA population (Supplementary Table 1). 
Some of these full-length transcripts also included intronic reads that potentially 
represent novel exons.  Retention of the 5’and 3’ exons for PLCZ1, CRISP2, and GSTM3 
were validated while many transcripts with FPKM<100 did not retain the 5’ exon, 
including DDX3Y (Figure 3A).  The presence of full-length transcripts for GSTM3 and 
GTSF1 was confirmed by RT-PCR amplification from the first to last exon (Figure 3B).  
A preliminary survey of the bovine spermatozoal transcript profile for previously 
reported spermatozoal RNA candidates identified several transcripts in bovine, human, 
porcine and mouse (Table 3).  These transcripts represented a wide range of FPKM 
levels, and nine of these transcripts retained the 5’ and 3’ ends, potentially indicating that 
these transcripts are also full-length (Table 3). 
 A number of additional full-length bovine spermatozoal transcripts were 
identified that have not been previously reported in spermatozoal RNA, including 
HMGB4, PSMA6, GTSF1, and CKS2 (Table 4).    The presence of select spermatozoal 
transcripts, CKS2, EEF1G, EIF1, GTSF1, PRM1, varied among individual bulls (Figure 
4).  Spermatozoa RNA from these bulls was not included in the pool submitted for RNA-
Seq.  
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Gene Ontology Analysis 
 For gene ontology analysis, spermatozoal transcripts were analyzed in two 
different populations: FPKM>0 (n= 6,166) and FPKM>100 (n= 368). Transcripts were 
classified into the following ontological categories: Biological Processes (BP), Cellular 
Components (CC), and Molecular Functions (MF) and the top ten categories for each are 
shown in Table 5.  In the total spermatozoal transcript population (FPKM>0), 367 BP, 
142 CC, and 161 MF categories were found.  It is important to note that an individual 
transcript can be represented in multiple categories.  The top BP categories included 
translation (GO: 0006412; 264 transcripts) and proteolysis (GO: 0051603; 241 
transcripts). Because a majority of full-length transcripts were found in the FPKM>100 
population, we also analyzed this population separately.  Translation remained the most 
predominant BP represented within this population (55 transcripts).  Within the 
translation category, 38 of the 55 transcripts encoded for ribosomal proteins and the 
remaining transcripts included eukaryotic translation initiation factors (EIF1 and EIF5), 
eukaryotic translation elongation factors (EEF1A1 and EEF1γ), polyubiquitin and 
unknown transcripts. Twenty-four of these ribosomal transcripts were full-length (all 
exons mapped), as well as EEF1A1, EEF1γ and polyubiquitin.  
 
 
Discussion 
 Here, we report the first cryopreserved bovine spermatozoal transcript profile 
using RNA-Seq, which includes degraded and full-length nuclear-encoded transcripts and 
mitochondrial-encoded RNA.  The dynamic range of RNA-Seq allows for accurate 
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identification and quantification of transcripts present at very low and high levels as well 
as the discovery of more transcripts, novel splicing junctions and novel exons than 
reported in previous microarray studies [7, 9, 10]. In addition to the identification of 
transcripts not previously reported in spermatozoal RNA, several known spermatozoal 
transcripts from a number of different species were also found. Gene ontology analysis of 
the highly abundant spermatozoal transcripts (FPKM>100) revealed that translation was 
the most predominant biological process represented.  The presence of full-length 
transcripts in transcriptionally-silent spermatozoa suggests that these transcripts could be 
translated after spermatogenesis is complete, potentially contributing to capacitation and 
early embryogenesis [1, 3].     
 Spermatozoal RNA isolation procedures have been developed to maximize yield 
and ensure elimination of somatic cell RNA.  The total amount of cryopreserved bovine 
spermatozoal RNA isolated in this study (31 fg RNA per spermatozoa) was comparable 
to the RNA content previously reported in bovine (10-140 fg), human (12.5 fg), rat (100 
fg), porcine (5 fg), and equine (20 fg) spermatozoa [reviewed in 1, 8].   
 In this study, RNA was isolated from the whole cryopreserved semen straw, after 
a wash to remove the cryoprotectant, without the removal of non-motile spermatozoa. 
Using the entire spermatozoa population is representative of the natural transcript 
variation present across a range of fertility scores for bulls used in artificial insemination 
and is consistent with the approach used in other studies [12, 21, 24, 34].  
 The focus of this study was to enrich for and sequence the polyA+ transcripts 
present in transcriptionally-silent spermatozoa. The mitochondrial-encoded rRNAs and 
mRNAs sequenced in this population were some of the most abundant transcripts 
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although these mitochondrial RNAs represented only 0.5% of the total transcripts. 
Mitochondrial rRNAs and mRNAs have been previously amplified in spermatozoa [10, 
19] and the presence of these transcripts is likely due to intact mitochondria present 
during the RNA isolation procedure and the high mitochondrial activity of spermatozoa.  
Poly(A-) transcripts and microRNAs were not evaluated in this study but probably 
present in the total bovine sperm RNA population [4]. 
 Using RNA-Seq, we identified several full-length transcripts in the bovine 
cryopreserved spermatozoal transcript profile.  While some of these transcripts were 
previously reported in spermatozoa, the presence of full-length transcripts could not be 
determined from previous microarray studies. The most abundant full-length transcript, 
PRM1, has been reported in spermatozoa from other species as well, including humans 
and porcine [7, 13, 20, 35].  The high level of PRM1 is probably due to retention of this 
transcript in elongating spermatids during the later stages of spermatogenesis.  A function 
for PRM1 after spermatozoa leave the testis is doubtful as Prm1 transcripts are rapidly 
degraded in the mouse embryo [15, 16].  Other transcripts are delivered to the oocyte 
after fertilization, including the Y chromosome-linked DBY and RPS4Y, were not 
identified as full-length transcripts in this study, therefore, a functional role in 
embryogenesis for these transcripts is also unlikely [17].  
 Polyubiquitin is also an abundant full-length transcript in bovine spermatozoa.  
The ubiquitin system has several functions during spermiogenesis and fertilization, 
including: histone removal, removal of damaged epididymal spermatozoa, and aiding in 
zona penetration [36, 37].  Disruption of the ubiquitin-proteosome pathway during 
spermatogenesis is characteristic of teratozoospermic males and can be detected in 
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human sperm RNA [22]. Spermatozoa-derived ubiquitin RNAs may also have a role in 
directing the degradation of paternal mitochondrial RNAs, ensuring exclusive maternal 
mitochondrial DNA inheritance [36].  Further investigation of a role for spermatozoal-
derived polyubiqutin mRNA pre- and post-fertilization is warranted. 
 Previously reported spermatozoal transcripts involved in capacitation and 
fertilization were also identified as full-length, including: PLCZ1, CRISP2 and CLGN1.  
PLCΖ1, a well-characterized activator of the calcium wave after fertilization, is translated 
in the oocyte and injections of PLCZ1 RNA into the oocyte are also sufficient for 
function [18].  PLCZ1 is present at lower amounts (FPKM= 41.3) in the bovine 
spermatozoa transcript profile demonstrating that functional transcripts may not be the 
most abundant transcripts in this population. The presence of full-length CRISP2 could 
be indicative of potential translation at fertilization as CRISP2 is one of the spermatozoal 
proteins involved in oocyte binding [38].  The CLGN1 protein is necessary for 
heterodimerization of fertilization proteins [39, 40].  The presence of spermatozoal 
mRNA for critical fertilization proteins may be necessary to ensure appropriate function.   
 A number of previously unreported spermatozoal transcripts are full-length and 
abundant in the bovine spermatozoal transcript profile including HMGB4, PSMA6, 
GTSF1, and CKS2 although a role of transcripts from spermatozoal-derived mRNAs is 
speculative.  HMGB4 is found at the basal pole of elongating spermatids and is a 
transcriptional repressor [41].  PSMA6 is an alpha subunit of proteasomes; inhibition of 
spermatozoal proteosomes blocks fertilization by preventing spermatozoa penetration of 
the zona pellucida [42].  GTSF1 is critical for the suppression of retrotransposons in the 
male germ cells, as well as causing meiotic arrest in knockout mice [43].  CKS2 is critical 
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in early embryonic development, where it controls cell proliferation [44]. In knockout 
studies of CKS2 and CKS1, embryos arrest development before the morula stage due to 
cyclin B1 downregulation [44].  
 A predominant function of the bovine spermatozoal transcripts with FPKM>100 
is translation and includes abundant transcripts for ribosomal proteins, polyubiquitin 
(discussed above), eukaryotic translation initiation factors (EIF1 and EIF5), and 
eukaryotic translation elongation factors (EEF1A1 and EEF1γ). EIF1A1 is present in 
human spermatozoa [24] but EIF1, EEF1γ and EIF5 have not been previously reported in 
any species.  The translation elongation factors EEF1A1 and EEF1γ were full-length in 
this study therefore a role for these transcripts in the early stage embryo is an interesting 
area for further investigation.      
 One-third of the transcripts with FPKM>100 were degraded (all exons were not 
mapped).  A predominance of degraded transcripts was also found in the FPKM<100 
transcript population although this was not quantified.  A degraded RNA population is 
characteristic of the spermatozoal RNA populations isolated in previous studies [7, 8] and 
large subset of the spermatozoal mRNAs are probably remnants from gene expression 
during spermatogenesis and do not have a function.  The relatively higher levels of most 
of the full-length transcripts is probably not due to a 3’ end bias, which can occur with 
RNA-Seq, due to the RNA amplification protocol that selectively amplified full-length 
transcripts [45]. Although full-length transcripts were identified, the proportion of 
degraded and full-length transcripts for an individual transcript could not be distinguished 
and the FPKM values probably represent a sum of the full-length and fragmented exons 
for each transcript making the levels of intact transcripts probably lower than these 
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reported values. The presence of degraded mRNAs and full-length mRNAs are not 
necessarily mutually exclusive events and functional transcripts could be present in a 
heterogeneous population.   
 The goal of this present study was to identify a full-range of poly(A+) mRNAs 
present in bovine spermatozoa to identify candidates for further investigation. 
Spermatozoa RNA from individual bulls with a wide range of fertility scores was pooled 
for RNA-Seq, and subsequent validation, and biological replicates were not conducted.  
The presence of select spermatozoal transcripts, CKS2, EEF1G, EIF1, GTSF1, PRM1, 
varied among spermatozoal RNA isolated from a separate population of bulls 
demonstrating that the spermatozoal transcript profile is probably different for each 
individual.  Additionally, the pool of mRNA from this spermatozoa population contains 
several previously reported transcripts therefore the likelihood that the identified 
transcripts are only present in this population of bulls is low but additional transcripts 
may be identified in other individuals.  
 The diagnostic potential of the total spermatozoal RNA population (degraded and 
full-length transcripts) is emerging.  Individual transcripts are stably regulated within and 
between individual males and perturbation of the ubiquitin-proteosome pathway during 
spermatogenesis could be detected in the spermatozoal RNA [22, 23]. The amount of 
specific transcripts, including PRM1, PRM2, CRISP2, CCT8, PEBP1 and CD36, have 
also been correlated to fertility in humans and bulls [10-12, 20, 46]. These transcripts are 
full-length in this bovine spermatozoal transcript profile, so prediction of fertility for 
some of these transcripts may be due to a functional role (for example CRISP2) and not 
just a representation of transcription during spermatogenesis (for example, PRM1 and 
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PRM2).  If the degraded mRNA population is stably regulated, this population can also 
be used to as a diagnostic tool. Spermatozoal transcript populations also vary with 
motility, morphology, DNA integrity and seasons [47-51]. The spermatozoal transcript 
profile reported here was sequenced from a pool of bulls that represent a normal range of 
fertility scores. While selected transcripts demonstrated individual variance among bulls, 
further quantitative analysis in a much larger population will better assess the level of 
individual bull variation and a correlation of transcript levels with fertility scores.  
 This is the first report of the spermatozoal transcript profile in any species using 
high-throughput sequencing, supporting the presence of mRNA in spermatozoa.  Further 
studies of the spermatozoal mRNA candidates identified will contribute to our knowledge 
of the function of spermatozoal mRNA and expand our approaches to assay male fertility. 
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FIGURES 
Figure 1. Purity of bovine cryopreserved spermatozoal RNA was confirmed by lack of 
somatic cell RNAs and genomic amplification. (A) Bioanalyzer analysis of testis RNA 
and spermatozoal RNA prior to amplification.  (B) Cell-specific transcripts for testicular 
germ cells (C-KIT), leukocytes (CD45) and epithelial cells (CDH1) did not amplify in the 
spermatozoal RNA (Lane S).  M= 100 bp DNA marker, T = testis RNA positive control 
and N = negative control that does not include cDNA template. (C) The spermatozoal 
RNA (Lane S) does not contain genomic DNA compared to amplification of genomic 
EIF1 in spermatozoal cDNA spiked with genomic DNA (Lane G). N = negative control 
that does include cDNA template.  
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Figure 2. Correlation of qPCR transcript copy number and RNA-Seq FPKM 
based on nine transcripts. Axes are base 10 log scale. 
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Figure 3. PCR amplification of (A) the 5’ and 3’ ends of DDX3Y, PLCZ1, CRISP2 and 
GSTM3 in amplified ds-cDNA. For 5’ end primers, all primers begin in the first exon, 
and for 3’ end primers, all primers end in the last exon.  All primer sets are intron-
spanning. N = negative control that did not include cDNA template and M = 100 bp DNA 
marker.  (B) Transcripts for GSTM3 and GTSF1 were PCR amplified using primers 
within the first and last exons in order to capture full-length transcripts. The cDNA for 
this section was used from the 3-bull pool created from a Superscript III Reverse 
Transcription of mRNA (Invitrogen, Carlsbad, CA) 
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Figure 4. PCR amplification of select transcripts in individual bull sperm amplified 
cDNA 
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TABLES 
Table 1.  Bovine primer sequences 
     Primer Sequences  
Gene 
Symbol 
Genbank 
ID   Forward Reverse 
Product 
Size (bp) 
BTF3A AB098942 qPCR 
5'- 
GGTGGTTCATAGAACAGCAACAG
C -3' 
5'- 
GGCACCAAGCTGGTTTAAGATGC
T -3' 
244 
CD45 AJ400864 
 PCR 
5'- 
TGGACGAAATTGCATCCCTCAGGA 
-3' 
5'- 
TGGTCAGGACGTTTACAGCTCAC
A -3' 
237 
CDH1 AY508164 
 PCR 
5'- 
ACCATGGACTTCTGCCAGAGGAAT 
-3' 
5'- 
TGGTCACCTGGTCTTTGTTCTGG
T -3' 
244 
CHMP5 BC103182 qPCR 5'- TGGCACGGTGGACAGCAGAG - 3' 
5' - TGGGCGAGATTGTCCCGCTG - 
3'  189 
C-KIT AF263827 
 PCR 
5'- 
TATAGCACCATTGATGACAGCACA 
- 3' 
5'- 
TTATCTCCTCGACAACTTTCCAC
T -3' 
268 
CKS2 BC105331 Var* 5' - GAGTCGAGTCGTTGCCTTCA -3' 
5'-GGACACCAAGTCTCCTCCAC -
3' 248 
CRISP2 BC109478 5' Set 5'-CGGCCGCTCTGCAACAGAAG-3' 
5'-
GGAAGCAGCACAGCGGTCAGA-3' 120 
  3' Set 5'-CACCTTGCGGCAGTTGCCCT-3' 
5'-
TGCCTTCACACAGACAAGTCGCC
-3' 
165 
DDX3Y GQ259590 5' Set 
5'- 
TTGTTTCCGGTAGACCAACCTGTG- 
3' 
5'- 
AGCGCCCTTTGCTAGCTGTACT -
3' 
220 
  3' Set 
5'- 
GGCCGTTCTAGGAGATTCAGTGG -
3' 
5'- 
CAACTGAATCTGCTTTCCAGCCA
AG -3' 
246 
EEF1G AB098752 Var* 5'-ATCCAGTTTCCGCCATGTGT-3' 5'-GTTGCAACGCTCATCACTGG-3' 198 
EIF1 BC103170 qPCR; Var* 
5'- 
AAGGGTGATGATCTGCTTCCTGCT 
-3' 
5'- 
AACTGGCATATGTTCTTGCGCTG
G -3' 
235 (379)* 
EIF4A BC103130 qPCR 
5'- 
TGCCTTCTGATGTGCTTGAGGTGA 
-3' 
5'- 
TGAAGTCTCGGGCATGCATCTTC
T -3' 
246 
GSTM3 BC112491 5' Set 5'-GCGCTAAGGCACACAGGCGA-3' 5'-TGCGGGCGATGTAGCGCAAG-3' 290 
  3' Set 
5'-
TGTGCCGTTTTGAGGCTTTGGAG-3' 
5'-
GGGCCATCTTGTTGTTGACAGGC
AT-3' 
90 
  
5' to 3' 
Exon 5'-GCGCTAAGGCACACAGGCGA-3' 
5'-
GGGCCATCTTGTTGTTGACAGGC
AT-3' 
679 
GTSF1 BC102713 Var* 5'-CAGGTTCCTCGGGCTGAAAT-3' 5'-ACTATGTTGCTTGCAGGGCT-3' 239 
  
5' to 3' 
Exon 5'-ACAAACTGGCAACTTGTCCCT-3' 
5'-
GAACACACTGTAGCGGGAAGA-3' 427 
HMGB4 BC109790 qPCR 5'- AGCTGGTCGGTGGTGCAGGT -3' 5'- GCAAGCATGTCTTCCGGGC -3' 167 
PLCZ1 BC114836 5' Set 5'- GGTGCCCGGCCAACCAGTTAT -3' 
5'- TGCCGCTTGGCAAGAAAGGG -
3' 138 
  3' Set 
5'- 
GTGGTATCCAGTTGCCTCCCAGT -
3' 
5'- GCGGGCTCAAGACTCTCACCC 
-3' 319 
  qPCR 
5'- CGGGTGGTCGGAATCCCACTCT 
-3' 
5'- 
AATTCCCTGGCTGCCAACTTTGT 
-3' 
194 
PRM1 BC108207 qPCR; Var* 
5'- 
AAGAAGATGTCGCAGACGAAGGA
G -3' 
5'- 
ACAGGTGGCATTGTTCGTTAGCA
G -3' 
228 
PSMA6 BC110260 qPCR 
5'- 
ACAGTGGAAACTGCGATTACATG
CC - 3' 
5' - ACAGGCAAGTGGCGTCACGG 
- 3' 205 
SEC61G BC102186 qPCR 5'- GCAGACGCGGAGCAGACATCA -3' 
5'- 
AGCGAATCCTATTGCTGTTGCCA 
-3' 
155 
* Primers used for individual bull spermatozoa RNA variation PCRs 
  ** Genomic DNA amplicon which includes 144 bp intron 
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Table 2. Top 10 bovine spermatozoal transcripts based on FPKM 
 
Gene Symbol Gene Name Accession Number FPKM 
PRM1 Protamine 1 BC108207; M14559 20667; 12461 
LOC783058 Hypothetical Protein BC126791 10290 
HMGB4 High mobility group box 4 BC109790 6022 
LOC404073 Histone 2B variant PT15 BC108210; AF315690 3048; 2158 
CHMP5 Chromatin modifying protein 5 BC103182 2778 
TMSB4X Thymosin beta 4 X-linked FJ795030 2487 
LOC281370 Polyubiquitin AB099044 2426 
GSTM3 Glutathione S-transferase mu 3 BC112491 2374 
N/A cDNA clone IMAGE:7944277 BC134702 2050 
KIF5C Kinesin family member 5C BC151732 1862 
  * Bold denotes full-length transcript.  
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Table 3. Previously reported spermatozoal transcripts identified in the bovine 
spermatozoal transcript profile 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    * Bold denotes full-length transcripts 
 
 
 
 
   
End 
Exons 
Intact 
  
Transcript 
Accession 
# FPKM 5' 3' Reference Species 
Accession 
# 
PRM1 BC108207 20667.2 Y Y 
Ziyyat, 1999; Gilbert, 2007; 
Kempisty, 2008; Hecht, 2010; 
Feugang, 2010 
H; B; P; B, 
Ma; B BC108207 
CHMP5 BC103182 2778.08 N N 
Zhao et al., 2006; Lalancette, 
2008 H BC103182 
TNP1 X16171 1287.96 Y Y Iguchi, 2006 M X16171 
TNP2 BC109800 1206.79 N Y Miller, 2005 M BC109800 
SMCP BC109542 938.502 Y Y Iguchi, 2006; Yang 2009 M BC109542 
CLGN BC103401 220.011 Y Y 
Kempisty, 2008; Ostermeier, 
2004; Wang, 2004 P BC103401 
TMBIM6 BC102469 196.512 N Y Gilbert, 2007 B BC102469 
PGK2 BC110004 173.412 Y Y Iguchi, 2006 M BC110004 
H2AFZ BC109743 166.742 N Y Gilbert, 2007 B BC109743 
LOC789867 
(EF-1, 
EEF1A1) AF013213 
133.722 Y Y 
Lalancette, 2008; Zhao, 2006 B AF013213 
AKAP4 AF100170 126.623 Y Y Gilbert, 2007; Ostermeier, 2004 B AF100170 
RPS4Y BC133507 53.0481 N Y Yao, 2009 M BC133507 
PRM2 BC109783 45.5481 N Y Hecht, 2010 B, Ma BC109783 
CLU BC118223 44.045 N Y Gilbert, 2007; Kempisty, 2008 B; P BC118223 
ACTG1 BC102951 43.7095 N Y Gilbert, 2007 B BC102951 
PLCZ1 AY646356 41.3639 Y Y Hamatani, 2012 H AY646356 
MYCBP BC109848 39.731 Y Y 
Lambard et al., 2004; Kumar et 
al. 1993 H BC109848 
PEBP1 BC102389 29.3446 N Y 
Bissonette, 2009; Arangasamy, 
2011 B BC102389 
SPAG4 BC109514 25.6132 N Y Gilbert, 2007 B BC109514 
CCT8 AF136609 17.9915 N N Arangasamy, 2011 B AF136609 
DDX3Y FJ659845 10.9846 N N Sekiguchi, 2004; Yao, 2009 H; M FJ659845 
PPIH BC120220 10.946 N N Gilbert, 2007 B BC120220 
STRBP BC123453 7.26818 N N Gilbert, 2007 B BC123453 
FLOT1 BC104516 5.44937 N N Gilbert, 2007 B BC104516 
CSN2 S67277 4.76535 N Y Feugang, 2010 B S67277 
CRISP2 BC109478 4.07274 Y Y Arangasamy, 2011; Zhao, 2006 B BC109478 
EIF2B2 BC123823 2.93951 N N Gilbert, 2007 B BC123823 
SPATA20 BC123689 2.16637 N N Gilbert, 2007 B BC123689 
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Table 4. Top 10 previously unreported full-length bovine spermatozoal transcripts based 
on FPKM.  
 
Gene Symbol Gene Name Accession Number FPKM 
HMGB4 High mobility group box 4 BC109790 6022 
TMSB4X Thymosin beta 4 X-linked FJ795030 2487 
LOC281370 Polyubiquitin AB099044 2426 
PSMA6 Proteosome subunit, alpha type, 6 BC110260 913 
GTSF1 Gametocyte specific factor 1 BC102713 896 
ZNF474 Zinc finger protein 474 BC108236 817 
COX7C Cytochrome oxidase subunit 7c X15725 733 
MLF1 Myeloid leukemia factor 1 BC109859 517 
PFDN5 Prefoldin subunit 5 BC102252 405 
CKS2 CDC28 protein kinase regulatory subunit 2 BC105331 352 
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Table 5. Top 10 gene ontology categories for all spermatozoal transcripts  
 
FPKM > 0 and for transcripts with FPKM > 100. 
 
 
All Transcripts Transcripts with FPKM > 100 
 
(% of Transcripts Per Category) (% of Transcripts Per Category) 
B
io
lo
gi
ca
l P
ro
ce
ss
 
Translation 4.91 Translation 14.55 
Proteolysis Involved In Cellular Protein CP 4.48 Protein Localization 6.18 
Cellular Protein CP 4.39 Precursor Metabolites And Energy 5.82 
Modification-Dependent Protein CP 4.02 Sexual Reproduction 5.45 
Modification-Dependent Macromolecule CP 4.02 Spermatogenesis 5.09 
Cellular Macromolecule CP 4.00 Male Gamete Generation 5.09 
Protein CP 3.57 Gamete Generation 5.09 
RNA Processing 3.52 Multicellular Organism Reproduction 5.09 
Macromolecule CP 3.40 Reproductive Process 5.09 
mRNA Processing 3.14 Protein Transport 5.09 
     
C
el
lu
la
r 
C
om
po
ne
nt
 
Intracellular NMBO 11.35 NMBO 25.82 
NMBO 11.35 Intracellular NMBO 25.82 
Mitochondrion 7.98 Ribonucleoprotein Complex 16.73 
Membrane-Enclosed Lumen 6.90 Ribosome 14.18 
Intracellular Org Lumen 6.64 Mitochondrion 12.36 
Org Lumen 6.64 Org Membrane 10.18 
Org Membrane 5.49 Org Envelope 8.73 
Cytoskeleton 5.15 Envelope 8.73 
Nuclear Lumen 4.91 Mitochondrial Part 8.36 
Ribonucleoprotein Complex 4.56 Mitochondrial Membrane 8.00 
     
M
ol
ec
ul
ar
 F
un
ct
io
n 
Ion Bi 15.68 Structural Molecule Activity 13.82 
Cation Bi 15.51 Structural Constituent Of Ribosome 13.09 
Metal Ion Bi 15.42 RNA Bi 4.73 
Nucleotide Bi 11.90 Hydrogen Ion TTA 4.36 
Transition Metal Ion Bi 10.86 Monovalent Inorganic Cation TTA 4.36 
Purine Nucleotide Bi 9.51 Inorganic Cation TTA 4.36 
Purine Ribonucleotide Bi 9.15 ATPase Activity 3.27 
Ribonucleotide Bi 9.15 Enzyme Bi 2.55 
Nucleoside Bi 7.44 Protein Domain Specific Bi 2.18 
Purine Nucleoside Bi 7.38 Heme-Copper Terminal Oxidase Activity 1.82 
*CP = Catabolic Process, Bi = Binding, Org = Organelle, NMBO = Non-Membrane Bound Organelle,  
TTA = Transmembrane Transporter Activity 
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Supplementary Table 1. Full-Length Transcripts for the population of FPKM >100. 
Genbank 
ID 
Official Gene 
Symbol Full Name FPKM 
Full 
Length 
Transcript 
5' Exon 
intact 
3' Exon 
intact 
    Percent Yes:   65.76 70.65 88.59 
AB098851 ORCS10804 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 383371 Y Y Y 
AB098854 ORCS10931 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 301214 Y Y Y 
AB098841 ORCS10096 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 216612 Y Y Y 
AB098863 ORCS11599 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 149030 Y Y Y 
AB098844 ORCS10257 Bos Taurus Mitochondrial Rna, Similar To 12S Rrna 145266 Y Y Y 
AB099138 ORCS12829 Bos Taurus Mitochondrial Rna, Similar To 16S Rrna 133966 Y Y Y 
AB098853 ORCS10848 Bos Taurus Mitochondrial Rna, Similar To 12S Rrna 82000.2 Y Y Y 
BC108207 PRM1 Bos Taurus Protamine 1 20667.2 Y Y Y 
DQ347622 H97 Bos taurus clone H97 COX1 mRNA 15042.7 Y Y Y 
M14559 PRM1 Protamine 1 12460.6 Y Y Y 
DQ347619 H31 Bos taurus clone H31 ND4 mRNA 11070.1 Y Y Y 
DQ347618 ATP6 Bos Taurus Clone A14 Atp6 Mrna 10379.2 Y Y Y 
BC126791 LOC783058 Bos taurus hypothetical protein LOC783058 10289.7 Y Y Y 
AB098808 ORCS12903 
Bos taurus mitochondrial 
mRNA for similar to 
ATPase 6 
10255 Y Y Y 
DQ347621 H63 Bos taurus clone H63 COX2 mRNA 9735.03 Y Y Y 
AB099097 ORCS11619 Bos Taurus Mitochondrial Rna, Similar To D-Loop 8300.97 Y Y Y 
AB098776 ORCS12073 
Bos Taurus Mitochondrial 
Mrna For Similar To 
Cytochrome Oxidase III 
7772.1 Y Y Y 
AB098777 ORCS12084 
Bos Taurus Mitochondrial 
Mrna For Similar To 
Cytochrome Oxidase III 
6720.22 Y Y Y 
BC109790 Hmgb4 High-Mobility Group Box 4 6021.96 Y Y Y 
AB099131 ORCS11856 Bos taurus mitochondrial RNA, similar to 12S rRNA 5795.61 Y Y Y 
DQ347627 H40 Bos taurus clone H40 COX2 mRNA 5408.65 Y Y Y 
AB099077 ORCS13694 
Bos taurus mitochondrial 
mRNA for similar to 
cytochrome oxidase I 
5297.64 Y Y Y 
AB098902 ORCS10210 
Bos taurus mRNA for 
similar to cytochrome 
oxidase I 
5046 Y Y Y 
AB099009 ORCS12081 Bos taurus mRNA for similar to cytochrome b 4319.09 Y Y Y 
AB098967 ORCS11394 Bos Taurus Mrna For Similar To Cytochrome B 3394.89 Y Y Y 
BC126791 MGC148328 Bos taurus hypothetical protein LOC783058, mRNA 3198.14 Y Y Y 
FJ976184 ND5 
Bos taurus NADH 
dehydrogenase subunit 5 
(ND5) mRNA 
3091.53 Y Y Y 
BC108210 LOC404073 Histone H2B Variant Pt15 3047.5 Y Y Y 
AB098941 ORCS10715 Bos taurus mRNA for similar to cytochrome b 2918.85 Y Y Y 
BC103182 Chmp5 Chromatin Modifying 2778.08 N N N 
 68 
Protein 5 
AB098789 ORCS12473 
Bos Taurus Mitochondrial 
Mrna For Similar To 
Cytochrome Oxidase III 
2521.74 Y Y Y 
FJ795030 LOC785455 Thymosin Beta 4, X-Linked 2486.99 Y Y Y 
AB099044 LOC281370 Polyubiquitin 2425.89 Y Y Y 
BC112491 GSTM3 Glutathione S-Transferase Mu 3 (Brain) 2373.84 Y Y Y 
AF315690 LOC404073 Histone H2B Variant Pt15 2158.22 Y Y Y 
AB098774 ORCS11961 
Bos taurus mitochondrial 
mRNA for similar to 
cytochrome oxidase III 
2133.68 Y Y Y 
AB099096 ORCS11109 Bos taurus mitochondrial RNA, similar to D-loop 2091.43 Y Y Y 
BC134702 IMAGE:7944277 Bos taurus cDNA clone IMAGE:7944277 2050.08 Y Y Y 
AB098801 ORCS12731 
Bos taurus mitochondrial 
mRNA for similar to 
cytochrome oxidase III 
2029.43 Y Y Y 
BC151732 KIF5C Kinesin Family Member 5C 1862.47 Y Y Y 
BC123382 LOC777592 Hypothetical Protein Loc777592 1846.72 N N Y 
BC126793 IMAGE:8056303 Bos taurus cDNA clone IMAGE:8056303 1808.5 N N Y 
AB098980 ORCS11606 
Bos taurus mitochondrial 
mRNA for similar to NADH 
dehydrogenase subunit 1 
1586.19 Y Y Y 
AB098969 ORCS11414 
Bos taurus mRNA for 
similar to NADH 
dehydrogenase subunit 1 
1563.82 Y Y Y 
BC114001 LOC281370 Polyubiquitin 1520.12 Y Y Y 
BC111648 MGC137055 Hypothetical Protein Mgc137055 1466.25 Y Y Y 
AB098767 ORCS11606  Bos taurus mitochondrial mRNA, similar to protein 1 1310.8 Y Y Y 
X16171 tnp1 Transition Protein 1 1287.96 Y Y Y 
BC109730 C13H20orf79 Chromosome 20 Open Reading Frame 79 Ortholog 1237.94 Y Y Y 
BC142065 IMAGE:8037824 Bos taurus cDNA clone IMAGE:8037824 1224.68 Y Y Y 
BC109800 LOC781496 
Similar To Tnp2 Protein; 
Transition Protein 2 (During 
Histone To Protamine 
Replacement) 
1206.79 N N Y 
BC126791 IMAGE:30957795 Bos taurus hypothetical protein LOC783058, mRNA 1137.99 Y Y Y 
AB098750 LOC614114 Cytochrome C Oxidase Subunit Vib Pseudogene 1099.5 N N Y 
BC111151 IMAGE:8052434 Bos taurus cDNA clone IMAGE:8052434 993.402 N N Y 
K00243 tRNA-Leu Bovine Mitochondrial Leu-Trna-Tag 972.836 Y Y Y 
AY796023 Smcp 
Sperm Mitochondria-
Associated Cysteine-Rich 
Protein 
938.502 Y Y Y 
BC109478 IMAGE:8048928 Bos taurus cysteine-rich secretory protein 2, mRNA 933.969 Y Y Y 
BC103421 Spa17 Sperm Autoantigenic Protein 17 927.374 Y Y Y 
BC110260 Psma6 
Proteasome (Prosome, 
Macropain) Subunit, Alpha 
Type, 6 
913.21 Y Y Y 
BC102663 C12orf54 Chromosome 12 Open Reading Frame 54 Ortholog 897.064 Y Y Y 
BC102713 GTSF1 Gametocyte Specific Factor 1 896.368 Y Y Y 
BC102609 C3H1orf182 Chromosome 1 Open Reading Frame 182 887.309 Y Y Y 
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Ortholog 
BC102599 GTSF1L Gametocyte Specific Factor 1-Like 861.791 Y Y Y 
BC108236 ZNF474 Zinc Finger Protein 474 816.725 Y Y Y 
BC102973 LOC539855 Histone H3-Like 805.895 Y Y Y 
AB099083 LOC281370 
Ubiquitin C; Polyubiquitin; 
Ubiquitin A-52 Residue 
Ribosomal Protein Fusion 
Product 1 
797.874 Y Y Y 
DQ347600 A24 
Bos Taurus Clone H1 
Atpase Na+/K+ 
Transporting Beta 3 
Polypeptide-Like Mrna 
786.943 Y Y Y 
BC126792 LOC784495 Hypothetical Protein Loc784495 741.663 Y Y Y 
X15725 Cox7c Cytochrome C Oxidase Subunit Viic 732.771 Y Y Y 
DQ347636 COX7A2 
Cytochrome C Oxidase 
Subunit Viia Polypeptide 2 
(Liver) 
719.358 Y Y Y 
BC109926 IQCF5 Iq Motif Containing F5 707.481 Y Y Y 
AB098957 LOC281370 Polyubiquitin 677.922 Y Y Y 
BC102598 tnp1 
Transition Protein 1 (During 
Histone To Protamine 
Replacement) 
676.993 Y Y Y 
BC103105 CISD1 Cdgsh Iron Sulfur Domain 1 656.043 N N Y 
BC114790 IMAGE:8063641 Bos taurus cDNA clone IMAGE:8063641 619.729 N N Y 
BC109542 Smcp 
Sperm Mitochondria-
Associated Cysteine-Rich 
Protein 
604.724 Y Y Y 
BC148014 rpl23 Ribosomal Protein L23 599.605 Y Y Y 
BC102582 MP68 6.8 Kda Mitochondrial Proteolipid 584.314 N N Y 
Z86042 LEO1 
Leo1, Paf1/Rna Polymerase 
Ii Complex Component, 
Homolog (S. Cerevisiae) 
562.891 Y Y Y 
BC110036 Clph Chromosome 4 Open Reading Frame 35 Ortholog 545.537 Y Y Y 
DQ347576 SLC25A5 
Solute Carrier Family 25 
(Mitochondrial Carrier; 
Adenine Nucleotide 
Translocator), Member 5 
542.739 Y Y Y 
M62428 LOC281370 
Ubiquitin C; Polyubiquitin; 
Ubiquitin A-52 Residue 
Ribosomal Protein Fusion 
Product 1 
538.61 N N Y 
K00194 tRNA-Glu Bovine Mitochondrial Glu-Trna-Uuc 533.929 Y Y Y 
BC111614 LOC768323 Hypothetical Protein Loc768323 522.375 Y Y Y 
BC109859 MLF1 Myeloid Leukemia Factor 1 516.634 Y Y Y 
AY911357 rpl31 
Similar To Ribosomal 
Protein L31; Ribosomal 
Protein L31 
507.005 Y Y Y 
AY260742 LIS1 
Bos taurus platelet 
activating factor 
acetylhydrolase 45 kDa 
subunit brain isoform (LIS1) 
mRNA 
503.684 Y Y Y 
J03604 GLUL Glutamate-Ammonia Ligase (Glutamine Synthetase) 500.939 Y Y Y 
BC102702 LOC782520 Ribosomal Protein S29 497.777 Y Y Y 
DQ347636 COX7A2 
Cytochrome C Oxidase 
Subunit Viia Polypeptide 2 
(Liver) 
496.514 Y Y Y 
BC109927 MORN2 Morn Repeat Containing 2 472.825 Y Y Y 
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BC105360 spata6 Spermatogenesis Associated 6 453.406 Y Y Y 
AF294616 TMSB10 Thymosin Beta 10 451.9 N N Y 
BC102650 MGC128040 Hypothetical Protein Mgc128040 442.179 Y Y Y 
BC149673 MGC152346 Uncharacterized Protein Loc285141 Homolog 440.761 Y Y Y 
BC126781 TXNDC8 Thioredoxin Domain Containing 8 (Spermatozoa) 433.154 Y Y Y 
S79980  RPL37 ribosomal protein L37 432.006 Y Y Y 
AB099079 LOC789867 Eukaryotic Translation Elongation Factor 1 Alpha 1 431.873 Y Y Y 
BC102748 rpl32 Ribosomal Protein L32 419.736 Y Y Y 
BC111614 LOC768323 Hypothetical Protein Loc768323 414.631 Y Y Y 
BC102252 PFDN5 Prefoldin Subunit 5 404.632 Y Y Y 
BC102044 RPL37A Ribosomal Protein L37A 403.288 N Y N 
BC109951 CAPZA3 
Capping Protein (Actin 
Filament) Muscle Z-Line, 
Alpha 3 
402.076 Y Y Y 
BC102248 LOC281370 Polyubiquitin 401.415 Y Y Y 
BC120080 CALM Calmodulin-Like 395.156 Y Y Y 
BC142077 IMAGE:8050622 Bos taurus cDNA clone IMAGE:8050622 393.899 N N Y 
AY186585 GLUL Glutamate-Ammonia Ligase (Glutamine Synthetase) 392.537 Y Y Y 
DQ347578 A17 Bos taurus clone A17 actin cytoplasmic 2 mRNA 387.604 Y Y Y 
AJ297742 GABARAP Gaba(A) Receptor-Associated Protein 384.967 Y Y Y 
BC142060 DNAJB7 Dnaj (Hsp40) Homolog, Subfamily B, Member 7 366.633 Y Y Y 
BC108144 BANF2 Barrier To Autointegration Factor 2 359.621 Y Y Y 
BC114198 IMAGE:8055902 Bos taurus cDNA clone IMAGE:8055902 357.25 Y Y Y 
BC105331 CKS2 Cdc28 Protein Kinase Regulatory Subunit 2 351.893 Y Y Y 
BC114201 IMAGE:8056539 Bos taurus cDNA clone IMAGE:8056539 348.138 Y Y Y 
BC149889 DCUN1D1 
Dcn1, Defective In Cullin 
Neddylation 1, Domain 
Containing 1 (S. Cerevisiae) 
342.726 Y Y Y 
AF109198 CLIC4 Chloride Intracellular Channel 4 338.487 Y Y Y 
BC126766 FAM24A Similar To Protein Fam24A 335.134 Y Y Y 
BC110256 Fam71d 
Family With Sequence 
Similarity 71, Member D 
Ortholog 
335.075 Y Y Y 
BC109624 cetn1 Centrin, Ef-Hand Protein, 1 332.853 N N Y 
BC102682 SERF2 Small Edrk-Rich Factor 2 330.258 N N Y 
BC102249 rps11 Ribosomal Protein S11 327.944 Y Y Y 
BC148018 rps17 Ribosomal Protein S17 327.412 Y Y Y 
BC109989 C13H20ORF71 Chromosome 20 Open Reading Frame 71 Ortholog 326.017 Y Y Y 
BC102437 atox1 Atx1 Antioxidant Protein 1 Homolog (Yeast) 320.276 Y Y Y 
DQ347614 LOC784052 40S Ribosomal Protein S26-2-Like 319.419 Y Y Y 
BC109725 SAA4 Serum Amyloid A4, Constitutive 319.23 Y Y Y 
U19802 btg1 B-Cell Translocation Gene 1, Anti-Proliferative 316.825 N N Y 
BC108179 RPL38 Ribosomal Protein L38 316.575 Y Y Y 
BC111617 Tmco2 Transmembrane And Coiled-Coil Domains 2 313.784 N N Y 
BC114194 IMAGE:8063913 Bos taurus cDNA clone 311.9 Y Y Y 
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IMAGE:8063913 
BC103057 UQCRB Ubiquinol-Cytochrome C Reductase Binding Protein 309.82 Y Y Y 
BC102186 sec61g Sec61 Gamma Subunit 309.446 Y Y Y 
AB098960 ORCS11043 
Bos taurus mRNA for 
similar to poly(A)-binding 
protein 1 
307.612 Y Y Y 
EU036210 BBD120 Bos taurus beta-defensin 120 mRNA 306.483 N Y N 
BC108218 C29H11orf10 Chromosome 11 Open Reading Frame 10 Ortholog 297.346 N N N 
BC103170 LOC781102 Eukaryotic Translation Initiation Factor 1 292.75 N N Y 
BC142260 taf10 
Taf10 Rna Polymerase Ii, 
Tata Box Binding Protein 
(Tbp)-Associated Factor, 
30Kda 
289.583 N N Y 
BC102743 Tmco5a Transmembrane And Coiled-Coil Domains 5A 287.894 N N Y 
BC108230 SERF1A Small Edrk-Rich Factor 1B (Centromeric) 277.569 N N Y 
AF058700 LOC281370 
Ubiquitin C; Polyubiquitin; 
Ubiquitin A-52 Residue 
Ribosomal Protein Fusion 
Product 1 
277.039 Y Y Y 
BC109684 LOC540268 Hypothetical Loc540268 272.881 Y Y Y 
BC102675 DCUN1D1 
Dcn1, Defective In Cullin 
Neddylation 1, Domain 
Containing 1 (S. Cerevisiae) 
269.749 Y Y Y 
M19217 Atp5j 
Atp Synthase, H+ 
Transporting, Mitochondrial 
F0 Complex, Subunit F6 
269.601 Y Y Y 
AY911383 LOC786337 Ribosomal Protein S24 267.359 N N Y 
BC102168 LOC781607 Ribosomal Protein L36A 262.035 N N Y 
BC103196 IMAGE:7986614 
Bos taurus transcription 
elongation factor B (SIII), 
polypeptide 2 
261.222 N N Y 
BC110154 MS4A13 
Membrane-Spanning 4-
Domains, Subfamily A, 
Member 13 
258.624 Y Y Y 
BC151426 LOC786258 Ran, Member Ras Oncogene Family 258.31 Y Y Y 
X15112 LOC614114 Cytochrome C Oxidase Subunit Vib Pseudogene 257.306 N N N 
BC109719 SPINK2 
Serine Peptidase Inhibitor, 
Kazal Type 2 (Acrosin-
Trypsin Inhibitor) 
248.263 Y Y Y 
BT030506 UBE2N 
Ubiquitin-Conjugating 
Enzyme E2N (Ubc13 
Homolog, Yeast) 
245.596 Y Y Y 
EU036209 BBD119 Bos taurus beta-defensin 119 mRNA 244.782 Y Y Y 
Z46789 CYLC2 Cylicin, Basic Protein Of Sperm Head Cytoskeleton 2 243.523 Y Y Y 
DQ347568 LOC781571 
Histidine Triad Nucleotide 
Binding Protein 1; Similar 
To Histidine Triad 
Nucleotide-Binding Protein 
1 
242.297 Y Y Y 
BC102631 LOC617040 Similar To Hcg23722 241.208 N Y N 
AY911363 LOC507141 Ce5 Protein-Like 241.165 Y Y Y 
BC108150 Selk Selenoprotein K 238.417 Y Y Y 
BC102957 GPX4 
Glutathione Peroxidase 4 
(Phospholipid 
Hydroperoxidase) 
238.117 N N Y 
BC149307 LOC100125949 Similar To Iq Domain-Containing Protein F1 235.802 Y Y Y 
AB099097 ORCS11619 Bos Taurus Mitochondrial 235.006 Y Y Y 
 72 
Rna, Similar To D-Loop 
BC110123 C16H1orf49 Chromosome 1 Open Reading Frame 49 Ortholog 234.333 Y Y Y 
BC105361 Ldhc Lactate Dehydrogenase C 230.203 Y Y Y 
BC123583 AP2B1 Adaptor-Related Protein Complex 2, Beta 1 Subunit 228.35 N Y Y 
AY911358 LOC781565 Ribosomal Protein S6 227.299 Y Y Y 
DQ347613 rps8 Ribosomal Protein S8 222.367 Y Y Y 
AB098827 LOC781379 Dynein, Light Chain, Lc8-Type 1 222.35 Y Y Y 
DQ347611 rps11 Ribosomal Protein S11 221.749 Y Y Y 
Y10372 CAPZB 
Capping Protein (Actin 
Filament) Muscle Z-Line, 
Beta 
220.387 Y Y Y 
BC103401 clgn Calmegin 220.011 Y Y Y 
BC114181 DBI 
Diazepam Binding Inhibitor 
(Gaba Receptor Modulator, 
Acyl-Coenzyme A Binding 
Protein) 
219.957 Y Y Y 
M19962 COX5B Cytochrome C Oxidase Subunit Vb 218.769 Y Y Y 
X16978 LOC782270 
Similar To Atp Synthase 
Subunit Epsilon, 
Mitochondrial 
217.565 Y Y Y 
BC108217 Dynlrb2 Dynein, Light Chain, Roadblock-Type 2 215.832 N Y N 
BC102491 LOC281370 Polyubiquitin 215.342 N Y N 
BC126796 C23H6orf129 
Chromosome 6 Open 
Reading Frame 129 
Ortholog 
211.668 N Y N 
BC148017 IMAGE:7946562 Bos taurus ribosomal protein L37, mRNA 208.936 Y Y Y 
BC103060 GABARAP Gaba(A) Receptor-Associated Protein 203.266 N N Y 
BC126795 DEFB123 Defensin, Beta 123 201.937 N Y N 
BC102751 SPATA19 Spermatogenesis Associated 19 201.143 Y Y Y 
BC108162 SEC62 Sec62 Homolog (S. Cerevisiae) 200.111 N N Y 
BC108191 C29H11orf67 Chromosome 11 Open Reading Frame 67 Ortholog 199.775 Y Y Y 
AY835842 H2AFZ Bos taurus histone H2A mRNA 197.567 N N N 
BC102469 tmbim6 Transmembrane Bax Inhibitor Motif Containing 6 196.512 N N Y 
BC102286 GNB2L1 
Guanine Nucleotide Binding 
Protein (G Protein), Beta 
Polypeptide 2-Like 1 
196.51 Y Y Y 
BC120462 tspan5 Tetraspanin 5 195.749 Y Y Y 
BC108233 polr2i 
Polymerase (Rna) Ii (Dna 
Directed) Polypeptide I, 
14.5Kda 
195.592 Y Y Y 
BC103314 LOC784243 
Ribosomal Protein L34; 
Similar To Ribosomal 
Protein L34 
195.156 Y Y Y 
BC102445 RpL30 Ribosomal Protein L30 195.066 N Y N 
BC114016 Ccdc54 Coiled-Coil Domain Containing 54 194.483 Y Y Y 
BC102549 Ropn1 Ropporin, Rhophilin Associated Protein 1 193.878 N N Y 
BC109557 meig1 Meiosis Expressed Gene 1 Homolog (Mouse) 193.741 N N Y 
BC111660 LOC526524 
Fk506 Binding Protein 1A, 
12Kda; Fk506 Binding 
Protein 1A, 12Kda-Like 
193.185 Y Y Y 
BC118480 S100G S100 Calcium Binding Protein G 192.026 Y Y Y 
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BC118372 SRPK2 Sfrs Protein Kinase 2 190.687 N N Y 
BC109867 DDX25 Dead (Asp-Glu-Ala-Asp) Box Polypeptide 25 188.791 N N Y 
BC108151 Rangrf Ran Guanine Nucleotide Release Factor 188.571 N N Y 
BC116060 capns1 Calpain, Small Subunit 1 187.956 N N Y 
AF520959 Fau 
Finkel-Biskis-Reilly Murine 
Sarcoma Virus (Fbr-Musv) 
Ubiquitously Expressed; 
Similar To Ubiquitin-
Like/S30 Ribosomal Fusion 
Protein 
187.816 N N N 
BC111147 LOC786899 
Similar To Gtpase 
Activating Protein 
Testicular Gap1; 
Hypothetical Loc786899; 
Hypothetical Protein 
Mgc134093 
187.06 Y Y Y 
AB099017 LOC789997 
Similar To 40S Ribosomal 
Protein S3A; Similar To 
Ribosomal Protein S3A; 
Ribosomal Protein S3A; 
Similar To Ribosomal 
Protein S3A 
186.803 Y Y Y 
BC110030 BCAP29 B-Cell Receptor-Associated Protein 29 186.465 Y Y Y 
BC142080 LOC100271685 Membrane-Spanning 4-Domains, Subfamily A-Like 186.038 Y Y Y 
AY911354 LOC785691 
Similar To Mcg10725; 
Ribosomal Protein S25; 
Similar To Ribosomal 
Protein S25 
185.298 Y Y Y 
BC109670 MRPL42 Mitochondrial Ribosomal Protein L42 184.466 Y Y Y 
BC111147 LOC786899 
Similar To Gtpase 
Activating Protein 
Testicular Gap1; 
Hypothetical Loc786899; 
Hypothetical Protein 
Mgc134093 
182.392 Y Y Y 
BC102669 Ppp1r2 
Protein Phosphatase 1, 
Regulatory (Inhibitor) 
Subunit 2 
181.173 N N Y 
AY911347 RpL35A Ribosomal Protein L35A 177.346 Y Y Y 
BC102382 YWHAZ 
Tyrosine 3-
Monooxygenase/Tryptophan 
5-Monooxygenase 
Activation Protein, Zeta 
Polypeptide 
175.813 N N Y 
BC102877 snrpd2 
Small Nuclear 
Ribonucleoprotein D2 
Polypeptide 16.5Kda 
173.477 Y Y Y 
BC110004 PGK2 Phosphoglycerate Kinase 2 173.412 Y Y Y 
AB098832 LOC789997 
Similar To 40S Ribosomal 
Protein S3A; Similar To 
Ribosomal Protein S3A; 
Ribosomal Protein S3A; 
Similar To Ribosomal 
Protein S3A 
173.237 Y Y Y 
GU817014 YWHAZ 
Bos Taurus Tyrosine-3-
Monooxygenase/Tryptophan 
5-Monooxygenase 
Activation Protein Zeta 
Polypeptide 
172.597 Y Y Y 
GU817014 YWHAZ 
Bos Taurus Tyrosine-3-
Monooxygenase/Tryptophan 
5-Monooxygenase 
Activation Protein Zeta 
Polypeptide 
172.597 Y Y Y 
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BC126782 LOC100126817 Hypothetical Protein Loc100126817 172.491 Y Y Y 
DQ347605 LOC782668 Ribosomal Protein L6 171.318 Y Y Y 
BC105179 rpl35 Ribosomal Protein L35 170.04 N N Y 
BC111663 LYRM7 Lyrm7 Homolog (Mouse) 168.54 Y Y Y 
BC102194 EIF5 Eukaryotic Translation Initiation Factor 5 168.115 N N Y 
BC109743 H2AFZ H2A Histone Family, Member Z 166.742 N N Y 
BC118158 IMAGE:8211381 
Bos taurus ST6 (alpha-N-
acetyl-neuraminyl-2,3-beta-
galactosyl-1, 3)-N-
acetylgalactosaminide 
alpha-2,6-sialyltransferase 
2, mRNA 
166.262 Y Y Y 
BT025435 C14orf153 Hypothetical Protein Loc617441 165.939 N N Y 
BC108222 IMAGE:8043996 Bos taurus cDNA clone IMAGE:8043996 165.44 Y Y Y 
DQ677839 C13H20ORF71 Chromosome 20 Open Reading Frame 71 Ortholog 165.204 Y Y Y 
BC108247 SLIRP Sra Stem-Loop-Interacting Rna-Binding Protein 162.812 Y Y Y 
AB099059 rps3 Ribosomal Protein S3 162.118 Y Y Y 
BC102455 LOC786431 
Atp Synthase, H+ 
Transporting, Mitochondrial 
F0 Complex, Subunit G 
160.879 Y Y Y 
AB098994 LOC784528 
Atpase, H+ Transporting, 
Lysosomal 34Kda, V1 
Subunit D 
160.731 Y Y Y 
BC102175 C26H10orf84 Chromosome 10 Open Reading Frame 84 Ortholog 160.09 Y Y Y 
BC109561 Rpl10l Ribosomal Protein L10-Like 159.931 N N N 
BC109732 IMAGE:8059175 Bos taurus cDNA clone IMAGE:8059175 159.464 Y Y Y 
BC111654 RpL35A Ribosomal Protein L35A 158.971 Y Y Y 
BC102313 Rpl27 
Similar To Ribosomal 
Protein L27; Ribosomal 
Protein L27 
158.242 N N N 
BC105143 LOC789244 
Lysophospholipase I; 
Similar To 
Lysophospholipase I 
157.322 N Y N 
DQ347607 LOC509829 
Ribosomal Protein L10; 
Ribosomal Protein L10 
Pseudogene; Similar To 
Ribosomal Protein L10 
157.248 N N N 
BC102970 hsbp1 Heat Shock Factor Binding Protein 1 156.888 Y Y Y 
BC102292 NDUFS4 
Nadh Dehydrogenase 
(Ubiquinone) Fe-S Protein 
4, 18Kda (Nadh-Coenzyme 
Q Reductase) 
156.337 Y Y Y 
BC103431 ELP2P Endozepine-Like Peptide 2 Pseudogene 156.076 N N Y 
BC120463 MGC151969 Uncharacterized Protein Ensp00000334415 Homolog 156.043 N N Y 
AY911366 rps11 Ribosomal Protein S11 155.631 Y Y Y 
S70447 GI:7579921 
F1Fo-ATP synthase 
complex Fo membrane 
domain f subunit 
155.371 Y Y Y 
BC109581 DYDC1 Dpy30 Domain Containing 1 154.473 Y Y Y 
BC111293 LOC780805 Hypothetical Protein Loc780805 152.434 Y Y Y 
BC146140 Dydc2 Dpy30 Domain Containing 2 152.001 N N Y 
DQ347605 LOC782668 Ribosomal Protein L6 151.466 Y Y Y 
AB098890 ORCS10052 Bos Taurus Mrna For 151.332 N N Y 
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Similar To Beta 2-
Microglobulin 
X64836 NDUFB9 
Nadh Dehydrogenase 
(Ubiquinone) 1 Beta 
Subcomplex, 9, 22Kda 
149.949 Y Y Y 
BC102593 MORF4L1 
Similar To Morf-Related 
Gene 15; Mortality Factor 4 
Like 1 
149.417 N N Y 
BC109924 Tspan6 Tetraspanin 6 147.491 N Y Y 
BC103363 KPNA2 Karyopherin Alpha 2 (Rag Cohort 1, Importin Alpha 1) 146.212 N N Y 
DQ347612 rps12 Ribosomal Protein S12 144.865 N N Y 
BC103260 CA2 Y Box Binding Protein 1 144.827 N N N 
BC109577 Cetn4 Centrin 4 144.395 Y Y Y 
BC108180 rps21 Ribosomal Protein S21 142.837 N Y N 
BC111609 Iqcf2 Iq Motif Containing F2 142.552 N N Y 
BC102890 Aif1 Allograft Inflammatory Factor 1 141.932 N Y N 
BC109726 C3H1orf189 
Chromosome 1 Open 
Reading Frame 189 
Ortholog 
141.298 Y Y Y 
DQ347592 LOC781370 
Ferritin, Heavy Polypeptide 
1; Similar To Ferritin Heavy 
Chain; Similar To Ferritin, 
Heavy Polypeptide 1 
140.117 Y Y Y 
BC103298 CCT2 Chaperonin Containing Tcp1, Subunit 2 (Beta) 140.009 Y Y Y 
AF265669 RPGRIP1 
Retinitis Pigmentosa Gtpase 
Regulator Interacting 
Protein 1 
139.66 N N Y 
AF164025 RNASE6 Ribonuclease, Rnase A Family, K6 138.861 Y Y Y 
BC102535 TPPP2 
Tubulin Polymerization-
Promoting Protein Family 
Member 2 
138.018 N N Y 
BC102655 LRRC67 Leucine Rich Repeat Containing 67 137.872 Y Y Y 
BC146224 QTRTD1 
Queuine Trna-
Ribosyltransferase Domain 
Containing 1 
137.523 N N N 
BC148911 TRDN Triadin 137.457 N N N 
BC111170 C10H15orf23 Chromosome 15 Open Reading Frame 23 Ortholog 137.17 N N Y 
BC111202 ilf2 Interleukin Enhancer Binding Factor 2, 45Kda 136.727 N N Y 
BC108198 PRM3 Bos taurus protamine 3, mRNA 136.117 N N N 
BC102492 LOC616936 Male-Enhanced Antigen 1 135.939 N N N 
BC102230 Rnf181 Ring Finger Protein 181 135.888 N N N 
BC102391 PSMC2 
Proteasome (Prosome, 
Macropain) 26S Subunit, 
Atpase, 2 
135.115 N Y N\ 
BC103021 LOC785297 Ferritin, Light Polypeptide 134.371 Y Y Y 
BC110226 C20orf111 Hypothetical Protein Loc510457 134.345 N N Y 
AY911377 LOC785455 
Similar To Thymosin, Beta 
4; Thymosin Beta 4, X-
Linked 
134.314 N N Y 
BC111643 IMAGE:8018076 Bos taurus cDNA clone IMAGE:8018076 134.23 N N Y 
BC140514 CSDE1 Cold Shock Domain Containing E1, Rna-Binding 134.098 Y Y Y 
BC102325 ARL4A Adp-Ribosylation Factor-Like 4A 133.928 N N N 
AF013213 LOC789867 Eukaryotic Translation Elongation Factor 1 Alpha 1 133.722 Y Y Y 
BC119912 C22H3ORF19 Chromosome 3 Open Reading Frame 19 Ortholog 132.945 Y Y Y 
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BC114202 SON Son Dna Binding Protein 132.028 Y Y Y 
BC114038 LOC540061 Hypothetical Loc540061 131.713 Y Y Y 
BC109696 Image:8061225 Bos Taurus Cdna Clone Image:8061225 131.694 N N Y 
DQ347583 myl6 
Myosin, Light Chain 6, 
Alkali, Smooth Muscle And 
Non-Muscle 
131.028 Y Y Y 
BC112612 Dnajc5b 
Dnaj (Hsp40) Homolog, 
Subfamily C, Member 5 
Beta 
130.665 Y Y Y 
X64897 Ndufa4 
Nadh Dehydrogenase 
(Ubiquinone) 1 Alpha 
Subcomplex, 4, 9Kda 
130.65 N N Y 
BC109715 MGC:134272 Bos taurus cDNA clone MGC:134272 130.387 N N N 
X64898 LOC781609 
Nadh Dehydrogenase 
(Ubiquinone) 1 Beta 
Subcomplex, 4, 15Kda 
130.066 Y Y Y 
AY911370 LOC786773 Ribosomal Protein L26 129.524 Y Y Y 
BC114805 SPATA3 Spermatogenesis Associated 3 129.437 N N Y 
BC102311 FILIP1L Filamin A Interacting Protein 1-Like 129.251 N N Y 
AY911320 Cox7c Cytochrome C Oxidase Subunit Viic 128.463 Y Y Y 
BT021019 Naca 
Nascent Polypeptide-
Associated Complex Alpha 
Subunit; Similar To 
Nascent-Polypeptide-
Associated Complex Alpha 
Polypeptide 
127.487 Y Y Y 
AF100170 AKAP4 A Kinase (Prka) Anchor Protein 4 126.623 Y Y Y 
BC120019 MLLT11 
Myeloid/Lymphoid Or 
Mixed-Lineage Leukemia 
(Trithorax Homolog, 
Drosophila); Translocated 
To, 11 
126.453 N Y N 
BC122782 LOC781500 Hypothetical Protein Loc781500 126.357 N N Y 
BT030513 Rpn2 Ribophorin Ii 126.355 Y Y Y 
AB099075 LOC784061 
Similar To 60S Ribosomal 
Protein L21; Similar To 
Ribosomal Protein L21; 
Ribosomal Protein L21 
125.979 Y Y Y 
BC120104 C1H3orf38 Chromosome 3 Open Reading Frame 38 Ortholog 125.625 Y Y Y 
BC140633 IMAGE:8190785 
Bos taurus platelet-
activating factor 
acetylhydrolase, isoform Ib, 
alpha subunit 45kDa, 
mRNA 
125.591 Y Y Y 
BC105172 STON1-GTF2A1L Ston1-Gtf2A1L Readthrough Transcript 125.133 Y Y Y 
BC102090 rps3 Ribosomal Protein S3 124.907 N N N 
AB099047 LOC531679 Ribosomal Protein 17-Like 123.815 N Y N 
AB434936 TERF2 Telomeric Repeat Binding Factor 2 123.541 Y Y Y 
BC108202 ube2b 
Ubiquitin-Conjugating 
Enzyme E2B (Rad6 
Homolog) 
123.39 N N Y 
BC109731 C16H1orf100 
Chromosome 1 Open 
Reading Frame 100 
Ortholog 
123.238 Y Y Y 
BC111270 srp54 Signal Recognition Particle 54Kda 123.224 Y Y Y 
BC126821 Upf2 
Upf2 Regulator Of 
Nonsense Transcripts 
Homolog (Yeast) 
122.278 N N N 
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AF144764 timp2 Timp Metallopeptidase Inhibitor 2 121.825 N N N 
BC102670 MGC127695 Hypothetical Protein Mgc127695 121.633 Y Y Y 
BC148013 RPL14 Bos Taurus Ribosomal Protein L14 120.553 Y Y Y 
BC112887 IMAGE:8009582 
Bos taurus ribosomal 
protein S27 
(metallopanstimulin 1), 
mRNA 
120.098 N N N 
BC110187 fhl5 Four And A Half Lim Domains 5 119.147 Y Y Y 
BC116058 KCMF1 Potassium Channel Modulatory Factor 1 118.853 N N Y 
DQ347593 LOC781370 
Ferritin, Heavy Polypeptide 
1; Similar To Ferritin Heavy 
Chain; Similar To Ferritin, 
Heavy Polypeptide 1 
117.121 Y Y Y 
AB098931 rps8 Ribosomal Protein S8 116.998 N N Y 
BC109560 LOC784487 
Ribosomal Protein L7; 
Similar To Ribosomal 
Protein L7; Similar To 60S 
Ribosomal Protein L7 
116.859 N Y N 
BC109745 LOC528549 
Similar To Dnaj (Hsp40) 
Homolog, Subfamily B, 
Member 3 
116.751 N N N 
BC150005 LSM2 
Lsm2 Homolog, U6 Small 
Nuclear Rna Associated (S. 
Cerevisiae) 
116.734 N N Y 
BC111147 LOC786899 
Similar To Gtpase 
Activating Protein 
Testicular Gap1; 
Hypothetical Loc786899; 
Hypothetical Protein 
Mgc134093 
116.682 Y Y Y 
BC103454 mrps36 Mitochondrial Ribosomal Protein S36 116.104 Y Y Y 
AB098752 LOC782525 
Eukaryotic Translation 
Elongation Factor 1 
Gamma; Similar To 
Eukaryotic Translation 
Elongation Factor 1 Gamma 
116.059 Y Y Y 
BC110254 TES 
Testis Derived Transcript (3 
Lim Domains); Similar To 
Testis Derived Transcript 
115.614 N N N 
BC111209 pdhA2 Pyruvate Dehydrogenase (Lipoamide) Alpha 2 114.458 N N Y 
BC109677 FXR1 
Fragile X Mental 
Retardation, Autosomal 
Homolog 1 
114.322 Y Y Y 
BC116167 FAIM2 Fas Apoptotic Inhibitory Molecule 2 112.984 N N Y 
BC112616 Trim59 Hypothetical Loc540154 112.836 Y Y Y 
BC102601 ropn1l Ropporin 1-Like 112.278 N N Y 
BC105363 YBX1 Y Box Binding Protein 1 112.262 N N Y 
BC146060 THAP7 
Tubulin, Alpha 1A; Tubulin, 
Alpha 1B; Similar To 
Alpha-Tubulin I; Thap 
Domain Containing 7 
112.181 N N N 
AF541971 DDX4 Dead (Asp-Glu-Ala-Asp) Box Polypeptide 4 111.38 Y Y Y 
BC114188 LOC507141 Ce5 Protein-Like 110.65 Y Y Y 
BC108246 MGC133632 Hypothetical Protein Loc614279 110.389 N N Y 
BC110170 CSNK2B Casein Kinase 2, Beta Polypeptide 110.244 N N Y 
BC109563 TRYX3 Trypsin X3 110.204 Y Y Y 
BC102081 DAD1 Defender Against Cell Death 1 110.078 Y Y Y 
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X55389  F1-ATPase mRNA for F1-ATPase gamma-subunit 110.066 N N Y 
BC109599 ADORA3 Adenosine A3 Receptor 109.351 Y Y Y 
BC102328 SNRPB2 
Small Nuclear 
Ribonucleoprotein 
Polypeptide B'' 
109.087 N N Y 
BC109851 Asb17 Ankyrin Repeat And Socs Box-Containing 17 108.906 Y Y Y 
BC108243 NDUFA5 
Nadh Dehydrogenase 
(Ubiquinone) 1 Alpha 
Subcomplex, 5, 13Kda 
108.605 Y Y Y 
AY911358 LOC781565 Ribosomal Protein S6 108.563 Y Y Y 
BC110237 Mlec Malectin 108.544 N N Y 
BC110212 LOC786673 
Atp Synthase, H+ 
Transporting, Mitochondrial 
F0 Complex, Subunit B1 
108.505 Y Y Y 
BC109625 Gkap1 G Kinase Anchoring Protein 1 108.462 Y Y Y 
BC140615 ADAM3A Adam Metallopeptidase Domain 3A (Cyritestin 1) 108.146 Y Y Y 
BC102873 Fau 
Finkel-Biskis-Reilly Murine 
Sarcoma Virus (Fbr-Musv) 
Ubiquitously Expressed; 
Similar To Ubiquitin-
Like/S30 Ribosomal Fusion 
Protein 
108.13 N N N 
BC102656 IMAGE:30956887 Bos taurus pituitary tumor-transforming 1, mRNA 107.717 Y Y Y 
AB373012 CYP1B1 
Cytochrome P450, Family 
1, Subfamily B, Polypeptide 
1 
107.159 Y Y Y 
BC102135 BZW1 Basic Leucine Zipper And W2 Domains 1 105.11 Y Y Y 
BT030749 LOC506261 
Similar To 14-3-3 Protein 
Theta (14-3-3 Protein Tau) 
(14-3-3 Protein T-Cell) 
(Protein Hs1) 
105.009 N N Y 
BC111628 IMAGE:8019171 Bos taurus cDNA clone IMAGE:8019171 104.983 Y Y Y 
BC109721 INSL6 Bos taurus insulin-like 6, 104.965 N N Y 
BC126695 KLHL10 Kelch-Like 10 (Drosophila) 104.86 N N Y 
BC112511 VTI1B 
Vesicle Transport Through 
Interaction With T-Snares 
Homolog 1B 
103.334 N N Y 
BC102885 Paip2 Poly(A) Binding Protein Interacting Protein 2 103.312 N N N 
AB098765 FTH1 mRNA for similar to ferritin H subunit 103.092 N N Y 
BC108215 RTF1 Rtf1, Paf1/RNA polymerase II complex component 102.78 N N Y 
BC111179 PSMG2 
Proteasome (prosome, 
macropain) assembly 
chaperone 2 
102.639 N Y N 
BC133582 cnot1 Ccr4-Not Transcription Complex, Subunit 1 102.582 Y Y Y 
BC109747 Hemgn Hemogen 102.453 Y Y Y 
AB098753 LOC781609 Similar To B15 Subunit Of The NADH 102.178 Y Y Y 
BC102499 naa38 
Lsm8 Homolog, U6 Small 
Nuclear Rna Associated (S. 
Cerevisiae) 
100.954 N N Y 
BC109698 FUNDC2 FUN14 domain containing 2 100.902 N N Y 
HQ423186 BBD126 Bos Taurus Beta-Defensin 126 Mrna 100.859 Y Y Y 
AF307320 RPS28 ribosomal protein S28-like protein mRNA 100.799 N N N 
BC109495 WDR61 WD repeat domain 61 100.679 N N Y 
BC102453 STMN1 Stathmin 1/oncoprotein 18 100.645 N N Y 
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BC126794 LYZL1 Lysozyme-Like 2 100.291 Y Y Y 
BC112727 CCDC91 Coiled-coil domain containing 91 100.177 N N Y 
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Abstract 
 Spermatozoal mRNA transcripts can reflect spermatogenic gene expression and 
therefore may have potential as accurate markers for sire fertility.  The goal of this study 
was compare the transcript profiles of lower fertility (Conception Rate scores (CR) -2.9 
to -0.4) and higher fertility (CR 1.8 to 3.5) sire spermatozoa using Ribonucleic Acid 
Sequencing (RNA-Seq).  A total of 5,366 transcripts and 3,227 transcripts were identified 
in the lower and higher fertility populations respectively.  Common transcripts between 
the two populations were identified (2,422 transcripts) while 2,944 transcripts were 
unique to the lower fertility populations and 805 transcripts were unique to the higher 
fertility population.  Gene ontology analysis for transcripts common between the 
populations revealed the most represented Biological Processes (BP) were translation, 
protein localization, and proteolysis while categories differed for transcripts unique to 
each population.  Differential expression of transcripts between the two populations 
identified 36 transcripts that were uniquely expressed between the lower and higher 
fertility populations (Cuffdiff analysis) and 432 transcripts with elevated expression in 
the lower fertility sires compared to 141 transcripts with elevated expression levels in the 
higher fertility sires (Ratio analysis).  Candidate fertility spermatozoal transcripts were 
identified and four transcripts, GTSF1, PRM2, TNP1 and COX7C have a negative 
correlation with sire fertility.  A number of spermatozoal transcripts varied across 
individual sires. Using high-throughput sequencing, candidate spermatozoal transcripts 
were identified for further study as potential markers for sire fertility.   
Key Words: RNA-Seq, spermatozoa, bovine, mRNA 
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Introduction 
 Male subfertility is a contributing factor to the reproductive efficiency of 
livestock production.  The range of dairy sire fertility exceeds the variation in fertility 
measured in females suggesting that male fertility can be a critical factor in both low and 
high herd fertility.  Accurate sire ranking by fertility is difficult with current fertility 
assays (Flowers, 2013).  Conventional methods of evaluating the fertilizing potential of 
bull semen typically measure compensable traits such as motility, morphology, and 
concentration, that can be compensated for in artificial insemination (AI) by increasing 
sperm numbers.  However, these evaluations are inadequate for assessing the variation in 
fertility typically found among individuals (Foote, 2003; Kastelic, 2013).  Conventional 
semen analysis can often detect sub-fertile animals but is unsuccessful in detecting 
differences in fertility amongst individuals with average and above average fertility 
(Gadea et al, 2004; Kastelic and Thundathil, 2008).  Inclusion of uncompensable sperm 
traits, traits that impact successful fertilization and early embryonic development, such as 
DNA fragmentation, in multi-parameter sire fertility assays have improved the accuracy 
of sire fertility rankings (Omran et al, 2013).  Although fertility assays have been 
improved, in vivo fertility scores have not been mirrored by in vitro assays to date.  It is 
likely that a number of traits need to be evaluated concurrently to get an accurate 
assessment of sire fertility (Omran et al, 2013). More precise fertility tests incorporating 
additional sperm traits are necessary to help ensure that the most fertile males are used 
for AI to improve herd pregnancy rates. 
In addition to the paternal genome, transcriptionally- and translationally-silent 
spermatozoa also carry a subset of RNA that contain coding and non-coding RNAs as 
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well as rRNAs (Hamatani, 2012; Card and Anderson et al., 2013; Sendler et al, 2013).    
Estimates from various species have identified approximately 6,000 mRNAs (nuclear and 
mitochondrial) and ribosomal RNAs in the spermatozoal transcript profile (Ostermeier et 
al., 2002; Gilbert et al., 2007; Das et al., 2010; Card and Anderson et al., 2013; Das et al., 
2013; Sendler et al., 2013).  Although most transcripts appear to be degraded, full-length 
sperm mRNAs with the potential to be translated into functional protein are also present 
(Ostermeier et al., 2005; Card and Anderson et al., 2013). These full-length mRNAs are 
interesting targets for further study as they are potentially critical for early embryonic 
development.   
Due to the lack of transcription in spermatozoa, the transcripts present represent 
spermatogenic gene expression including past efficiencies and therefore may be useful as 
a “fingerprint” of past spermatogenic events (Ostermeier et al., 2002; Lambard et al., 
2004; Ostermeier et al., 2005; Platts et al., 2007; Lalancette et al., 2009).   Spermatozoal 
transcripts associated with the ubiquitin-proteosome pathway, acrosome formation, and 
proper tail formation have different expression levels between normal semen and 
teratozoospermic samples (Platts et al., 2007).  Spermatid and spermatocyte specific 
transcripts are also absent in teratozoospermatozic samples thus indicating errors in the 
later stages of spermatogenesis (Platts et al., 2007). The spermatozoal RNA population 
can reveal the success or failure of past spermatogenic events therefore errors in 
spermatogenesis could be detected through transcript profiling of spermatozoa, aiding in 
fertility assessment.  
 Previously, differences in bovine spermatozoal transcripts between sires with 
different fertility have been reported (Gilbert et al., 2007; Lalancette et al., 2008; 
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Feugang et al., 2010). Differentially expressed transcripts have been identified when 
utilizing hybridization-based microarray analysis to compare spermatozoal transcripts 
from higher and lower fertility bulls (Gilbert et al., 2007; Lalancette et al., 2008; Feugang 
et al., 2010). Additionally, individual spermatozoal transcripts have been individually 
correlated with sire fertility. A positive correlation with fertility was found with AK1, 
IB5, DOPPEL, NGF, TIMP2, PLCZ1, CRISP2, and PEBP1 while CCT8 and PRM2 have 
a negative correlation with fertility (Arangasamy et al., 2011; Lalancette et al., 2008; 
Kasimanickam et al., 2012).  Due to the limitations of the microarray approach that lead 
to the identification these individual transcripts, the comparison of the spermatozoa 
transcript profiles among sires of different fertility is incomplete.  
The objective of this study was to sequence and compare the complete 
spermatozoal transcript profiles of lower and higher fertility sires with RNA-Seq.  RNA-
Seq has several advantages over hybridization-based methods, including microarrays, 
namely the ability to accurately assess absolute transcript levels, full-length transcripts, 
and novel splicing/exon discovery (Wang et al., 2009; Werner, 2011).  It is hypothesized 
that the composition of spermatozoal transcript profiles will differ with fertility and select 
transcripts will show correlations with fertility score. This study will provide a greater 
understanding of the potential utility of spermatozoal mRNA as a diagnostic tool for 
assessing sire fertility.   
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Materials and Methods 
Spermatozoa 
 Cryopreserved semen straws were obtained from Genex Cooperative Inc. 
(Shawano, WI). Semen from four bulls (-2.9 to -0.4 CR) was used to create the lower 
fertility amplified cDNA pool and four separate bulls (1.8 to 3.5 CR) were used for the 
higher fertility pooled sample submitted for RNA-Seq and subsequent validation by 
qPCR.  For variation of selected transcripts in individual sires, spermatozoal RNA, from 
9 additional bulls with varying CR scores (-6.7, -5.5, -3.5, -3.4, -2.7, 0.1, 0.8, 2.2, 3.6), 
was used.  
 
RNA Isolation 
 For all bulls, two straws were thawed in a 37° water bath for one minute and 
subsequently washed in 4 mL PBS (2 times at 600 x g).  Spermatozoa RNA isolations 
were performed using TRIzol (Sigma Aldrich, St. Louis, MO) as outlined in Card and 
Anderson et al., 2013. The NanoDrop UV/Vis Spectrometer (Thermo Scientific; 
Wilimington, DE) was used to determine RNA concentrations and samples were then 
stored at -80°C.   
 
Double-Stranded cDNA (ds-cDNA) Synthesis and Amplification 
 Equal amounts of spermatozoal RNA from individual sires (to ensure equal 
representation of all sires in the pool) was combined to generate a lower fertility pool and 
a higher fertility pool that were converted to ds-cDNA and linearly amplified for RNA-
Seq and qPCR validation (SMARTer Pico PCR cDNA Synthesis Kit; Clontech, 
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Mountain View, CA).  During cDNA amplification, cycle optimization was performed to 
maintain amplification in the linear phase.  For lower and higher fertility pooled ds-
cDNA samples, 5 µg of each sample was submitted for RNA-Seq. Additional ds-cDNA 
from each pool was used in qPCR validation analysis described below.  
 
RNA-Seq and Analysis 
 Lower and higher fertility spermatozoal ds-cDNA samples were sequenced on a 
Illumina HiSeq 2000 to generate paired-end 100 bp reads (Otogenetics; Norcross, GA).  
All read processing and alignment to the bovine genome (UMD 3.1/bosTau6) via Tophat 
was performed using Galaxy (Giardine et al., 2005; Blankenberg et al., 2010; Langmead 
et al., 2009; Goecks et al., 2010; Trapnell et al., 2012).  The sequencing adapter 
(AGATCGGAAGAGC) was removed from all reads which resulted in the removal of 
1,594,647 reads from high fertility file 1(HF1), 64,282 reads from high fertility file 2 
(HF2), 1,533,238 reads from low fertility file 1 (LF1), and 61,059 included removed due 
to being adapter only reads, reads < 15 nucleotides, and reads with unknown bases (N).  
Over-expressed sequences due to concatemer formation during the amplification of the 
SMARTer II A Oligonucleotide (AAGCAGTGGTATCAACGCAGAGTAA) were 
removed from all file reads.  This removed 5,406,296 reads from HF1, 5,041,856 reads 
from HF2, 4,905,729 reads from LF1, and 5,488,985 reads from LF2. The maximum 
number of mismatches allowed during alignment was two.  Read and post-alignment 
statistics were obtained using analysis from RSeQC (Wang et al., 2012).  Cufflinks 
analysis was performed on aligned reads to determine transcripts present and their 
respective expression levels, denoted as Fragments Per Kilobase of exon per Million 
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fragments mapped (FPKM; Giardine et al., 2005). All raw read files are stored in the 
NCBI SRA database under SRA#XXXXX (http://www.ncbi.nlm.nih.gov/sra).   
 
Gene Ontology Analysis 
 Gene ontology analysis was performed using the DAVID Bioinformatics 
Database (http://david.abcc.ncifcrf.gov/) using three main categories: Biological 
Processes (BP), Molecular Function (MF), and Cellular Component (CC).  Three 
different populations were analyzed: transcripts common between higher and lower 
fertility populations, unique to higher fertility, and unique to lower fertility.   
 
Differential Expression Analysis 
 Differential expression analysis was performed using Cuffdiff (Trapnell et al, 
2012) with a false discovery rate of 5% and a significance value of p < 0.05.  Alternate 
differential expression analysis (Ratio analysis) examined lower fertility:higher fertility 
FPKM ratios and vice versa.  The parameters that were required for a transcript to be 
considered differentially expressed between the populations include FPKM of ≥5 in both 
populations and a minimum 2:1 ratio between FPKM of the two populations.   
 
Polymerase Chain Reaction (PCR) 
 Select fertility candidate transcripts were analyzed via PCR on the lower and 
higher fertility pools and 9 individual bulls with variable CR scores to determine 
individual variation in transcript presence.  PCR cycling conditions are outlined in (Card 
and Anderson et al, 2013) and PCR primers can be found in Table 1.  Along with 
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spermatozoal RNA samples, a testis RNA positive control and a no template negative 
control were included in each experiment.  
 
qPCR 
 qPCR was performed to validate RNA-Seq expression levels (FPKM) and  
transcripts identified by Ratio analysis, as well as to compare transcript levels among 
individual sires for fertility correlation analysis.  Seven transcripts with FPKM ranges 
from (12 - 42,275 for higher fertility; 58 - 28,826 for lower fertility) were run for 
validation qPCRs. For FPKM validation qPCR analysis, standard curves were made for 
all transcripts by serial dilutions of purified cDNA into 8 standard concentrations from 
1x109 to 1x102 copies/ul.  qPCR reactions were run using LightCycler 480 SYBR Green I 
Master Mix Kits (Roche; Indianapolis, IN).  Negative template controls were run with all 
reactions.  All reactions were run in duplicate and performed on the Roche LightCycler 
480 at the Genome Sequencing Center at the University of Rhode Island.  All primers 
used for qPCR reactions can be found in Table 1.  All correlations were determined using 
linear regression analysis using GraphPad Prism 6.0.   
 
Results 
RNA-Seq 
 Sequencing of the higher fertility spermatozoal RNA resulted in 11,832,830 x 2 
paired-end 100-bp reads while lower fertility spermatozoal RNA sequenced 11,434,525 x 
2 paired-end 100-bp reads.  Read and genome mapping statistics can be found in Table 2.   
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High and Low Fertility Transcript Profiles 
 A total of 5,366 transcripts were expressed in lower fertility sires while 3,227 
transcripts were expressed in higher fertility sires (FPKM > 0).  Common transcripts 
between the lower and higher fertility populations were identified (2,422 transcripts) 
while 2,944 transcripts were unique to the lower fertility population and 805 transcripts 
were unique to the higher fertility population (Figure 1). The qPCR expression levels 
showed a high correlation with FPKM values for both high fertility (r2 = .9646) and low 
fertility (r2 = .9485) populations (Figure 2).  The top 10 transcripts expressed, unique to 
high and low fertility populations excluding mitochondrial transcripts can be found in 
Tables 3 and 4.   
 
 
Gene Ontology Analysis  
 Gene ontology analysis was carried out for transcripts common between the two 
fertility groups as well as transcripts unique to each group (Table 5). It is important to 
note that an individual transcript can be classified into multiple ontological categories 
during this analysis.  When examining transcripts common to the lower and higher 
fertility populations (2,422 transcripts), 224 BP, 105 CC, and 84 MF categories were 
represented.  The top three BP categories represented were translation, protein 
localization, and proteolysis.  The top categories differed for transcripts unique to the 
lower and higher fertility transcript profiles. Transcripts unique to the lower fertility 
population (2,930 transcripts), there were 284 BP, 92 CC, and 101 MF categories 
represented.  The top three BP categories represented were transcription, proteolysis, and 
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phosphate metabolic process.  Transcripts unique to the higher fertility population (798 
transcripts) had a total of 148 BP, 74 CC, and 47 MF categories represented.  The top 
three BP represented in this population were oxidation reduction, intracellular signaling 
cascade, and protein localization.   
 
Differential Expression Analysis 
 Two analysis methods were conducted to identify transcripts differentially 
expressed between the lower and higher fertility spermatozoal RNA populations that 
would be potential fertility candidates.  Using Cuffdiff, 36 transcripts were differentially 
expressed between fertility groups (Table 6).  Five transcripts were chosen (DDX4, 
DDX20, PCNA, G2E3, PSMA1; all present in low fertility only) and were validated via 
PCR (Figure 3).  The Ratio analysis revealed 432 transcripts with greater expression in 
the lower fertility population and 142 transcripts with greater expression in the higher 
fertility population (Figure 4, Appendix 1 and Appendix 2). Eight transcripts were chosen 
from this analysis and five of the eight transcripts were validated by showing a fold 
change consistent with FPKM ratios.   
 
Individual sire variation of spermatozoal mRNA presence 
 To determine if spermatozoal transcript presence varied among sires, candidate 
fertility transcripts (n=27) were run on 9 individual bulls across a range of CR scores -6.7 
to 3.6 (Table 7).  These transcripts were identified from differential expression analysis 
(Cuffdiff and Ratio analysis) and previously published spermatozoal transcripts.  Only 
one transcript, PRM1, was present in all 9 individuals.  Two transcripts, PRM2 and 
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TNP1, were amplified in 8 of the 9 bulls.  Eleven transcripts were present in 5 or more 
bulls while the other 16 transcripts were present in less than half of the bulls.  The bull 
with the most transcripts present was the lowest fertility bull that had 17 of the 27 
transcripts.  Transcripts identified from Cuffdiff analysis (n=3; APOABP1, G2E3 and 
PCNA) were only present in 1-2 bulls.  One transcript identified by ratio analysis, 
COX7C was present in 7 of the 9 bulls tested while ATP5J and GPX4 were only present 
in 1 and 2 bulls respectively.  Three transcripts, AKAP4, APOABP1, and BRP were not 
amplified in any bull spermatozoa.  
 
Spermatozoal RNAs identified from previous publications  
 The spermatozoal transcript profiles for both fertility populations were mined for 
the presence of transcripts previously reported to be associated with bull fertility 
(Arangasamy et al, 2007; Feugang et al, 2010; Kasimanickam et al, 2012; Kasimanickam 
et al, 2013).  Only a few of the transcripts examined were identified in the transcript 
profiles reported here including PRM1 and CRISP2 (Table 8).  Additionally, the 
transcripts for spermatozoa fertility proteins were also identified in the transcript profiles; 
many transcripts for these proteins, including PSMA6 and ROPN1, were found in both 
populations with the lower fertility population typically having greater expression FPKM 
values (Table 9).  
 
Individual spermatozoal transcripts and sire fertility 
 To determine if amount of spermatozoal transcripts is correlated with sire fertility, 
12 transcripts (identified from Cuffdiff analysis, Ratio analysis and previous 
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publications) were amplified in an independent population of 9 individual bull 
spermatozoal ds-cDNA samples with fertility scores ranging from CR -6.7 to 3.6 (Table 
10).  Four out of eleven transcripts, PRM2, TNP1, COX7C, and GTSF1 have a negative 
correlation with fertility.  The other 7 transcripts, PRM1, PSMA1, PSMA6, ACRV1, 
SPAG4, ATP5J, and GPX4 showed no significant correlations with fertility.  
 
 
 
Discussion 
 Overall, high-throughput sequencing of spermatozoal transcript profiles for lower 
and higher fertility bulls resulted in transcript profiles with several common transcripts 
(2,422 transcripts) between the two populations.  In previous studies, over 1,700 
transcripts have been shown to be common in spermatozoal RNA populations amongst 
23 fertile human subjects while 96 and 37 transcripts were common between high and 
medium quality semen samples and medium and poor quality semen samples respectively 
(Lalancette et al., 2009; Ostermeier et al., 2005).  When comparing 9 pooled individual 
ejaculates (3,281 transcripts) and one individual (2,780 transcripts), all but four 
transcripts from the individual were found in the pooled sample (Ostermeier et al., 2002).  
Transcripts that are present across individuals and populations are considered stably 
regulated, though their expression levels may vary.  
 Though there are a number of stably regulated transcripts between the two 
populations reported here, there remain a number of differences between fertility groups 
as well, including a number of transcripts unique to each population, differences in 
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expression levels, and variability in prominent gene ontology categories represented by 
each population.  These differences between fertility groups are consistent with previous 
studies in subfertile males using microarrays (Lalancette et al, 2008; Lalancette et al, 
2009; Feugang et al, 2010).  The lower fertility population had a much larger transcript 
profile (greater than 2,000 more transcripts) than the higher fertility populations.  The 
greater number of transcripts in the lower fertility population could be accounted for by 
inefficiencies in translation during spermatogenesis leading to missing essential proteins 
for further development of critical mRNAs/proteins needed for proper fertilization or 
early embryo development (Jodar et al, 2013).  
 In transcripts unique to higher fertility sires there was a prevalence of 
transcription and RNA processing as well as cell proliferation based transcripts. The 
highly represented transcripts unique to the lower fertility population were transcripts 
associated with phosphate metabolic processes and a group of categories involving 
protein production/processing.  A focus on transcription and RNA processing unique to 
higher fertility population could have an additive effect to common transcripts in making 
sure that an excess of essential RNAs are produced in early stages of spermatogenesis.  
These RNAs might be necessary to protein production as sperm develop or required in 
the egg at fertilization or during early embryonic development.  Having a much larger 
focus on protein processing in the low fertility population could be indicative of greater 
inefficiency in protein formation in spermatozoa as many transcripts appear to be leftover 
that may have been essential for protein formation.  Though transcripts are involved in 
translation and related processes, some overarching error in translational machinery could 
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be inhibiting these from being translated and usable to aid further protein 
formation/processing.   
 Two methods of differential transcript expression were validated and identified 
approximately 600 transcripts that differed in expression between the two fertility 
populations. Further validation of transcripts identified with the Cuffdiff analysis found 
that most transcripts were only expressed in a few bulls and of the transcripts analyzed, 
none were correlated with fertility.  This is likely due to the fact that Cuffdiff analysis for 
this dataset only reported transcripts unique to each population, thus only represented by 
a maximum of 4 out of 8 bulls that were in the RNA-Seq samples.  To determine if a 
difference in transcript abundance was present with transcripts expressed in both the 
lower and higher fertility populations, we also compared expression levels by Ratio 
analysis.  Transcripts chosen from this analysis were tested in 9 individual sires and some 
transcripts were only expressed in a few bulls (SPAG4, ATP5J and GPX4) while others 
(PSMA6, COX7C and PRM1) were expressed in most, if not all, sires analyzed.   Both 
analysis methods identified further fertility transcript candidates and more can be 
extracted from the datasets for presence and quantification analysis.    
 Significant variation of transcript presence among sires was prevalent with several 
transcripts only being expressed in a few individuals.  While some transcripts were 
conserved, individual variation in transcript presence exists. Many spermatozoal 
transcripts are found as stably regulated, in terms of being commonly expressed, across 
individuals while there remains a lot of individual variation in terms of expression 
quantity as well as some transcripts that are not expressed in all individuals (Ostermeier 
et al, 2005; Lalancette et al, 2009).  Of the 27 transcripts tested for presence by PCR 
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analysis, only one transcript (PRM1) was expressed in all individuals.  It has been shown 
that transcript expression level differences can be indicative in fertility but it is evident 
with these results that there is potential to compare individuals for transcript presence for 
those transcripts that are not consistent across the population.  There is a great deal of 
interest in stably regulated transcripts, such as PRM1 in this study, because any 
transcripts that are present in all individuals that show a correlation with fertility are 
candidates for a potential fertility assay.  To be able to detect subtle differences in fertility 
amongst sires, one must be able to test expression levels for a transcript that is present in 
all individuals.  PRM1 did not show a correlation with fertility when compared across 9 
individuals but there is the potential for other stably regulated transcripts in our 
differential expression analysis that could be further explored for possible correlations 
with fertility.  Though transcripts present in only some bulls can offer insight into 
fertility, a stably regulated transcript that shows a very high correlation with fertility 
score would be optimal for ranking individuals across an entire population.        
 Other than PRM1, ten more transcripts were chosen from differential expression 
analysis methods and previous literature for qPCR analysis to examine possible 
correlations with fertility (Table 10).  Four of these genes, TNP1, GTSF1, PRM2, and 
COX7C have a negative correlation with fertility.  Other transcripts tested, PSMA1, 
PSMA6, ACRV1, SPAG4, ATP5J, and GPX4 did not have significant linear correlations 
with sire fertility.  Many of these transcripts that did not show correlations with fertility 
were not present, or present at very low levels, in some of the individuals.  Cytochrome 
oxidase subunit 7c (COX7C) is one of many subunits involved in the terminal step in the 
electron transport chain and has been found in the inner mitochondrial membrane, aiding 
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in the synthesis of ATP (Seelan et al, 1997).  We hypothesize that the correlation with 
fertility may be an indication of sperm mitochondrial function; in turn potentially have an 
effect on motility.  Transition protein 1 (TNP1) is one of two transition proteins that 
replace the histones that DNA is bound to during spermatogenesis before protamines 
replace the transition proteins to compact the DNA much tighter than originally via 
histones (Oliva, 2006).  Correlation of TNP1 with fertility may indicate inefficient 
translation, and therefore reduced DNA compaction, during spermatogenesis.  
Gametocyte-specific factor 1 (GTSF1) has been found in murine testes and knockout 
studies to be essential for spermatogenesis as a retrotransposon suppressor (Yoshimura et 
al., 2009).     
  A number of transcripts have shown positive correlations of the mRNA levels and 
fertility in previous studies including AK1, IB5, DOPPEL, NGF, TIMP2, PLCZ1, 
CRISP2, PEBP1, CD36, CENPA, ADIPO, ADIPOR1, and ADIPOR2 (Feugang et al., 
2010; Arangasamy et al., 2011; Kasimanickam et al., 2012; Kasimanickam et al., 2013).  
Select transcripts including CCT8 and PRM2 have negative correlations with fertility in 
bulls in previous publications (Lalancette et al., 2008; Arangasamy et al., 2011).  In this 
study, none of the previously identified differentially expressed transcripts were 
identified with the Cuffdiff analysis.  Three previously identified transcripts (PLCZ1, 
CRISP2, PEBP1) were identified by the Ratio analysis.  However, it is important to keep 
in mind factors that differed among studies including different isolation/amplification 
methods, a different population of bulls, and differences in fertility ranges amongst the 
populations.  As we have seen in this study, variation in transcript presence or amount is 
prevalent between individual bulls, which could lead to differences between our data and 
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previously published data as individuals studied as well as methods utilized differ 
between studies.  PLCZ1 is crucial in initiation of the Ca2+ waves in the oocytes at 
fertilization that triggers the resumption of meiosis, initiating early embryonic 
development.  This transcript is particularly interesting because it is spermatozoa-specific 
but has been shown to be transferred to the oocyte at fertilization and even has been 
found to be translated post-fertilization (Swann et al., 2006).  Our data suggests no 
significant correlation with PLCZ1 and fertility but this is a candidate that shows some 
promise moving forward in looking at fertilizing potential of spermatozoa.  Both CRISP2 
and PEBP1 are associated with spermatozoa capacitation and could contribute to the 
spermatozoal RNA population predicting sperm function (Arangasamy et al, 2010).    
 A number of other spermatozoa mRNAs have been explored for having potential 
links to fertility in other species.  Though a potential link to fertility has been 
hypothesized in humans, these transcripts were not expressed in sire fertility 
spermatozoal transcript profiles.  Both PSG1 and HLA-E were found to have mRNA 
levels significantly higher in fertile men than infertile men (Avendano et al., 2009).  
Proteins for these genes were not found in spermatozoa, however the transcripts were 
found to be present in the zygote more than 24 hours after fertilization.  PSG1 is 
hypothesized to aid in protection from the maternal immune system while HLA-E helps 
avoid death from NK cells.  Both of these transcripts could be key for early embryonic 
development and maintenance of pregnancy in humans.  
 Although the Cuffdiff and Ratio analysis did not identify PRM1 and PRM2 as 
differentially expressed between the two fertility populations, we investigated these 
transcripts further because other studies have found that protamine mRNA and protein 
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levels had positive correlations with spermatozoa concentration, motility, fertilization 
potential, and embryo quality (Kempisty et al., 2007; Depa-Martynow et al., 2012).  
During spermatogenesis, the protamines replace the histones and compact DNA tighter.  
This in turn, protects the DNA from any damage as well as halting transcription.  
Improper compaction may leave DNA open to damage, which can cause various defects 
including the inability to fertilize. Infertile males have increased levels of protamine 
mRNA and decreased protamine protein levels as well as abnormal protamine 
1/protamine 2 ratios (Aoki et al., 2006a; Aoki et al., 2006b).  This result offers the 
possibility that improper translation of protamines leads to spermatozoa that do not offer 
the ability to fertilize due to proper compaction of the DNA.   
 In this study, the PRM1 levels were increased in the higher fertility population 
(FPKM = 42276) versus the lower fertility population (FPKM = 28826).  The same trend 
was evident with PRM2 with the higher fertility (FPKM = 98) have slightly higher levels 
than the lower fertility population (FPKM = 78).  Though neither of these appeared in 
either differential expression analysis method, these trends agree with most previously 
published data in that protamine transcript levels are higher in individuals of higher 
fertility.  Both protamines were further examined utilizing qPCR on 9 individuals with a 
range of fertility scores via linear correlation analysis.  PRM1 showed no correlation (r2 = 
0.36; p = 0.08) to CR score while PRM2 showed a negative correlation with CR score (r2 
= 0.60; p = 0.01).  PRM2 has previously been shown to have higher expression levels in 
lower fertility bulls (Lalancette et al, 2008), which is in agreement with these results.  
This is an interesting candidate to show a connection with fertility, as PRM2 protein is 
not found in bulls. It appears that protamines have the potential to show the ability to 
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predict fertility based on this and previous studies, but further exploration is needed, 
especially in PRM2 levels. 
 Some proteomic studies have been performed to evaluate protein differences 
amongst bulls of varying fertility.  Higher fertility animals have higher protein expression 
levels for proteins associated with spermatogenesis, cell motility, energy metabolism, and 
cell communication (Peddinti et al., 2008).  A number of proteins are expressed at higher 
levels in high fertility bulls including ATPSB, ENO1, ASPP2, GPX4, AHSG, AKI, and 
PEBP1.  Some proteins, on the other hand, have lower expression levels in high fertility, 
including CCT5, CCT8, ELSPBP1, PSMA6, BSP1, VDAC1, UQCRC2, and 
ROPPORIN-1 (D’Amours et al., 2010; Park et al., 2012).  In this study, a number of the 
transcripts for these proteins were present in the lower and higher fertility populations 
(Table 8).  All of the transcripts that were present in both populations were at higher 
levels in the lower fertility population.  Those transcripts that are at increased levels in 
the lower fertility population in this study and have been shown to be increased protein 
levels in high fertility animals, such as GPX4, could be an example of a transcript that 
undergoes incomplete or insufficient translation in lower fertility animals.  Coupling 
RNA-Seq data with proteomic data can hopefully provide more insight into silencing or 
translation of transcripts in sires with varying fertility ratings.   
 Spermatozoa RNA has been proposed as a potential diagnostic tool for fertility 
due to its representation of proper spermatogenesis but it is also hypothesized to play a 
role in early embryonic development. Spermatozoal transcripts can be delivered to the 
oocyte at fertilization and persist for hours in the zygote (Ostermeier et al., 2004).  
PLCZ1 is the only transcript thus far that has proven to be translated post-fertilization in 
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the zygote (Swann et al., 2006).  This shows how there is the potential for full-length 
transcripts that are delivered by spermatozoa to have function post-fertilization.  A 
number of full-length transcripts have been found in spermatozoa showing the potential 
for some of these to have early embryonic function if they are to be translated into protein 
post-fertilization (Ostermeier et al., 2005; Card and Anderson et al., 2013).   
 This study is the first to directly sequence and compare the complete 
spermatozoal transcript profiles of sires with different fertility.  Using this approach, 
similarities and differences in transcript presence were identified and a correlation of 
individual transcripts with fertility was found.  This data offers insight into a number of 
potential candidates for further investigation as potential markers for measuring fertility.   
Although fertility assays have been improved, in vivo fertility scores have not been 
mirrored by in vitro assays to date. It is likely that a number of traits need to be evaluated 
concurrently to get an accurate assessment of sire fertility (Omran et al, 2013). Inclusion 
of spermatozoal RNA abundance in multi-parameter sire fertility assays may improve 
accuracy of sire fertility rankings to ensure that the most fertile sires are used for AI to 
improve herd pregnancy rates. 
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Figures 
 
Figure 1. Common and unique transcripts in lower (A) and higher (B) fertility 
populations.  
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Figure 2. Correlation of qPCR transcript copy number and RNA-Seq FPKM for lower 
and higher fertility populations. Axes are base 10 log scale. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 107 
Figure 3. Differentially expressed transcripts (Cuffdiff analysis) in T = testis, H = higher 
fertility ds-cDNA, L = lower fertility ds-cDNA, N = no template control.   
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Figure 4. Differentially expressed transcripts (Ratio analysis) between higher and lower 
fertility populations.  
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T
able 1.  B
ovine prim
er sequences 
 
 
 
 
 
Prim
er Sequences 
 
G
ene Sym
bol 
G
enbank ID
 
  
Forw
ard 
R
everse 
Product Size 
(bp) 
AC
RV1 
B
C
109966 
qPC
R
 
5'- TG
A
A
C
A
G
G
C
C
G
TA
G
G
TG
A
A
C
 -3' 
5'- C
A
G
C
TTA
A
TG
G
TG
G
G
C
C
TG
A
 -3' 
174 
AK
AP4 
A
F100170 
Ind 
5'- A
G
G
G
G
TC
A
G
TG
TG
C
C
TTTTC
 -3' 
5'- TC
C
A
G
A
C
G
TA
G
G
C
TC
TG
A
G
G
 -3' 
234 
APO
ABP1 
A
Y
528250 
Ind 
5'- C
C
C
TG
A
C
A
C
G
G
A
A
TG
TG
TC
T -3' 
5'- A
G
A
G
A
G
G
C
A
C
TA
A
G
TC
TTTA
TTG
A
 -3' 
80 
ATPIF1 
N
M
_175816  
Ind; R
atio 
5'- C
TTTG
G
C
TC
G
G
A
A
TC
G
G
G
A
G
 -3' 
5'- G
C
C
A
G
C
TG
TTC
TTTA
G
C
A
C
G
 -3' 
132 
ATP5J 
N
M
_174717  
Ind; qPC
R
; R
atio 
5'- C
TTC
C
TG
TC
C
G
G
A
TC
A
C
C
A
T -3' 
5'- TC
C
TC
C
A
G
A
TG
TC
TG
TC
G
C
T -3' 
195 
BRP 
N
M
_001012682 
Ind 
5'- C
C
A
G
G
C
TTTA
G
G
C
A
TC
A
C
C
A
 -3' 
5'- G
G
C
G
C
C
TA
C
TTTG
TC
TC
C
TG
T -3' 
94 
C
C
T8 
N
M
_001033609 
Ind 
5'- TG
G
A
TC
A
G
A
TC
A
TC
A
TG
G
C
A
A
 -3' 
5'- A
G
G
G
TG
C
A
A
G
A
TA
C
A
A
A
C
A
C
A
A
A
A
 -
3' 
202 
C
ETN
2 
N
M
_001038515 
Ind; R
atio 
5'- G
TC
C
G
G
G
A
TG
G
C
C
TC
TA
A
C
T -3' 
5'- TC
C
TG
TTTC
TG
C
TC
TTC
G
G
T -3' 
102 
C
LG
N
 
B
C
103401 
Ind 
5'- A
TC
C
C
TG
A
TG
C
TTC
TG
C
TG
TC
 -3' 
5'- A
TTC
A
C
C
A
C
A
C
C
C
A
A
TC
C
G
A
 -3' 
243 
C
K
S2 
B
C
105331 
Ind 
5'- C
C
TC
G
C
TTC
G
C
TC
TA
G
TC
A
G
 -3' 
5'- A
G
G
A
TG
TG
TG
G
TTC
TG
G
TTC
A
 -3' 
245 
C
M
YC
 
B
C
109848 
Ind 
5'- C
C
A
C
C
TA
G
G
A
G
G
A
G
A
A
A
C
G
 -3' 
5'- A
C
A
G
TTA
A
C
G
TG
TG
A
TA
G
G
TG
A
A
T -3' 
168 
C
O
X7A2 
D
Q
347636 
Ind 
5'- A
A
C
TG
G
C
TG
TG
G
C
TTC
G
TTT -3' 
5'- TG
C
TTTA
TTG
G
TG
G
C
A
G
C
TA
A
 -3' 
204 
C
O
X7C
 
N
M
_175831   
Ind; qPC
R
; R
atio 
5'- G
A
G
G
A
G
G
G
TC
C
A
G
G
G
A
A
G
A
A
TA
 -3' 
5'- TTTC
A
G
C
A
G
TTG
G
TG
TC
TTA
C
T -3' 
129 
C
RISP2 
B
C
109478 
Ind; qPC
R
 
5'- C
G
G
C
C
G
C
TC
TG
C
A
A
C
A
G
A
A
G
 -3' 
5'- G
G
A
A
G
C
A
G
C
A
C
A
G
C
G
G
TC
A
G
A
 -3' 
120 
D
D
X4 
A
F541971 
C
uff 
5'- TC
G
C
A
TG
C
TG
G
A
TA
TG
G
G
TT -3' 
5'- TC
C
C
C
A
G
C
C
A
A
C
C
TTTG
A
A
T -3' 
135 
D
D
X20 
B
C
151337 
C
uff 
5'- G
C
TG
G
C
C
G
TTTTG
G
A
A
C
TTT -3' 
5'- G
C
TTC
A
A
C
C
TC
C
A
C
A
TC
C
C
A
 -3' 
173 
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T
able 1.  B
ovine prim
er sequences (continued) 
D
N
AJB7 
B
C
142060 
Ind 
5'- G
C
A
C
TTA
A
A
TG
G
C
A
C
C
C
A
G
A
 -3' 
5'- TG
G
C
TTA
C
G
G
A
A
TG
TG
A
A
G
C
 -3' 
204 
EEF1G
 
A
B
098752 
Ind; V
al 
5'- A
TC
C
A
G
TTTC
C
G
C
C
A
TG
TG
T -3' 
5'- G
TTG
C
A
A
C
G
C
TC
A
TC
A
C
TG
G
 -3' 
198 
EIF1 
B
C
103170 
Ind; V
al 
5'- A
A
G
G
G
TG
A
TG
A
TC
TG
C
TTC
C
TG
C
T -3' 
5'- A
A
C
TG
G
C
A
TA
TG
TTC
TTG
C
G
C
TG
G
 -3' 
235 
G
2E3 
N
M
_001038671 
C
uff; Ind 
5'- TC
A
C
TG
G
C
A
A
TTTTG
C
G
TC
A
 -3' 
5'- TG
C
A
C
C
TG
C
A
A
A
C
A
G
TC
TC
T -3' 
187 
G
PX4 
N
M
_174770  
Ind; qPC
R
; R
atio 
5'- C
A
A
TG
TG
G
C
C
TC
G
C
A
A
TG
A
G
 -3' 
5'- C
A
TTA
C
TC
C
C
TG
G
C
TC
C
TG
C
 -3' 
140 
G
STM
3 
B
C
112491 
Ind 
5'- TG
TG
C
C
G
TTTTG
A
G
G
C
TTTG
G
A
G
 -3' 
5'- G
G
G
C
C
A
TC
TTG
TTG
TTG
A
C
A
G
G
C
A
T -3' 
112 
G
TSF1 
B
C
102713 
Ind; qPC
R
; R
atio 
5'- C
A
G
G
TTC
C
TC
G
G
G
C
TG
A
A
A
T -3' 
5'- A
C
TA
TG
TTG
C
TTG
C
A
G
G
G
C
T -3' 
239 
H
EM
G
N
 
B
C
109747 
Ind 
5'- C
A
G
C
A
A
G
A
A
A
TG
G
C
TG
TG
C
C
 -3' 
5'- C
A
G
G
TG
C
A
TA
G
G
C
TTC
A
G
G
T -3' 
247 
H
M
G
B4 
B
C
109790 
V
al 
5'- A
G
C
TG
G
TC
G
G
TG
G
TG
C
A
G
G
T -3' 
5'- G
C
A
A
G
C
A
TG
TC
TTC
C
G
G
G
C
 -3' 
167 
PABPC
1 
N
M
_174568  
R
atio 
5'- A
C
A
TG
G
A
TG
A
TG
A
G
C
G
C
C
TT -3' 
5'- TC
TC
A
TC
C
A
C
A
G
C
TTTTTG
TG
C
 -3' 
150 
PC
N
A 
B
C
103068 
C
uff; Ind 
5'- G
A
A
C
C
TC
A
C
C
A
G
C
A
TG
TC
C
A
 -3' 
5'- A
C
G
TG
TC
C
G
C
G
TTA
TC
TTC
A
 -3' 
86 
PLC
Z1 
B
C
114836 
V
al 
5'- C
G
G
G
TG
G
TC
G
G
A
A
TC
C
C
A
C
TC
T -3' 
5'- A
A
TTC
C
C
TG
G
C
TG
C
C
A
A
C
TTTG
T -3' 
194 
PRM
1 
B
C
108207 
Ind; qPC
R
; V
al; R
atio 
5'- A
A
G
A
A
G
A
TG
TC
G
C
A
G
A
C
G
A
A
G
G
A
G
 -3' 
5'- A
C
A
G
G
TG
G
C
A
TTG
TTC
G
TTA
G
C
A
G
 -3' 
228 
PRM
2 
N
M
_174157 
Ind; qPC
R
 
5'- A
TG
C
G
G
A
A
G
G
C
A
G
C
TC
TA
A
G
 -3' 
5'- C
TC
A
A
G
A
TC
TC
G
TG
G
G
C
TC
C
 -3' 
109 
PSM
A1 
B
C
102216 
C
uff; qPC
R
 
5'- TG
G
TTA
A
G
C
A
TG
G
TC
TG
C
G
T -3' 
5'- G
G
TTG
A
G
TA
G
G
C
TG
TG
C
C
TT -3' 
187 
PSM
A6 
B
C
110260 
Ind; qPC
R
 
5'- A
C
A
G
TG
G
A
A
A
C
TG
C
G
A
TTA
C
A
TG
C
C
 -3' 
5'- A
C
A
G
G
C
A
A
G
TG
G
C
G
TC
A
C
G
G
 -3' 
205 
SEC
61G
 
B
C
102186 
V
al 
5'- G
C
A
G
A
C
G
C
G
G
A
G
C
A
G
A
C
A
TC
A
 -3' 
5'- A
G
C
G
A
A
TC
C
TA
TTG
C
TG
TTG
C
C
A
 -3' 
155 
SPAG
4 
N
M
_001076507  
qPC
R
; R
atio 
5'- C
C
A
C
G
G
TTA
TC
TTG
G
A
G
C
C
A
G
 -3' 
5'- G
A
TG
C
TG
C
A
G
A
G
TG
A
TG
TC
G
 -3' 
123 
SPATA6 
N
M
_001046371 
Ind; R
atio 
5'- G
A
TG
A
G
A
TC
C
A
TG
A
C
C
G
G
G
TA
 -3' 
5'- TA
A
G
A
G
G
C
TG
C
C
C
TG
TTG
G
A
 -3' 
230 
TN
P1 
N
M
_174199 
Ind; qPC
R
 
5'- A
A
A
C
G
C
TG
TG
A
C
G
A
TG
C
C
A
A
 -3' 
5'- C
TTG
G
C
A
G
TC
C
C
C
TTC
TG
TT -3' 
118 
C
uff = C
uffdiff validation; Ind = individual variation PC
R
; qPC
R
 = qPC
R
 9 individuals; R
atio = R
atio diff validation; V
al = qPC
R
 copy/FPK
M
 validation 
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T
able 2. R
N
A
-Seq read and m
apping statistics 
 
T
otal 
R
eads 
R
eads M
apped 
R
eads U
niquely 
M
apped 
R
eads in 
C
oding 
E
xons 
R
eads in 
5' U
T
R
s 
R
eads in 
3' U
T
R
s 
T
ranscripts 
E
xpressed 
H
igher 
Fertility 
10,454,393 
1,021,536 (9.77%
) 
537,102 (52.57%
) 
56,736 
9,732 
8,320 
3,227 
L
ow
er 
Fertility 
10,721,121 
1,336,844 (12.47%
) 
940,778 (70.37%
) 
177,359 
24,227 
24,776 
5,336 
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Table 3. Top 10 transcripts unique to higher fertility population based on FPKM 
Transcript Gene Name Accession Number FPKM 
MIR708 microRNA 708 n/a 200.937 
C4H7orf55 chromosome 4 open reading fram, human C7orf55 NM_001076997 122.222 
VSNL1 visinin-like 1 NM_174490 106.011 
AKR1B1 aldo-keto reductase family 1, member B1 (aldose reductase) NM_001012519 95 
APOA1BP apolipoprotein A-I binding protein NM_205796 91 
SQRDL sulfide quinone reductase-like (yeast) NM_001040511 91.0495 
CD28 CD28 molecule NM_181004 87 
MPI mannose phosphate isomerase NM_001035284 65 
RNGTT RNA guanylyltransferase and 5'-phosphatase NM_001046085 64 
FCF1 
similar to rRNA-processing protein FCF1 homolog; FCF1 small 
subunit (SSU) processome component homolog (S. cerevisiae) NM_001037452 63 
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Table 4. Top 10 transcripts unique to lower fertility population based on FPKM 
Transcript Gene Name Accession Number  FPKM 
RN5-8S1 5.8S ribosomal RNA NR_036643 348.918 
VDAC3 voltage-dependent anion channel 3 NM_174729 300.26 
DEFB122A beta-defensin 122a NM_001102339 247.702 
ATP6V1D 
ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D; 
similar to Vacuolar proton pump subunit D (V-ATPase 
subunit D) (V-ATPase 28 kDa accessory protein) NM_001075141 228.678 
LOC526524 
FK506 binding protein 1A, 12kDa; FK506 binding protein 
1A, 12kDa-like NM_001035456 203.048 
UQCR10 ubiquinol-cytochrome c reductase complex 7.2 kDa protein NM_001113723 195.179 
PSMA1 proteasome (prosome, macropain) subunit, alpha type, 1 NM_001035310 171.487 
INSL6 insulin-like 6 NM_001077521 162.748 
C10H14orf1
66 chromosome 14 open reading frame 166 ortholog NM_001035280 161.771 
METAP2 methionyl aminopeptidase 2 NM_001040493 157.701 
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Table 5. Top 10 Biological Processes (BP) for common transcripts and unique transcripts when comparing 
lower and higher fertility populations via gene ontology (GO) analysis 
   
 
Biological Processes % of Transcripts  
Unique to 
Higher Fertility  
regulation of transcription 9.23 
regulation of transcription, DNA-dependent 6.53 
oxidation reduction 4.41 
macromolecule catabolic process 3.55 
RNA processing 3.27 
protein catabolic process 2.98 
cellular macromolecule catabolic process 2.98 
positive regulation of macromolecule metabolic process 2.84 
negative regulation of macromolecule metabolic process 2.56 
regulation of cell proliferation 2.56 
Unique to 
Lower Fertility 
phosphate metabolic process 4.92 
phosphate metabolic process 4.92 
phosphorus metabolic process 4.92 
transcription 4.41 
proteolysis 4.41 
phosphorylation 4.09 
oxidation reduction 3.97 
protein localization 3.86 
protein transport 3.71 
establishment of protein localization 3.71 
intracellular signaling cascade 3.54 
Common 
Transcripts 
regulation of transcription 8.04 
protein localization 5.35 
proteolysis 5.05 
protein transport 4.86 
establishment of protein localization 4.86 
translation 4.61 
transcription 4.51 
macromolecule catabolic process 3.92 
protein catabolic process 3.78 
cellular macromolecule catabolic process 3.78 
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Table 6. Differentially expressed transcripts between high and low fertility populations via cuffdiff analysis 
Accession Number Gene Symbol* Gene Name 
NM_001035310 PSMA1 proteasome (prosome, macropain) subunit, alpha type, 1 
NM_001035280 C10H14orf166 chromosome 14 open reading frame 166 ortholog 
NM_001015639 PSMC2 proteasome (prosome, macropain) 26S subunit, ATPase, 2 
NM_001101989 TMEM144 transmembrane protein 144 
NM_001040493 METAP2 methionyl aminopeptidase 2 
NM_001035284 MPI mannose phosphate isomerase 
NM_001034494 PCNA proliferating cell nuclear antigen 
NM_174490 VSNL1 visinin-like 1 
NM_001040511 SQRDL sulfide quinone reductase-like (yeast) 
NM_001075141 ATP6V1D ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D 
NM_001079628 TMEM217 transmembrane protein 217 
NM_001075926 ACRV1 acrosomal vesicle protein 1 
NM_001038671 G2E3 G2/M-phase specific E3 ubiquitin ligase 
NM_001012519 AKR1B1 aldo-keto reductase family 1, member B1 (aldose reductase) 
NM_001077068 TMBIM1B hypothetical protein MGC134563; similar to CG3814 CG3814-PA 
NM_001046085 RNGTT RNA guanylyltransferase and 5'-phosphatase 
NM_001046143 CDKN2AIP CDKN2A interacting protein 
NM_001075396 PIAS1 protein inhibitor of activated STAT, 1 
NM_001075836 RIOK3 RIO kinase 3 (yeast) 
NM_205796 APOA1BP apolipoprotein A-I binding protein 
NM_001015595 GFRA2 GDNF family receptor alpha 2 
NM_001075527 CRBN cereblon 
NM_001083728 MAPK10 mitogen-activated protein kinase 10; mitogen-activated protein kinase 8 
NM_001076077 PHTF1 putative homeodomain transcription factor 1 
NM_001007819 DDX4 DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 
NM_001081584 ATF2 activating transcription factor 2 
NM_001103234 ACAP1 ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 
NM_001099062 FBXO3 F-box protein 3 
NM_001102118 DDX20 DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 
AJ439530 CACNA2D1 calcium channel, voltage-dependent, alpha 2/delta subunit 1 
AF086808 ADAM2 ADAM metallopeptidase domain 2 
XM_870523 SDC3 syndecan 3 
NM_001206525 CCDC41 coiled-coil domain containing 41 
NM_001114192 HSPA4 heat shock 70kDa protein 4 
NM_174729 VDAC3 voltage-dependent anion channel 3 
NM_001242584 IGBP1 immunoglobulin (CD79A) binding protein 1 
* bold = present in higher fertility only; not bold = present in lower fertility only 
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Table 7. Transcript presence (x) in individual bulls from 
lower (1) to higher (9) fertility. 
 
1 2 3 4 5 6 7 8 9 
AKAP4 
         APOABP1 
         ATPIF1 
    
x 
   
x 
ATP5J 
  
x 
      BRP 
         CCT8 x 
        CETN2 
  
x x x 
 
x 
  CLGN 
 
x 
    
x 
  CKS2 
 
x x x x 
 
x 
 
x 
CMYC 
   
x x x 
 
x 
 COX7A2 x 
  
x 
  
x x 
 COX7C x x 
 
x 
 
x x x x 
CRISP2 x x 
 
x 
 
x 
 
x 
 DNAJB7 
 
x 
 
x x 
    EEF1G x x 
 
x x x x 
 
x 
EIF1 
   
x x x 
  
x 
G2E3 x x 
 
x 
 
x x x x 
GPX4 x 
   
x 
    GSTM3 x 
 
x x x x x x 
 GTSF1 x 
 
x x x 
 
x x x 
HEMGN 
      
x 
  PCNA x 
       
x 
PRM1 x x x x x x x x x 
PRM2 x x x x x x x x 
 PSMA6 x x 
 
x x x 
  
x 
SPATA6 x 
  
x 
   
x x 
TNP1 x x x x x x x x 
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Table 8. Higher and lower fertility expression levels of previously published bovine 
spermatozoal transcripts 
 
Higher Fert. 
FPKM 
Lower Fert. 
FPKM Publication 
CCT8 - 18 Arangasamy et al. 2011 
CRISP2 661 1366 " 
PEBP1 5 41 " 
TSSK6 - - Feugang et al. 2010 
ADAM5P - - " 
CD36 - - Kasimanickam et al. 2012 
CENPA - - " 
AKI - - " 
IB5 - - " 
DOPPEL - - " 
NGF 11 2 " 
TIMP2 4 14 " 
LDC1 - - " 
SNRPN 0.0001 3 " 
ODF2 50 35 " 
PLCZ1 27 59 " 
ADIPOR1 4 3 Kasimanickam et al. 2013 
ADIPOR2 - 0.66 " 
ADIPO - - " 
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Table 9. Transcript expression levels in lower and higher fertility populations 
for spermatozoal proteins previously identified as having correlations with 
fertility.  - = not present 
 
Higher Fert. 
FPKM 
Lower Fert. 
FPKM Publication 
ATPSB - - Park et al. 2012 
ENO1 6 15 " 
ASPP2 - - " 
GPX4 18 138 " 
AHSG - - " 
AKI 10 20 D'Amours et al. 2010 
PEBP1 5 41 " 
CCT5 3 9 " 
CCT8 - 18 " 
ELSPBP1 - - " 
PSMA6 537 1296 " 
BSP1 11 67 " 
VDAC1 - 0.62 Park et al. 2012 
UQCRC2 7 18 " 
ROPN1 85 409 " 
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T
able 10. L
inear correlation analysis for expression levels (qPC
R
) of 12 transcripts across 9 individual bulls of varying fertility 
 
G
TSF1 
PR
M
2 
TN
P1 
PSM
A1 
PSM
A6 
ACR
V1 
SPAG
4 
CO
X
7C
 
ATP5J 
G
PX
4 
PR
M
1 
r
2 
0.8432 
0.6019 
0.497 
0.04819 
0.1217 
0.0962 
0.1045 
0.7776 
0.0005 
0.04733 
0.3673 
p value 
0.0005 
0.014 
0.0339 
0.5704 
0.3574 
0.5496 
0.3961 
0.0017 
0.9643 
0.5739 
0.0836 
     Note: A
 positive correlation indicates that higher fertility sires have low
er copy #s for a given transcript 
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Appendix 1.  Transcripts with > 2:1 ratios in lower:higher fertility populations 
 
Official Gene 
Symbol Gene Long Name 
Higher 
FPKM 
Lower 
FPKM 
Lower/ 
Higher 
Ratio 
RPL30 #N/A 8.06 420.66 52.22 
CETN1 centrin, EF-hand protein, 1 9.31 433.41 46.57 
MRPS33 #N/A 6.45 209.46 32.49 
PTTG1 protein tyrosine phosphatase type IVA, member 1 6.62 194.87 29.43 
C28H10orf53 UPF0728 protein C10orf53 homolog 12.68 333.48 26.30 
LOC781895 hypothetical protein LOC768323 39.07 980.19 25.09 
FANCD2OS #N/A 7.00 135.75 19.39 
HSFY2 #N/A 13.56 259.74 19.16 
HSFY2 #N/A 13.56 259.74 19.16 
HSFY2 #N/A 13.56 259.74 19.16 
HSFY2 #N/A 13.56 259.74 19.16 
COPS5 
similar to COP9 signalosome subunit 5; COP9 constitutive 
photomorphogenic homolog subunit 5 (Arabidopsis) 8.57 160.08 18.67 
DYNLL1 #N/A 12.17 222.01 18.24 
TOMM7 translocase of outer mitochondrial membrane 5 homolog (yeast) 6.41 116.32 18.15 
NDUFA7 
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 
14kDa 5.80 93.32 16.09 
H2AFZ H2A histone family, member Z 11.16 178.18 15.97 
CDO1 cysteine dioxygenase, type I 8.56 134.59 15.72 
HINT1 #N/A 6.31 98.05 15.55 
RPS18 ribosomal protein S17 14.02 216.93 15.47 
SRR signal recognition particle 72kDa 8.17 124.32 15.23 
MGC148328 hypothetical protein MGC137055 1625.53 23928.30 14.72 
MGC148328 #N/A 1625.53 23928.30 14.72 
RPL34 ribosomal protein L32 14.58 191.73 13.15 
ERH 
similar to enhancer of rudimentary homolog; enhancer of 
rudimentary homolog (Drosophila) 7.77 99.55 12.80 
IFT57 intraflagellar transport 57 homolog (Chlamydomonas) 5.67 65.99 11.64 
RPL14 ribosomal protein L13a 21.60 250.16 11.58 
SUMO2 
sulfotransferase family, cytosolic, 1A, phenol-preferring, 
member 1 8.71 95.97 11.02 
SUMO2 SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) 8.71 95.97 11.02 
CD59 CD59 molecule, complement regulatory protein 12.22 134.27 10.99 
MRFAP1 #N/A 13.90 152.68 10.99 
CEP57 centrosomal protein 57kDa 6.12 66.63 10.89 
ATP5B 
ATP synthase, H+ transporting, mitochondrial F1 complex, beta 
polypeptide 8.10 84.88 10.48 
NDUFA5 
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 
9kDa 9.05 93.86 10.37 
PGK2 FGF receptor activating protein 1 35.68 369.93 10.37 
PABPC1 proliferation-associated 2G4, 38kDa 22.22 228.22 10.27 
CCDC23 coiled-coil domain containing 23 8.50 85.90 10.11 
FAIM2 Fas apoptotic inhibitory molecule 2 8.33 83.50 10.03 
KLHL10 #N/A 14.12 140.42 9.94 
LOC788142 #N/A 7.26 70.41 9.70 
ASB17 ankyrin repeat and SOCS box-containing 17 21.52 205.35 9.54 
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UBE2K ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast) 7.65 72.61 9.49 
C8H9orf135 #N/A 12.17 115.21 9.47 
CHPT1 choline phosphotransferase 1 6.65 63.00 9.47 
CA6 carbonic anhydrase VI 5.65 52.50 9.28 
PSENEN #N/A 8.19 76.04 9.28 
RPS14 ribosomal protein S12 8.73 81.05 9.28 
COX7C cytochrome c oxidase subunit VIIc 52.63 484.73 9.21 
GHITM #N/A 6.74 61.96 9.20 
SLIRP solute carrier family 30 (zinc transporter), member 3 53.19 482.84 9.08 
UCHL3 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) 9.85 88.44 8.97 
C1H21orf59 chromosome 21 open reading frame 59 ortholog 14.51 128.88 8.88 
CLIC4 chloride intracellular channel 4 14.66 129.83 8.86 
RPS4Y1 
ribosomal protein S4, Y-linked 2; similar to ribosomal protein 
S4, X-linked X; ribosomal protein S4, X-linked 11.98 105.73 8.82 
ATP5J 
ATP synthase, H+ transporting, mitochondrial F0 complex, 
subunit F6 50.28 441.92 8.79 
PPP1R2 
protein phosphatase 1G (formerly 2C), magnesium-dependent, 
gamma isoform 47.53 414.36 8.72 
PLK1S1 phospholipase D1, phosphatidylcholine-specific 5.28 45.53 8.62 
ATP5O 
ATP synthase, H+ transporting, mitochondrial F1 complex, O 
subunit 20.64 175.16 8.49 
TRIM59 tripartite motif-containing 36 13.99 116.44 8.32 
RPS24 ribosomal protein S23; similar to ribosomal protein S23 54.06 449.04 8.31 
RPL10L #N/A 27.93 229.88 8.23 
PHYHIPL phosphoglycolate phosphatase 18.77 153.54 8.18 
GNAS GNAS complex locus 6.58 53.73 8.17 
NUPL2 nucleobindin 1 13.63 110.49 8.11 
C21H15orf63 #N/A 6.28 50.53 8.05 
LZTFL1 lysozyme-like 2 6.47 52.02 8.05 
LZTFL1 leucine zipper transcription factor-like 1 6.47 52.02 8.05 
PEBP1 #N/A 5.28 40.88 7.74 
SAMD13 serum amyloid A4, constitutive 27.50 212.74 7.74 
RPS19 ribosomal protein S18 10.32 79.29 7.68 
CSDE1 cold shock domain containing E1, RNA-binding 22.61 173.34 7.67 
LOC783012 hypothetical protein LOC781895 121.35 926.74 7.64 
NUPR1L nucleoporin like 2 13.20 100.80 7.63 
SPCS1 spermatogenesis associated, serine-rich 2 5.25 39.83 7.58 
GPX4 glutathione peroxidase 4 (phospholipid hydroperoxidase) 18.29 138.68 7.58 
LOC768323 testis-specific histone 2a-like 194.47 1472.79 7.57 
LOC768323 hypothetical protein LOC768323 194.47 1472.79 7.57 
TXNDC17 thioredoxin 7.71 57.29 7.43 
PSMA4 presenilin enhancer 2 homolog (C. elegans) 6.85 50.87 7.43 
ATPIF1 ATPase inhibitory factor 1 6.31 46.83 7.43 
SELK Sec61 gamma subunit 36.11 268.22 7.43 
MS4A14 membrane-spanning 4-domains, subfamily A, member 13 8.49 62.32 7.34 
RPS23 ribosomal protein S21 11.43 82.94 7.26 
PCBP1 poly (ADP-ribose) polymerase family, member 11 5.62 40.56 7.22 
ADAM32 ADAM metallopeptidase domain 32 17.83 128.51 7.21 
SOD1 sine oculis binding protein homolog (Drosophila) 9.69 68.96 7.12 
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C17H5orf52 chromosome 5 open reading frame 52 ortholog 10.92 76.04 6.96 
KHDRBS3 potassium channel modulatory factor 1 9.23 64.28 6.96 
SH3GLB1 SH3 domain binding glutamic acid-rich protein like 3 8.10 55.98 6.91 
C7H5orf48 #N/A 56.24 385.08 6.85 
NEDD8 
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa 
(NADH-coenzyme Q reductase) 10.63 72.36 6.81 
STK17A 
signal transducer and activator of transcription 1, 91kDa; signal 
transducer and activator of transcription 4 13.08 88.03 6.73 
ARL3 ADP-ribosylation factor-like 3 18.51 122.73 6.63 
RNF181 ring finger protein 138 12.51 82.60 6.60 
PSMB3 proteasome (prosome, macropain) subunit, alpha type, 6 8.70 57.43 6.60 
DYDC1 DPY30 domain containing 1 44.45 292.98 6.59 
FTH1 #N/A 13.19 85.70 6.50 
STT3B 
STT3, subunit of the oligosaccharyltransferase complex, 
homolog A (S. cerevisiae) 13.94 90.19 6.47 
RNF138 similar to ring finger protein 103 15.15 97.93 6.46 
HMGN3 high mobility group nucleosomal binding domain 3 5.19 32.14 6.19 
OXCT2 OTU domain, ubiquitin aldehyde binding 2 6.54 40.46 6.19 
DCUN1D1 
DCN1, defective in cullin neddylation 1, domain containing 1 
(S. cerevisiae) 165.17 1022.28 6.19 
HSBP1 heat shock factor binding protein 1 52.82 324.18 6.14 
UBC #N/A 9.04 55.19 6.10 
MGC134066 hypothetical protein MGC133647 5.33 32.18 6.03 
SERP2 stress-associated endoplasmic reticulum protein 1 20.26 121.81 6.01 
BSP1 seminal vesicle secretory protein 109 11.27 67.42 5.98 
USP50 ubiquitin specific peptidase 44 18.49 109.18 5.90 
C8H9orf24 #N/A 6.82 40.10 5.88 
MEA1 #N/A 30.55 179.29 5.87 
GLUL glutamate-ammonia ligase (glutamine synthetase) 11.52 66.94 5.81 
RPS12 ribosomal protein S11 42.29 243.05 5.75 
ARRDC4 arrestin domain containing 4 20.37 117.05 5.75 
PCYT1A protein-L-isoaspartate (D-aspartate) O-methyltransferase 12.30 70.59 5.74 
AKAP4 A kinase (PRKA) anchor protein 4 31.55 179.45 5.69 
TEX26 testis expressed 101 11.31 64.16 5.67 
C10H15orf23 chromosome 15 open reading frame 23 ortholog 50.81 284.82 5.61 
AGPAT3 1-acylglycerol-3-phosphate O-acyltransferase 3 6.49 36.13 5.57 
ARGLU1 arginine and glutamate rich 1 40.61 226.22 5.57 
ARGLU1 arginine and glutamate rich 1 40.61 226.22 5.57 
CKS2 CDC28 protein kinase regulatory subunit 2 86.19 477.80 5.54 
GLRX2 glutaredoxin 2 11.83 65.56 5.54 
CDC5L CDC5 cell division cycle 5-like (S. pombe) 5.43 29.85 5.50 
RPS6 ribosomal protein S4, Y-linked 1 92.63 506.01 5.46 
RPS6 #N/A 92.63 506.01 5.46 
LDHC lysosomal protein transmembrane 4 alpha 62.50 341.40 5.46 
MS4A5 MS4A13 protein 23.81 128.92 5.42 
ODF1 OCIA domain containing 1 16.65 87.01 5.23 
NPC2 #N/A 9.09 46.88 5.16 
C21H14orf14
2 Uncharacterized protein C14orf142 homolog 7.87 40.57 5.16 
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SHCBP1L SH3-domain GRB2-like endophilin B1 19.92 102.37 5.14 
PSMG1 proteasome (prosome, macropain) inhibitor subunit 1 (PI31) 7.69 39.24 5.11 
CSDA cold shock domain protein A 22.72 115.67 5.09 
CCNB1 similar to Cyclin B1; cyclin B1 6.27 31.80 5.08 
SRP72 signal recognition particle 54kDa 17.49 88.69 5.07 
COX7A2 cytochrome c oxidase subunit VIIa polypeptide 2 (liver) 46.39 235.08 5.07 
CAPZA1 capping protein (actin filament) muscle Z-line, alpha 1 8.33 42.17 5.06 
CLGN calmegin 82.69 417.94 5.05 
C18H16orf87 #N/A 17.27 87.05 5.04 
RPS11 ribosomal protein S10; similar to 40S ribosomal protein S10 177.02 886.91 5.01 
BCL2L14 Bcl2-like 14 (apoptosis facilitator) 27.05 135.40 5.01 
SNHG4 #N/A 6.88 34.06 4.95 
RPL18 #N/A 7.37 36.51 4.95 
KRTCAP2 karyopherin alpha 4 (importin alpha 3) 6.51 32.24 4.95 
KIF27 #N/A 9.88 48.75 4.94 
EEF1A1 #N/A 59.09 290.46 4.92 
TFAM #N/A 18.14 88.90 4.90 
PAFAH1B1 poly(A) binding protein, cytoplasmic 1 13.95 68.36 4.90 
TMBIM4 #N/A 14.07 68.86 4.89 
HIST1H2BN #N/A 6.69 32.44 4.85 
PPP1R42 protein phosphatase 1, regulatory (inhibitor) subunit 2 39.21 189.94 4.84 
ROPN1 reactive oxygen species modulator 1 84.95 408.68 4.81 
SS18L2 #N/A 6.65 31.90 4.80 
SS18L2 #N/A 6.65 31.90 4.80 
COX6B1 #N/A 17.02 80.78 4.75 
EIF4G2 eukaryotic translation initiation factor 4 gamma, 2 11.49 54.34 4.73 
MMADHC 
myeloid/lymphoid or mixed-lineage leukemia (trithorax 
homolog, Drosophila); translocated to, 11 15.80 74.69 4.73 
FXR1 fragile X mental retardation, autosomal homolog 1 46.08 217.73 4.72 
RPL4 ribosomal protein L39 13.38 62.92 4.70 
SRSF2 #N/A 5.49 25.83 4.70 
MESDC2 maternal embryonic leucine zipper kinase 5.53 25.99 4.70 
BLZF1 basic leucine zipper nuclear factor 1 16.20 75.93 4.69 
VDAC2 vasohibin 2 16.24 75.77 4.67 
RPL5 similar to ribosomal protein L4; ribosomal protein L4 7.67 35.49 4.63 
CYLC1 cylicin, basic protein of sperm head cytoskeleton 1 33.50 150.68 4.50 
FRG1 #N/A 16.15 72.48 4.49 
FAM81B family with sequence similarity 81, member B 42.17 187.90 4.46 
PICALM phytanoyl-CoA 2-hydroxylase interacting protein-like 15.76 69.65 4.42 
RPS26 #N/A 15.98 70.29 4.40 
FKBP2 #N/A 5.40 23.41 4.33 
AMZ2 archaelysin family metallopeptidase 2 11.71 50.73 4.33 
EID3 EP300 interacting inhibitor of differentiation 3 6.21 26.89 4.33 
CHCHD7 coiled-coil-helix-coiled-coil-helix domain containing 7 10.27 44.51 4.33 
CETN4 centrin 4 77.47 329.77 4.26 
IGFBP7 insulin-like growth factor binding protein 7 5.16 21.29 4.13 
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STMN1 serine/threonine kinase 17a 12.21 50.37 4.13 
MORF4L1 meiosis-specific nuclear structural 1 52.56 216.69 4.12 
NDUFB4 
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 
12kDa 81.78 336.24 4.11 
SBDS 
similar to Cytokine induced protein 29 kDa; SAP domain 
containing ribonucleoprotein 11.24 46.09 4.10 
DYDC2 DPY30 domain containing 2 19.33 78.96 4.08 
DAD1 defender against cell death 1 99.92 406.94 4.07 
MFF methyltransferase like 13 44.85 181.10 4.04 
GML #N/A 5.78 23.25 4.02 
GGNBP2 gametogenetin binding protein 2 19.12 76.33 3.99 
RPGRIP1 RAR-related orphan receptor A 20.51 80.71 3.94 
COX7B2 #N/A 58.19 228.08 3.92 
ADORA3 adenosine A3 receptor 35.26 137.83 3.91 
C16H1orf100 chromosome 1 open reading frame 100 ortholog 61.96 241.06 3.89 
YBX2 Y box binding protein 1 34.08 132.03 3.87 
ADAM3A ADAM metallopeptidase domain 3A (cyritestin 1) 36.65 141.01 3.85 
CCT2 chaperonin containing TCP1, subunit 2 (beta) 18.39 70.57 3.84 
NDUFB3 #N/A 35.05 133.77 3.82 
RPS27A #N/A 223.62 852.29 3.81 
SKP1 
signal-regulatory protein delta; similar to signal-regulatory 
protein delta 39.11 149.05 3.81 
C23H6orf106 #N/A 13.58 51.64 3.80 
HMGB1 
high-mobility group box 1-like 1; high-mobility group box 1; 
similar to Hmgb1 protein 12.31 46.65 3.79 
RPL17 #N/A 18.74 70.74 3.78 
GPI glucose phosphate isomerase 13.89 52.13 3.75 
SNRPG small nuclear ribonucleoprotein polypeptide F 29.55 110.44 3.74 
NDUFB1 
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 
assembly factor 3 22.98 85.34 3.71 
RPL39 ribosomal protein L38 19.44 72.19 3.71 
CAPZB capping protein (actin filament) muscle Z-line, beta 30.03 111.53 3.71 
UBXN6 UBX domain protein 4 5.51 20.45 3.71 
NDUFS5 
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 
22kDa 11.39 42.30 3.71 
C3H1orf189 chromosome 1 open reading frame 189 ortholog 70.91 261.32 3.69 
BCAP29 B-cell receptor-associated protein 29 62.95 231.40 3.68 
GNG5 #N/A 18.11 64.44 3.56 
FAM71E1 #N/A 11.19 39.82 3.56 
ATP1B3 ATPase, Na+/K+ transporting, beta 3 polypeptide 56.01 198.96 3.55 
RPL38 ribosomal protein L37a 180.85 639.59 3.54 
SPATA9 #N/A 29.98 105.73 3.53 
HSP90B1 tumor rejection antigen (gp96) 1 19.68 69.27 3.52 
ROPN1L ropporin, rhophilin associated protein 1 14.79 51.87 3.51 
NDUFA6 
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 
13kDa 65.71 229.21 3.49 
PSMB7 proteasome (prosome, macropain) subunit, beta type, 3 16.95 59.01 3.48 
RNF38 ring finger protein 216 19.27 66.93 3.47 
TOMM70A translocase of outer mitochondrial membrane 7 homolog (yeast) 18.52 64.30 3.47 
PSMG2 proteasome (prosome, macropain) assembly chaperone 1 28.63 98.73 3.45 
SHFM1 #N/A 41.97 144.73 3.45 
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C15H11orf71 chromosome 11 open reading frame 71 ortholog 17.83 61.47 3.45 
TMBIM6 transmembrane BAX inhibitor motif containing 4 26.85 92.08 3.43 
PPWD1 protein phosphatase 2, regulatory subunit B', gamma isoform 17.56 60.04 3.42 
EIF3K eukaryotic translation initiation factor 3, subunit K 5.59 19.01 3.40 
CSRP3 cysteine and glycine-rich protein 3 (cardiac LIM protein) 9.07 30.86 3.40 
ATP5E #N/A 50.85 173.08 3.40 
TMSB10 transmembrane protein 60 265.87 897.20 3.37 
USP15 ubiquinol-cytochrome c reductase hinge protein 7.42 25.05 3.37 
ELK4 ELK4, ETS-domain protein (SRF accessory protein 1) 5.58 18.65 3.34 
ETF1 eukaryotic translation termination factor 1 6.14 20.41 3.33 
TAF9 
TAF10 RNA polymerase II, TATA box binding protein (TBP)-
associated factor, 30kDa 28.71 95.44 3.32 
DNAJB3 #N/A 67.47 224.17 3.32 
C4H7orf10 #N/A 14.02 46.57 3.32 
PFN1 prefoldin subunit 5 7.76 25.63 3.30 
EIF5 eukaryotic translation initiation factor 5 36.95 121.20 3.28 
MELK meiosis expressed gene 1 homolog (mouse) 7.79 25.42 3.26 
ROMO1 RNA (guanine-7-) methyltransferase 15.80 51.35 3.25 
RPL10A #N/A 19.30 62.21 3.22 
STAT4 
signal transducing adaptor molecule (SH3 domain and ITAM 
motif) 2 22.73 73.23 3.22 
NBN N-acyl phosphatidylethanolamine phospholipase D 6.88 22.13 3.22 
YPEL2 YME1-like 1 (S. cerevisiae) 11.53 37.11 3.22 
SLC30A3 #N/A 8.94 28.78 3.22 
SCAMP1 Shwachman-Bodian-Diamond syndrome 24.97 79.99 3.20 
NME2 NIPA-like domain containing 3 13.73 43.97 3.20 
CALU calumenin 5.34 17.06 3.20 
ARL2BP ADP-ribosylation factor-like 2 binding protein 13.28 42.46 3.20 
CISD1 CDGSH iron sulfur domain 1 354.71 1133.38 3.20 
AIF1 allograft inflammatory factor 1 95.89 305.21 3.18 
DNAJB4 DnaJ (Hsp40) homolog, subfamily B, member 4 48.84 154.38 3.16 
SF3B1 
stress-associated endoplasmic reticulum protein family member 
2 7.22 22.74 3.15 
HSP90AA1 #N/A 43.10 135.28 3.14 
PGP phosphoglycerate kinase 2 11.81 36.94 3.13 
LAPTM4A #N/A 55.64 173.85 3.12 
CYLC2 cylicin, basic protein of sperm head cytoskeleton 2 138.04 427.82 3.10 
C1D C1D nuclear receptor co-repressor 16.78 51.94 3.09 
PFN2 #N/A 6.08 18.82 3.09 
CIAPIN1 cytokine induced apoptosis inhibitor 1 10.35 32.02 3.09 
LOC1001259
13 leukemia NUP98 fusion partner 1 9.85 30.50 3.09 
PDHB pyruvate dehydrogenase (lipoamide) alpha 2 6.73 20.82 3.09 
ACOT7 acyl-CoA thioesterase 7 5.15 15.94 3.09 
NDUFB2 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa 10.39 32.14 3.09 
CABYR calcium binding tyrosine-(Y)-phosphorylation regulated 21.15 65.21 3.08 
FAM92A1 #N/A 27.53 83.42 3.03 
C5H12orf50 chromosome 12 open reading frame 50 ortholog 28.76 86.78 3.02 
SPESP1 spermatid maturation 1 11.12 33.56 3.02 
 126 
CUL3 cullin 3 15.33 45.85 2.99 
IQCF1 integrator complex subunit 12 36.67 109.69 2.99 
TMEM258 transmembrane and coiled-coil domains 5B 101.28 301.68 2.98 
SERF1A SERPINE1 mRNA binding protein 1 162.97 485.41 2.98 
ARL4A ADP-ribosylation factor-like 4A 75.36 224.41 2.98 
COIL coilin 9.14 27.08 2.96 
BRD2 bromodomain containing 2 6.47 19.13 2.96 
RABEPK RAB5A, member RAS oncogene family 28.56 84.21 2.95 
HSPA5 heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) 20.32 59.86 2.95 
VTI1B very low density lipoprotein receptor 34.70 101.74 2.93 
FAM229B #N/A 965.33 2823.04 2.92 
PFDN5 phosphatidylethanolamine-binding protein 4 108.54 317.07 2.92 
LYZL1 Lyrm7 homolog (mouse) 33.52 97.51 2.91 
TMA16 #N/A 19.54 56.43 2.89 
HSP90AB1 heat shock 90kDa protein 1, beta 9.29 26.62 2.87 
HSP90AB1 heat shock 90kDa protein 1, beta 9.29 26.62 2.87 
MEIG1 mediator complex subunit 6 117.34 334.29 2.85 
NDUFA4 #N/A 93.47 265.58 2.84 
SPINK2 sperm equatorial segment protein 1 192.07 545.75 2.84 
UBB #N/A 384.20 1088.56 2.83 
TOX4 
translocase of outer mitochondrial membrane 70 homolog A (S. 
cerevisiae) 9.26 26.20 2.83 
GSG1 germ cell associated 1 24.89 70.19 2.82 
LELP1 lactate dehydrogenase C 36.39 102.60 2.82 
CDV3 CDV3 homolog (mouse) 27.46 77.42 2.82 
TERF2 tektin 3 8.88 24.92 2.81 
RPS21 #N/A 62.43 173.88 2.79 
H3F3A #N/A 16.81 46.23 2.75 
BANF2 barrier to autointegration factor 2 251.77 692.54 2.75 
AKTIP AKT interacting protein 14.65 40.21 2.75 
WBP2NL Wiskott-Aldrich syndrome-like 18.68 51.20 2.74 
BAZ2B bromodomain adjacent to zinc finger domain, 2B 14.22 38.93 2.74 
DCUN1D4 
DCN1, defective in cullin neddylation 1, domain containing 4 
(S. cerevisiae) 61.63 166.89 2.71 
MS4A13 mitochondrial ribosomal protein S9 151.90 411.21 2.71 
CCDC54 coiled-coil domain containing 54 69.36 186.97 2.70 
SRP54 signal recognition particle 19kDa 92.91 247.01 2.66 
DNAJA1 DnaJ (Hsp40) homolog, subfamily A, member 1 15.92 42.16 2.65 
TPI1 TOX high mobility group box family member 4 12.05 31.69 2.63 
RPS15 #N/A 22.07 58.05 2.63 
KIF2B kinesin heavy chain member 2A 12.48 32.83 2.63 
PTGR1 proteasome (prosome, macropain) assembly chaperone 2 5.99 15.76 2.63 
SAA4 S100 calcium binding protein G 67.67 175.29 2.59 
ENO1 enolase 1, (alpha) 6.00 15.47 2.58 
WASL 
vesicle transport through interaction with t-SNAREs homolog 
1B 5.82 15.01 2.58 
FAM103A1 #N/A 20.22 52.15 2.58 
PRPS1L1 protein interacting with cyclin A1 6.03 15.45 2.56 
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FAU 
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) 
ubiquitously expressed; similar to ubiquitin-like/S30 ribosomal 
fusion protein 100.22 256.54 2.56 
FAU 
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) 
ubiquitously expressed; similar to ubiquitin-like/S30 ribosomal 
fusion protein 100.22 256.54 2.56 
C15H11orf88 #N/A 28.37 72.44 2.55 
AP2B1 adaptor-related protein complex 2, beta 1 subunit 94.45 240.14 2.54 
AP2B1 adaptor-related protein complex 2, beta 1 subunit 94.45 240.14 2.54 
TRIM36 trafficking protein particle complex 3 20.97 53.24 2.54 
CNOT2 CCR4-NOT transcription complex, subunit 2 8.19 20.73 2.53 
CLU clusterin 12.20 30.88 2.53 
MRPS18C #N/A 77.78 195.99 2.52 
RPL37A #N/A 375.70 945.04 2.52 
ZNF451 zinc finger protein 432 9.83 24.70 2.51 
YWHAQ 
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, gamma polypeptide 82.64 206.93 2.50 
UQCRC2 ubiquinol-cytochrome c reductase binding protein 7.02 17.52 2.50 
RANGRF #N/A 95.84 238.84 2.49 
UBE2V1 ubiquitin-conjugating enzyme E2R 2 17.63 43.66 2.48 
C19H17orf98 #N/A 6.02 14.90 2.48 
ARF4 #N/A 21.19 52.45 2.48 
CAP1 
similar to CAP1 protein; CAP, adenylate cyclase-associated 
protein 1 (yeast) 7.49 18.53 2.48 
LOC504599 histone H2B variant PT15 7.46 18.47 2.48 
RPS27 #N/A 120.56 298.47 2.48 
CCDC167 #N/A 8.88 21.98 2.48 
C11H2orf43 #N/A 8.07 19.97 2.48 
C15H11orf1 #N/A 39.83 98.29 2.47 
FSCN3 
fascin homolog 3, actin-bundling protein, testicular 
(Strongylocentrotus purpuratus) 28.32 69.49 2.45 
FAM209B #N/A 328.88 805.05 2.45 
C21H14orf2 #N/A 339.04 826.64 2.44 
ATP5L #N/A 92.45 225.29 2.44 
GALNTL5 
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase-like 5 42.73 103.89 2.43 
EIF1 #N/A 87.71 212.72 2.43 
TEX101 
testis derived transcript (3 LIM domains); similar to testis 
derived transcript 23.63 57.28 2.42 
PSME4 #N/A 5.55 13.46 2.42 
DNAJC21 DnaJ (Hsp40) homolog, subfamily C, member 21 19.41 47.01 2.42 
C4H7orf62 #N/A 95.34 230.41 2.42 
PSMA6 proteasome (prosome, macropain) subunit, alpha type, 4 537.25 1296.79 2.41 
MGC134093 hypothetical protein MGC134066 128.66 310.48 2.41 
MGC134093 #N/A 128.66 310.48 2.41 
MGC134093 #N/A 128.66 310.48 2.41 
PIGF protein interacting with PRKCA 1 58.77 141.32 2.40 
RAB5A RAB28, member RAS oncogene family 7.20 17.19 2.39 
KIF5C kinesin family member 5B 43.01 102.51 2.38 
TMEM30A #N/A 21.60 51.48 2.38 
TEX35 #N/A 111.07 262.35 2.36 
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HNRNPC heterogeneous nuclear ribonucleoprotein C (C1/C2) 11.00 25.95 2.36 
ARPM1 actin related protein M1 21.94 51.76 2.36 
ERICH2 #N/A 364.32 858.46 2.36 
HNRNPU 
heterogeneous nuclear ribonucleoprotein U (scaffold attachment 
factor A) 8.51 20.06 2.36 
FNDC3A fibronectin type III domain containing 3A 11.09 26.11 2.35 
TSACC hypothetical LOC540154 791.86 1857.74 2.35 
PRSS37 protease, serine, 23 79.01 184.74 2.34 
CCDC101 coiled-coil domain containing 101 24.12 56.39 2.34 
CCDC101 coiled-coil domain containing 101 24.12 56.39 2.34 
RPS20 #N/A 82.82 193.11 2.33 
DBI 
diazepam binding inhibitor (GABA receptor modulator, acyl-
Coenzyme A binding protein) 245.96 572.66 2.33 
DKKL1 dickkopf-like 1 (soggy) 8.27 19.18 2.32 
RPS7 #N/A 39.81 92.39 2.32 
LY6G6C leucine zipper protein 1 18.64 43.26 2.32 
CALM2 #N/A 233.28 539.14 2.31 
BPIFA3 #N/A 119.02 272.68 2.29 
CDKL3 cyclin-dependent kinase-like 3 10.09 23.10 2.29 
FBP1 #N/A 49.85 114.05 2.29 
KLHL2 kelch-like 10 (Drosophila) 8.41 19.23 2.29 
ALB albumin 6.09 13.91 2.28 
TMCO2 transmembrane BAX inhibitor motif containing 6 152.54 348.14 2.28 
RPSA ribosomal protein S8 11.98 27.18 2.27 
MED6 mediator complex subunit 31 11.43 25.94 2.27 
HNRNPD 
heterogeneous nuclear ribonucleoprotein D (AU-rich element 
RNA binding protein 1, 37kDa) 7.24 16.44 2.27 
RPL13 #N/A 19.73 44.76 2.27 
RPL32 similar to ribosomal protein L31; ribosomal protein L31 283.92 641.10 2.26 
RPS3A ribosomal protein S3 224.15 506.05 2.26 
ATP6V1C1 ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 33.73 75.89 2.25 
RPL22L1 #N/A 14.43 32.27 2.24 
UBXN1 #N/A 9.07 20.21 2.23 
KIF5B kinesin family member 3A 5.39 11.81 2.19 
RPL35A ribosomal protein L35 238.98 519.68 2.17 
SPATA6 spermatogenesis associated 4 314.58 681.94 2.17 
RBM4B RNA binding motif protein 46 30.40 65.85 2.17 
C9H6orf165 chromosome 6 open reading frame 165 ortholog 6.14 13.30 2.17 
PLCZ1 phospholipase C, delta 4 27.33 58.96 2.16 
C1H3orf38 chromosome 3 open reading frame 38 ortholog 88.13 190.05 2.16 
KLHDC10 kinesin family member 5C 19.54 42.01 2.15 
COPS4 
COP9 constitutive photomorphogenic homolog subunit 4 
(Arabidopsis) 32.03 68.68 2.14 
GTF2H5 general transcription factor IIH, polypeptide 5 50.85 108.57 2.14 
LPIN1 hypothetical protein LOC788205 28.98 61.85 2.13 
UQCRB ubiquitin interaction motif containing 1 245.77 523.54 2.13 
CALM3 #N/A 28.81 61.37 2.13 
TXN tumor suppressor candidate 3 36.83 78.15 2.12 
ATOX1 ATX1 antioxidant protein 1 homolog (yeast) 92.30 195.86 2.12 
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SAMD4A #N/A 6.02 12.73 2.11 
BEX4 hypothetical protein LOC783451 16.67 35.25 2.11 
BEX4 hypothetical protein LOC783451 16.67 35.25 2.11 
RPS25 #N/A 184.22 388.38 2.11 
RPL36AL #N/A 190.90 401.36 2.10 
RPL23 
similar to Ribosomal protein L22-like 1; ribosomal protein L22-
like 1 445.87 936.58 2.10 
SMCP 
SWI/SNF related, matrix associated, actin dependent regulator 
of chromatin, subfamily a, member 5 458.59 961.76 2.10 
C16H1orf114 #N/A 145.46 304.18 2.09 
DCTN6 dynactin 6 41.67 86.91 2.09 
BAG4 BCL2-associated athanogene 4 15.79 32.92 2.08 
TPT1 #N/A 38.79 80.79 2.08 
CRISP2 #N/A 661.17 1366.46 2.07 
SUGP1 
STT3, subunit of the oligosaccharyltransferase complex, 
homolog B (S. cerevisiae) 15.21 31.39 2.06 
MGC134473 hypothetical protein MGC134427 6.87 14.17 2.06 
FAM71D family with sequence similarity 71, member D ortholog 210.75 434.67 2.06 
KCMF1 #N/A 49.08 101.01 2.06 
YBX1 YY1 associated factor 2 104.98 215.97 2.06 
CCDC91 coiled-coil domain containing 91 29.89 61.39 2.05 
GSTM3 glutathione S-transferase mu 3 (brain) 1991.48 4088.10 2.05 
GDI2 
similar to GDP-dissociation inhibitor; GDP dissociation 
inhibitor 2 9.53 19.52 2.05 
TES telomeric repeat binding factor 2 93.05 189.96 2.04 
BZW1 basic leucine zipper and W2 domains 1 23.34 47.63 2.04 
MYCBP mitochondrial fission regulator 1 36.11 73.44 2.03 
RPL10 retinitis pigmentosa GTPase regulator interacting protein 1 21.64 44.01 2.03 
BBX bobby sox homolog (Drosophila) 13.45 27.26 2.03 
AMD1 #N/A 26.34 53.39 2.03 
MGC148714 #N/A 54.96 111.33 2.03 
TSPAN6 tetraspanin 5 105.27 213.03 2.02 
RPL21 ribosomal protein L19 35.03 70.84 2.02 
EEF1D 
eukaryotic translation elongation factor 1 delta (guanine 
nucleotide exchange protein) 24.78 50.09 2.02 
TXNL1 thioredoxin domain containing 8 (spermatozoa) 50.57 101.98 2.02 
TUBB3 #N/A 5.40 10.89 2.02 
CFL2 cofilin 2 (muscle) 5.42 10.90 2.01 
TAOK1 #N/A 6.21 12.49 2.01 
HIST2H2BE #N/A 5.99 12.04 2.01 
LOC513111 #N/A 12.02 24.17 2.01 
DCAF12 WD repeat domain 40A 13.54 27.16 2.01 
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Appendix 2.  Transcripts with > 2:1 ratios in higher:lower fertility populations 
 
 
Official Gene 
Symbol Gene Long Name 
Higher 
FPKM 
Lower 
FPKM 
Higher/ 
Lower 
Ratio 
UCHL1 UBX domain protein 6 142.15 5.23679 27.14 
ENY2 enhancer of yellow 2 homolog (Drosophila) 113.50 5.66497 20.04 
PLAC1 #N/A 119.24 8.02166 14.86 
CETN2 centrin, EF-hand protein, 2 62.39 5.67822 10.99 
BCL2L11 BCL2-like 11 (apoptosis facilitator) 141.55 15.5432 9.11 
EMC2 #N/A 87.94 10.5031 8.37 
LSM12 limbic system-associated membrane protein 43.79 5.5314 7.92 
NAPEPLD #N/A 40.84 5.20358 7.85 
CHRAC1 chromatin accessibility complex 1 72.12 9.76486 7.39 
UBE2R2 ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast) 143.09 21.255 6.73 
COPS3 
COP9 constitutive photomorphogenic homolog subunit 3 
(Arabidopsis) 58.32 8.87618 6.57 
SH3BGRL3 #N/A 64.91 10.4808 6.19 
ASB12 ankyrin repeat and SOCS box-containing 12 56.81 9.58963 5.92 
ANP32B 
acidic (leucine-rich) nuclear phosphoprotein 32 family, 
member B 42.45 7.50689 5.66 
AHCY adenosylhomocysteinase 33.02 6.04565 5.46 
MANF maelstrom homolog (Drosophila) 69.42 12.7308 5.45 
GLYATL3 #N/A 60.05 11.4356 5.25 
KPNA4 kelch-like 24 (Drosophila) 59.37 11.5279 5.15 
C11H9orf9 chromosome 9 open reading frame 9 ortholog 106.29 21.0511 5.05 
CDKL4 cyclin-dependent kinase-like 4 93.75 18.686 5.02 
SPAG4 sperm associated antigen 17 46.37 9.30735 4.98 
PTMA prostaglandin reductase 1 34.13 7.04153 4.85 
RPS28 ribosomal protein S27-like 35.99 7.42415 4.85 
MIR1307 missing oocyte, meiosis regulator, homolog (Drosophila) 420.45 86.7418 4.85 
MRPS16 mitochondrial ribosomal protein L42 29.61 6.10836 4.85 
SNRPF small nuclear ribonucleoprotein D2 polypeptide 16.5kDa 24.60 5.37417 4.58 
LSM2 LSM12 homolog (S. cerevisiae) 277.89 60.9775 4.56 
FAM76B #N/A 48.69 10.7459 4.53 
PRSS23 proline rich 13 24.72 5.56424 4.44 
CEP76 centrosomal protein 76kDa 25.96 5.91952 4.39 
AMAC1L3 acyl-malonyl condensing enzyme 1-like 3 27.76 6.442 4.31 
TRAPPC3 transformer 2 beta homolog (Drosophila) 74.24 17.5969 4.22 
SYNE4 SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) 21.54 5.12758 4.20 
UBE2J1 ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast) 101.78 24.4097 4.17 
FBXL2 F-box and leucine-rich repeat protein 2 33.65 8.12796 4.14 
PNN #N/A 23.51 5.69404 4.13 
CCNB2 similar to cyclin B2; cyclin B2 34.12 8.2962 4.11 
LYRM4 #N/A 52.41 12.9745 4.04 
C23H6orf25 #N/A 39.98 9.99186 4.00 
SEC61A2 succinate dehydrogenase complex, subunit B, iron sulfur (Ip) 70.32 17.871 3.94 
YAE1D1 #N/A 69.71 17.8064 3.92 
PMPCB non-protein coding RNA 153 34.91 9.06111 3.85 
WDR53 WBP2 N-terminal like 64.89 17.7455 3.66 
GALNT3 
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-
acetylgalactosaminyltransferase 3 (GalNAc-T3) 39.51 10.8672 3.64 
EIF3G eukaryotic translation initiation factor 3, subunit G 19.08 5.36828 3.55 
ASB8 ankyrin repeat and SOCS box-containing 8 50.71 14.4483 3.51 
HIST1H2AG #N/A 23.82 6.80562 3.50 
RPS3 #N/A 236.85 68.2526 3.47 
SSRP1 #N/A 65.61 19.085 3.44 
BTBD10 BTB (POZ) domain containing 10 44.81 13.1859 3.40 
DYNLRB2 dynein, light chain, roadblock-type 2 260.34 77.7852 3.35 
IQCF2 IQ motif containing F1 120.31 35.9479 3.35 
GOSR1 golgi SNAP receptor complex member 1 61.50 18.5172 3.32 
REEP6 RNA binding motif protein 4B 28.81 8.79414 3.28 
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SDHA #N/A 17.34 5.36623 3.23 
C11H9orf16 chromosome 9 open reading frame 16 ortholog 38.57 11.9349 3.23 
SRP19 spermatogenic leucine zipper 1 24.08 7.45045 3.23 
ADK #N/A 23.34 7.22263 3.23 
SCP2D1 #N/A 743.18 232.871 3.19 
GTSF1L gametocyte specific factor 1-like 862.80 276.158 3.12 
RFWD2 receptor accessory protein 6 35.98 11.5462 3.12 
CDC27 cell division cycle 27 homolog (S. cerevisiae) 20.91 6.86248 3.05 
WFDC15B #N/A 33.28 10.9419 3.04 
CCDC67 coiled-coil domain containing 67 52.53 17.417 3.02 
AGPAT9 1-acylglycerol-3-phosphate O-acyltransferase 9 19.66 6.5189 3.02 
SERP1 small EDRK-rich factor 2 56.38 19.0346 2.96 
LOC520057 #N/A 114.95 39.0595 2.94 
ZDHHC20 zinc finger, CCHC domain containing 6 14.93 5.1975 2.87 
SERBP1 SUMO1/sentrin specific peptidase 6 16.13 5.61632 2.87 
TMEM41B transmembrane protein 30A 16.67 5.80419 2.87 
ILF2 interleukin enhancer binding factor 2, 45kDa 207.66 72.6433 2.86 
GDE1 glycerophosphodiester phosphodiesterase 1 33.40 11.7081 2.85 
CYB5R1 cytochrome b5 reductase 1 21.55 7.55951 2.85 
DNAJC7 DnaJ (Hsp40) homolog, subfamily C, member 7 19.15 6.77096 2.83 
RHOBTB1 ring finger and WD repeat domain 2 18.93 6.69607 2.83 
CFL1 cofilin 1 (non-muscle) 60.20 21.4534 2.81 
MCFD2 
MARCKS-like 1; similar to MARCKS-related protein 
(MARCKS-like protein 1) (Macrophage myristoylated 
alanine-rich C kinase substrate) (Mac-MARCKS) 
(MacMARCKS) (Brain protein F52) 17.65 6.32279 2.79 
WDR96 WD repeat domain 74 14.69 5.33539 2.75 
TAF10 synaptophysin-like 1 354.99 129.035 2.75 
FAM76A family with sequence similarity 76, member A 42.42 15.6108 2.72 
BTG1 B-cell translocation gene 1, anti-proliferative 30.42 11.2972 2.69 
GLOD4 glyoxalase domain containing 4 64.59 24.1218 2.68 
AFF4 AF4/FMR2 family, member 4 69.77 26.1796 2.67 
FAM98A #N/A 22.78 8.61676 2.64 
LIN7C lipoic acid synthetase 23.65 8.94574 2.64 
CCDC135 coiled-coil domain containing 135 18.51 7.01963 2.64 
EIF5A eukaryotic translation initiation factor 5A 79.68 30.2392 2.63 
ATP5I 
ATP synthase, H+ transporting, mitochondrial F0 complex, 
subunit e 200.95 76.5374 2.63 
USP44 ubiquitin specific peptidase 16 45.64 17.547 2.60 
UAP1 thioredoxin-like 1 36.26 13.9643 2.60 
HNRNPH1 #N/A 22.54 8.71883 2.59 
CCDC70 coiled-coil domain containing 70 25.22 9.93395 2.54 
ANKRD32 ankyrin repeat domain 32 23.33 9.34499 2.50 
ACTL7A actin-like 7A 44.54 17.8814 2.49 
IQCG IQ motif containing F5 115.05 46.2528 2.49 
SSR1 #N/A 23.27 9.37931 2.48 
TEKT3 tektin 1 25.22 10.1809 2.48 
RNMT similar to ring finger protein 38; ring finger protein 38 28.31 11.478 2.47 
MCL1 #N/A 19.43 8.01607 2.42 
NXN #N/A 16.39 6.76194 2.42 
SPATA6L spermatogenesis associated 6 89.91 37.4999 2.40 
LSAMP #N/A 14.72 6.14617 2.40 
VIMP vimentin 101.90 42.9584 2.37 
VGLL3 
similar to voltage-dependent anion channel 2; voltage-
dependent anion channel 2 94.26 39.7495 2.37 
POLB pinin, desmosome associated protein 63.50 26.7976 2.37 
FZD7 frizzled homolog 7 (Drosophila) 13.86 5.88325 2.36 
FN3KRP fructosamine 3 kinase related protein 40.66 17.254 2.36 
APOPT1 #N/A 291.65 124.488 2.34 
ACAT1 acetyl-Coenzyme A acetyltransferase 1 99.09 42.3472 2.34 
LOC788205 #N/A 15.40 6.60052 2.33 
BAZ1A bromodomain adjacent to zinc finger domain, 1A 17.47 7.5322 2.32 
RN45S 
RNA component of mitochondrial RNA processing 
endoribonuclease 258.48 113.249 2.28 
RN45S #N/A 258.48 113.249 2.28 
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RN45S #N/A 258.48 113.249 2.28 
RN45S #N/A 258.48 113.249 2.28 
TM9SF2 T-cell immunoglobulin and mucin domain containing 4 31.74 14.211 2.23 
TM9SF2 #N/A 31.74 14.211 2.23 
RAD21 RAB interacting factor 41.18 18.4569 2.23 
ZNF706 hypothetical protein LOC100125413 180.19 81.1021 2.22 
PSMD1 proteasome (prosome, macropain) subunit, beta type, 7 18.26 8.30929 2.20 
CNBP CCHC-type zinc finger, nucleic acid binding protein 30.43 13.921 2.19 
CHMP5 chromatin modifying protein 5 
4359.8
0 1995.9 2.18 
GSTO2 glutathione S-transferase omega 2 121.97 56.3501 2.16 
CSN3 casein kappa 19.71 9.14845 2.15 
MND1 
methylmalonic aciduria (cobalamin deficiency) cblD type, 
with homocystinuria 58.49 27.1507 2.15 
RORA ropporin 1-like 53.29 24.7343 2.15 
CSPP1 centrosome and spindle pole associated protein 1 12.16 5.64413 2.15 
ZNF33B zinc finger protein 24 23.93 11.3243 2.11 
HDGFRP3 #N/A 54.71 26.1645 2.09 
FGA fibrinogen alpha chain 14.62 7.03925 2.08 
BCKDHB 
branched chain keto acid dehydrogenase E1, beta 
polypeptide 20.81 10.1199 2.06 
SHOC2 #N/A 23.88 11.6139 2.06 
MLL5 myeloid leukemia factor 1 10.48 5.131 2.04 
YWHAE yippee-like 2 (Drosophila) 24.40 11.9553 2.04 
RPL23A ribosomal protein L23 34.30 16.8916 2.03 
PPM1G #N/A 40.24 19.8221 2.03 
APOO apolipoprotein O 59.03 29.2261 2.02 
TUBB testis-specific serine kinase 3 10.77 5.33413 2.02 
ZNF428 zinc finger protein 33B 13.24 6.55637 2.02 
STRBP #N/A 21.34 10.5645 2.02 
MAP9 mitogen-activated protein kinase kinase kinase kinase 3 40.52 20.1516 2.01 
MAP9 microtubule-associated protein 9 40.52 20.1516 2.01 
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APPENDIX I 
 
Spermatozoal RNA amount and its relationship with fertility and conventional 
semen parameters 
 
Card CJ and Sartini BL 
 
Abstract 
 While current in vitro male fertility tests can identify infertile sires, they are 
insufficient at detecting differences in individuals that show similar levels of fertility or 
sub-fertility.  The need for more accurate in vitro fertility tests for artificial insemination 
(AI) sires in the dairy industry is apparent.  Currently in vivo fertility tests such as sire 
conception rate (SCR) require hundreds of inseminations per individual bull which 
requires an excess of time and resources.  Mirroring in vivo fertility ratings accurately 
with a fast and reproducible in vitro fertility test would economically benefit the dairy 
industry while also aiding the development of new methods for measuring sperm quality 
in humans.  The goal of this study was to determine if RNA content of transcriptionally 
and translationally silent bovine spermatozoa is an indicator of sperm motility, sperm 
DNA fragmentation, sperm head morphology and in vivo fertility.  A column based RNA 
isolation procedure (Method #1) was developed for bovine spermatozoal RNA.  Although 
this RNA isolation method yielded RNA with acceptable 260/280 ratios (1.85) and no 
detectable somatic cell contamination, transcripts known to be present in spermatozoa 
were not amplified in RNA samples consistently decreasing our confidence that this 
method yielded representative and pure spermatozoal RNA.  Twenty-eight bulls with 
known in vivo fertility scores (CR) were used for analysis of RNA amount, motility, 
sperm head morphology, and DNA fragmentation. No significant correlations were found 
via Pearson correlation analysis between RNA/10 million spermatozoa and CR score,  % 
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motility, percent DNA fragmentation (% DFI), or sperm head morphology harmonics.  
When ranking bulls by RNA/10 million spermatozoa, no significant differences in 
fertility or semen parameters were found when comparing splits of lowest 14/highest 14 
or lowest 10/highest 10 individuals.  These results show that RNA amount isolated with 
this method does not appear to be a good predictor of fertility or semen quality across a 
population of bulls with a wide range of fertility and semen quality parameters.  The lack 
of validation, measured by the ability to amplify spermatozoal transcripts via PCR, of this 
spermatozoal RNA isolation method by amplification of known transcripts also brings 
into question the accuracy of these spermatozoal RNA amounts.  
 
Introduction 
 Male in vitro fertility assays aim to correlate semen parameters with in vivo 
fertility as accurately as possible.  Several sperm traits have been in used recently as in 
vitro fertility assays including scrotal circumference, sperm concentration, motility, 
morphology, and DNA fragmentation (Foote, 2003).  Higher percent motility is 
associated with higher fertility as it increases the chances of sperm reaching the site of 
fertilization.  Sperm head morphology is a conventional semen parameter often analyzed 
and has shown correlations with in vivo fertility (Al-Makhzoomi et al, 2008; Nagy et al, 
2013). Large or misshaped sperm heads could hinder motility or be indicators of 
improper DNA compaction, leading to high susceptibility to DNA damage (Ostermeier et 
al, 2001b).  Higher fertility individuals tend to have more elongated sperm heads than 
their lower fertility counterparts, possibly to due proper chromatin structure (Ostermeier 
et al, 2001b).  Other sperm head measurements, classified as harmonics, have shown 
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correlations with fertility, and may be able to act as markers for bull fertility (Ostermeier 
et al, 2001a).  Normal head morphology has been negatively correlated with DNA 
integrity as measured the sperm chromatin structure assay (SCSA), a flow cytometric 
based assay, in humans and bulls (Garcia-Macias et al, 2007; Nagy et al, 2013; Omran et 
al, 2013).  
 During sperm production, tight compaction of genomic DNA is necessary to 
prevent damage from free radicals, oxidative stress, nucleases, and other factors (Evenson 
et al, 2002).  When DNA is not compacted properly, the chromatin is cleaved; causing 
DNA fragmentation and impaired gene transcription. Sperm DNA fragmentation has 
been correlated with decreased sperm function and can predict sire fertility more 
accurately than sperm motility, morphology, and concentration (Aoki et al, 2005; 
Agarwal et al, 2003; Madrid-Bury et al, 2005).  DNA fragmentation is not only a problem 
for fertilization but post-fertilization as well.  Embryo quality is negatively impacted 
when spermatozoa containing fragmented DNA are used for in vitro fertilization in mice, 
with no resulting embryos progressing to the blastocyst stage (Gawecka et al, 2013).  
Pregnancy is 3.5 times more likely to occur if lower fragmentation sperm is used for in 
vitro fertilization (Avendano et al, 2009).   The percentage of DNA fragmentation in the 
sperm head is correlated with field fertility estimates for bulls, based on non-return rate.   
Semen with lower DNA fragmentation rates (1.6 - 3.8% fragmentation) have a 7% 
increase in successful artificial insemination (Waterhouse et al, 2006).  
 Although each of these sperm parameters have shown correlations with in vivo 
fertility, conventional semen parameters often cannot identify subfertile sires and are 
therefore not consistent indicators of high fertility (Colengrander et al, 2003).  In the last 
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35 years, herd values for scrotal circumference, sperm concentration, and morphological 
traits have stayed consistent while fertility has steadily declined over the same period 
further highlighting the inability of these sperm traits to predict fertility (Dejarnette et al, 
2004).   More accurate fertility tests are needed, perhaps with more of a focus on sperm 
functionality, which could include looking at spermatozoal RNAs.   
It has long been thought that the only function of spermatozoa was to deliver the 
paternal half of the genome to the egg for fertilization.  However, more recently, 
spermatozoa have been shown to also deliver other components to the oocyte at 
fertilization that are necessary for successful early embryogenesis, including a population 
of RNAs from the transcriptionally-inert spermatozoa (as reviewed in Hamatani, 2012; 
Jodar et al, 2013). Spermatozoa contain lower amounts of RNA (5-400 fg/sperm 
depending on species) in contrast to oocytes (0.5-1.5 ng) and other cell types (10-30 pg)  
(Boerke et al, 2007; Das et al, 2010; Hamatani, 2012). The sperm RNA population 
includes coding and non-coding RNAs, such as mRNA, miRNA, siRNA, piRNA, and 
lncRNAs (Jodar et al, 2013).  
The amount of total RNA is higher in morphologically normal sperm than that of 
abnormal sperm (Roudebush et al, 2004).  Amounts of individual spermatozoal RNAs are 
correlated with sperm functional parameters such as sperm concentration, motility, 
morphology, and DNA fragmentation (Lambard et al, 2004; Aoki et al, 2005; Aoki et al, 
2006).  Specifically, sperm motility levels are correlated with the ratio of protamine 
transcripts, Prm1/Prm2 ratios, in human sperm; high motility samples had a low ratio of 
Prm1/Prm2 (Lambard et al, 2004).  Increased Prm1/Prm2 transcript levels and 
corresponding low protein levels in an individual could be an indicator of inefficient 
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translation during spermatogenesis (Aoki et al, 2006).  Also, specific measurements of 
fertility, including in vitro fertilization, sperm concentration, motility, and morphology, 
are all negatively affected when the PRM1/PRM2 protein ratios are abnormally high or 
low (Aoki et al, 2006). DNA fragmentation, or the extent of damaged chromatin in the 
sperm nucleus, is significantly higher in sperm with low PRM1/PRM2 protein ratios 
(Aoki et al, 2005).  
 The goal of this study was to measure the amount of RNA per 10 million sperm 
cells and determine if the amount of sperm RNA is correlated with bovine semen 
parameters such as motility, morphology and DNA fragmentation as well as fertility 
rankings.  Conventional semen parameters are not optimal for ranking individuals by 
fertility or detecting subtle differences between individuals of similar fertility ratings.  
This study is designed to explore a different parameter, sperm RNA amount, as a 
potential predictor for fertility.   
 
Materials and Methods 
Semen Samples 
Cryopreserved semen from twenty-eight bull studs was obtained from Genex Cooperative 
Inc. (Shanawo, WI).  The bulls had CR fertility scores that ranged from -4.7 to 2.2.   
 
DNA Fragmentation Analysis 
DNA fragmentation analysis was conducted on semen from the 28 bulls using the Sperm 
Chromatin Structure Assay (SCSA; Evenson et al, 2002)  
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Head Morphology Analysis 
Morphology analysis was conducted on semen from the 28 bulls using Fourier harmonic 
amplitudes (Ostermeier et al, 2001a).  Harmonic 0 is a measure of overall sperm head 
size.  Harmonic 1 is a measure of the rounding of the anterior portion of the sperm head 
while harmonic 2 measures head elongation.  The remaining harmonics (3-5) are 
measures of the shape of the posterior part of the head.  
 
Semen Thawing 
Frozen bovine semen straws (n=2 for each bull) were thawed in a 37°C water bath for 
one minute.    
 
Sperm-TALP Wash  
Semen was washed with 4 mls sperm-TALP media (100 mM NaCl, 3.1 mM KCl, 25 mM 
NaHCO3, 0.3 mM NaH2PO4, 2 mM CaCl22H2O, 0.4 mM MgCl26H2O, 21.6 mM sodium 
lactate, 1 mM pyruvate, 6 mg/ml BSA, pH 7.3-7.4; Parrish et al, 1999) and centrifuged 
for 10 minutes at 800 x g to remove cryoprotective media.  This sperm-TALP wash is 
repeated a second time, the supernatant is removed and the sperm pellet is subsequently 
used for RNA isolation.   
 
Sperm Motility/Concentration Analysis 
Sperm analysis was conducted to determine motility and concentration values on a Nikon 
Eclipse 50i microscope (MVI; Avon, MA).  Five ul of 100 ul re-suspension solution was 
placed on a warmed slide to maintain motility.  Percent motile sperm was subjectively 
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determined by the same person for all samples by recording motility of 100 sperm.  
Sperm concentration was determined with a hemocytometer.  Numbers of sperm on each 
side of the hemocytometer were averaged together and the sample concentration was 
calculated using a standard hemocytometer formula based on dilution factor.  Using 
concentration numbers, 10 x 106 sperm cells from the remaining re-suspension solution 
were used in the RNA isolation for each bull.   
 
Sperm RNA Isolation (Method #1) 
The sperm pellets were re-suspended into 700 ul of buffer (10 ul 2-Mercaptoethanol + 
1000 ul buffer RLT) for cell disruption (Qiagen; Valencia, CA).  The samples were 
subsequently homogenized using a 26-gauge needle (3x) and extruded into RNase-free 
microfuge tubes.  Subsequent RNA isolation was conducted with the RNeasy kit 
(Qiagen; Valencia, CA) per manufacturer’s directions.  Modifications to the standard 
RNeasy protocol included warming the elution water to 37° C and extending the final 
incubation of the sample on the column for 8 minutes per elution.  RNA concentrations 
were measured using the NanoDrop UV/Vis Spectrometer (Thermo Scientific; Waltham, 
MA).  RNA preparations with A260/A280 ratios over 1.80 (indicating pure RNA) were 
stored at -80°C until needed for further experiments. Amount of total RNA per 106 
spermatozoa for each sample was calculated by dividing the RNA concentration by the 
total number of sperm then multiplying by 106 
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Removal of genomic DNA 
RNA samples were DNAse treated using Turbo DNA-free Kit according to 
manufacturer’s protocol (Ambion/Life Technologies; Carlsbad CA).   
 
Statistical Analysis 
For correlations between semen parameters, a Pearson’s correlation test was used.  When 
ranked by total RNA amount/10 million spermatozoa, motility, % DFI, and head 
morphology parameters H0-H5 were compared between various groupings of the 28 
bulls.  Groups analyzed included 14/14, and lowest 10/highest 10 when ranked by RNA 
amount/10 million spermatozoa and were subjected to unpaired t-tests.   
 
Results 
Semen Analysis 
 After RNA isolation and removal of genomic DNA, the total RNA per 106 sperm 
ranged from 2,782 ng to 13,807 ng.  During the RNA isolation, an aliquot of the sample 
was used for motility analysis, which ranged from 37.5% to 52.5% with one bull’s DFI 
showed a variable range per bull from 6.1% to 30.5%.  The CR, motility, % DFI, 
RNA/10 million sperm are presented in Table 1 and the sperm head morphology ratings 
are presented in Table 2. 
 
Relationships Between Fertility (CR score) and Semen Parameters 
 Head morphology harmonics H0-H5 were not correlated with CR score, with the 
highest correlation at r = 0.164.  CR score showed a moderate correlation with % 
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motility, r2 = 0.385; p = 0.043 (Table 3).  There was no correlation between CR score and 
% DNA fragmentation (r2 = -0.093).   
 
Spermatozoal RNA Amount Related to Semen Parameters 
 No high correlations were found between RNA/10 million sperm and any of the 
semen parameters (Table 3).  No correlations were found between RNA/10 million 
spermatozoa and CR score as (r2 = 0.30), % motility (r2 = 0.25), and HA0 (r2 = 0.32) 
were not significant.  Correlations with other sperm parameters were between  -0.13 < r2 
> 0 .13 thus showing no correlation.  A number of high correlations were found among 
the sperm morphology harmonics (HA0-HA5) ranging from 0.58 - 0.92 when compared 
to one another.    
 Bulls were ranked by RNA/10 million sperm and comparisons were analyzed for 
the 14 lowest RNA amount with 14 highest RNA amount then the 10 lowest RNA 
amount with the 10 highest RNA amount. No significant differences were found for CR 
score or any other semen parameters when ranked by RNA amount and separated into 
these lower and higher groups.  
 
Discussion 
 A correlation of total spermatozoal RNA amount with bovine semen quality or 
fertility has not been explored previously.  In this study, no significant correlations were 
found between total spermatozoal RNA amount and CR score or any semen parameters. 
A previous study reported a higher amount of total RNA in morphologically normal 
sperm than in of abnormal sperm (Roudebush et al, 2004).  In this study however, RNA 
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amount had no correlation with the 6 sperm head morphological harmonics.  It has been 
hypothesized that RNA amount could be related to morphology due to impaired 
transcriptional or translational pathways.  If a greater amount of RNA is present, it may 
be an indicator of inefficient translation of key proteins that aid motility or chromatin 
packaging, thus causing abnormal morphology (Roudebush et al, 2004).  There was only 
a very modest correlation between motility and RNA amount (approaching significance), 
not enough support for this hypothesis with the current data.  Because transcripts known 
to be present in spermatozoa could not amplified in RNA samples consistently, the 
representation and purity of these RNA populations are questionable and definitive 
conclusions about sperm RNA amount and semen parameters cannot be made (see 
Appendix 2).  
 Though linear correlations were lacking between RNA amount and semen quality 
parameters, bulls were separated into groups based upon their spermatozoal RNA levels.  
There were still no significant differences between the low and high RNA groups for any 
parameters when the half and half split (14/14) and the lowest 10 and highest 10 (10/10) 
were compared.  Total RNA amount seems to offer little relevance in predicting fertility 
or semen quality amongst bulls with variable fertility scores.  
 Compensable traits, those that can have deficiencies overcome to an extent by 
fertilizing with more semen, measured in this study included motility and head 
morphology harmonics.  Though the focus of this study was to determine if RNA amount 
could predict fertility or any other semen parameters, other parameters were examined for 
relationships with fertility and the remaining semen parameters.  Motility showed a 
modest correlation with CR score (r = 0.385) while none of the morphology harmonics 
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showed any correlation to CR score (highest at r = 0.164).  Motility and morphology have 
long been used as predictors of sperm fertilization potential (Foote, 2003).  However 
recent evidence supports the notion that these semen characteristics are very limited in 
their ability to predict fertility.  Often these measures only pick out the most sub-fertile 
individuals from the population but have a hard time differentiating the rest of the 
individuals (Petrunkina et al, 2007).   
 Morphological status of semen has been shown to be a better predictor of fertility 
than some other compensable traits such as motility and concentration.  Improper head 
morphology is detrimental to the fertilization potential of spermatozoa as it is often 
indicative of acrosomal defects and incomplete DNA compaction.  Sperm head 
morphology is correlated with fertility in many species (Al-Makhzoomi et al, 2008; 
Gillan et al, 2008; Love, 2011; Nagy et al, 2013).  Like motility, morphological 
measurements have shown variable levels of correlation with fertility in the past but 
individual head morphology harmonics did not show a link to fertility in this study.  
 DNA fragmentation, an uncompensable trait, has shown more promise as an 
indicator of semen quality and fertility.  DNA fragmentation has shown correlations to 
both sperm head morphological status and motility in various studies (Giwercman et al, 
2003; Moskovtsev et al, 2009).  However, another study has shown that DNA 
fragmentation is only linked to sperm vitality and patient age while showing no 
relationship to motility, morphology, or concentration (Cohen-Bacrie et al, 2009).  In this 
study there was no correlation between % DFI and fertility, motility, or RNA amount 
though negative correlations were found with three of the head morphology harmonics, 
possibly indicating that particular head shapes may be indicative of DNA fragmentation.  
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Although there was no link with fertility in this study, DNA fragmentation has been 
found to be a better predictor than compensable traits such as motility and morphology 
(Aoki et al, 2005; Agarwal et al, 2003; Madrid-Bury et al, 2005; Castilla et al, 2010).   
 The need for better in vitro fertility measurements that accurately predict in vivo 
fertility is readily apparent.  Total RNA amount does not appear to predict sire fertility. 
However, a number of individual sperm mRNAs have shown links to fertility when 
expression levels are measured, including PRM1, AK1, IB5, CD36, TIMP, SNRPN2, 
PLCZ1, CRISP2, CCT8, and PEBP1 (Feugang et al, 2009; Feugang et al, 2010; 
Arangasamy et al, 2011; Kasimanickam et al, 2012).  It is apparent that sperm RNA can 
be a valuable diagnostic tool but it must be observed at the individual mRNA level and 
not in regards to total RNA quantity isolated with the column-based RNA isolation 
method.   
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Table 1. CR score, RNA/10 million spermatozoa, % motility, and % DFI 
for Individual Bulls 
Bull CR Score RNA/10 mill sperm (ng) % Motility % DFI 
1 -4.7 2782.789 0 6.8 
2 -3.3 11648.07 37.5 11.7 
3 -2.9 11070.2 47 9.8 
4 -1.9 10650.5 48 14.4 
5 -1.5 5344.173 36.5 30.5 
6 -1.5 3037.502 51.5 9.1 
7 -1.4 9659.487 34 10.9 
8 -1 7424.739 51 13.1 
9 -0.9 10405.7 46.5 21.5 
10 -0.9 6003.03 49.5 21.1 
11 -0.7 7309.06 35.5 7.9 
12 -0.6 9042.087 58 10.9 
13 0.7 11326.42 45 11.1 
14 0.8 11936.45 38.5 14.4 
15 0.8 8714.513 34 12.7 
16 0.8 8105.15 23.5 12 
17 1 10636.82 45.5 11.8 
18 1.1 8535.056 46 12.7 
19 1.2 6309.815 55 14 
20 1.3 11983.17 46.5 8.7 
21 1.3 12528.57 47 8 
22 1.5 13807.37 42 16.5 
23 1.5 6438.878 38 12 
24 1.5 9606.453 41 10.5 
25 1.5 8031.272 48.5 8.9 
26 2 11465.24 39 12.6 
27 2.1 7564.077 45.5 13.3 
28 2.2 8185.131 52.5 6.1 
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Table 2. Sperm Head Morphology Fourier Harmonic Measurements for 
Individual Bulls. 
 Bull HA0 HA1 HA2 HA3 HA4 HA5 
1 3.067075 0.1196819 1.187841 0.09194465 0.2957738 0.09069261 
2 3.118647 0.09430127 1.173004 0.09625085 0.2538151 0.0700948 
3 3.087277 0.1175812 1.032603 0.1278038 0.2130631 0.08314797 
4 3.072428 0.09753479 0.9832771 0.1177246 0.1815846 0.0669689 
5 3.102513 0.08865031 0.9192595 0.113693 0.1282369 0.04416647 
6 2.957772 0.1175632 1.075898 0.1203994 0.2338014 0.08099175 
7 3.280553 0.1549128 1.232687 0.1491078 0.3107107 0.1087798 
8 3.19624 0.09921172 1.102563 0.1136219 0.2066654 0.06916805 
9 3.25312 0.1019572 1.051068 0.1159668 0.1896874 0.06847527 
10 3.068156 0.09327969 1.079726 0.09733689 0.228799 0.06309004 
11 3.066665 0.1514072 1.136857 0.1475045 0.2686795 0.1078571 
12 3.098434 0.136584 1.099823 0.147715 0.2315209 0.09987295 
13 3.209306 0.1015355 1.140226 0.1122499 0.2244274 0.06950404 
14 3.23141 0.1080424 1.10632 0.1266937 0.216668 0.07381759 
15 3.198411 0.09730248 1.115984 0.1052048 0.2122806 0.06275318 
16 3.02259 0.1685147 1.223936 0.129008 0.3381399 0.1217816 
17 3.322652 0.1088058 1.145906 0.1112953 0.2462428 0.09052296 
18 3.127135 0.1310327 1.132599 0.1410027 0.2365529 0.09296565 
19 3.127742 0.1146983 1.106599 0.1163031 0.2591915 0.09443299 
20 3.068512 0.1122507 1.188197 0.1055449 0.2717835 0.08661904 
21 3.230158 0.1039717 1.059529 0.1191768 0.1756475 0.05743645 
22 3.064542 0.1011781 1.14048 0.1015061 0.2422783 0.07707373 
23 3.096737 0.1008863 1.044269 0.1023432 0.1978347 0.06918425 
24 3.214521 0.09727702 1.058098 0.1048204 0.1969743 0.0712937 
25 3.253222 0.09543855 1.105198 0.1083746 0.1943067 0.05374382 
26 3.018042 0.1025259 1.112031 0.1074448 0.2319929 0.07037682 
27 3.221139 0.1255516 1.130806 0.1401007 0.2313195 0.08714826 
28 2.986035 0.09526549 0.9917883 0.1170227 0.1850216 0.06695067 
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APPENDIX 2 
 
Bovine Spermatozoal transcript profile from RNA isolated by RNeasy column-
based method 
 
Card CJ and Sartini BL 
 
Abstract 
 
 Sperm not only deliver the paternal half of the genome to the oocyte but also a 
population of various RNA types.  These RNAs may be crucial for fertilization and 
embryonic development but also offer the potential as a diagnostic tool for fertility.  To 
date the bovine spermatozoal transcript profile remains incomplete due to the reliance on 
hybridization-based technology such as microarrays.  The goal of this study was to utilize 
Illumina RNA-Seq to sequence the bovine spermatozoal RNA profile.  RNA was isolated 
via an RNeasy column based extraction (Method #1) from a pool of bulls with known 
fertility ratings of Conception Rate (CR) -2.9 to 3.5.  Spermatozoal RNA isolated with 
this method had 260/280 ratios > 1.80, lacked contamination from somatic cells, and 
bioanalyzer profiles were consistent with previously published sperm RNA profiles.  A 
total of 8,311 transcripts were found in the bovine spermatozoal RNA population when 
reads were aligned to the bovine genome (UMD 3.1/bosTau6).  Some of the most 
abundantly expressed transcripts include RPS3, YWHAE, and H2AFZ.  Gene ontology 
analysis revealed 762 Biological Processes (BP) categories represented by at least 6 
transcripts and as many as 669 transcripts.  The top three BP categories represented were 
regulation of transcription, regulation of RNA metabolic processes, and regulation of 
transcription (DNA-dependent).  We were unable to validate the presence of a number of 
transcripts therefore the validity of this sequenced spermatozoal transcript profile is 
questionable. A second method for spermatozoal RNA isolation was developed and the 
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sequenced spermatozoal transcript profile is reported in Chapter 2 (Card and Anderson et 
al., 2013). 
 
Materials and Methods 
Semen samples 
Cryopreserved semen from twenty-eight bull studs was obtained from Genex Cooperative 
Inc. (Shanawo, WI).  The bulls had CR fertility scores that ranged from -2.9 to 3.5.   
 
Semen thawing 
Frozen bovine semen straws (n = 2 for each bull) were thawed in a 37°C water bath for 
one minute.    
 
Sperm-TALP wash  
Semen was washed with 4 ml sperm-TALP media (100 mM NaCl, 3.1 mM KCl, 25 mM 
NaHCO3, 0.3 mM NaH2PO4, 2 mM CaCl22H2O, 0.4 mM MgCl26H2O, 21.6 mM sodium 
lactate, 1 mM pyruvate, 6 mg/ml BSA, pH 7.3-7.4; Parrish et al, 1998) and centrifuged 
for 10 minutes at 800 x g to remove cryoprotective media.  This sperm-TALP wash is 
repeated a second time, the supernatant is removed and the sperm pellet is subsequently 
used for RNA isolation.   
 
Sperm RNA isolation (Method #1) 
The sperm pellets were re-suspended into 700 ul of buffer (10 ul 2-Mercaptoethanol + 
1000 ul buffer RLT) for cell disruption (Qiagen; Valencia, CA).  The samples were 
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subsequently homogenized using a 26-gauge needle (3x) and extruded into RNase-free 
microfuge tubes.  Subsequent RNA isolation was conducted with the RNeasy kit 
(Qiagen; Valencia, CA) per manufacturer’s directions.  Modifications to the standard 
RNeasy protocol included warming the elution water to 37° C and extending the final 
incubation of the sample on the column for 8 minutes per elution.  RNA concentrations 
were measured using the NanoDrop UV/Vis Spectrometer (Thermo Scientific; Waltham, 
MA).  RNA preparations with A260/A280 ratios over 1.80 (indicating pure RNA) were 
stored in the -80°C freezer until needed for further experiments.  
 
Removal of genomic DNA 
RNA samples were DNAse treated using Turbo DNA-free Kit according to 
manufacturer’s protocol (Ambion/Life Technologies; Carlsbad CA).   
 
mRNA amplification 
RNA samples were mRNA linearly amplified using the SMART mRNA amplification kit 
per manufacturer’s protocol (Clontech; Mountain View, CA).  
 
 
 
Polymerase chain reaction (PCR) 
PCR conditions were 94° for 5 min, followed by 35 cycles of 94° for 30 sec, 60° for 30 
sec, 72° for 30 seconds and a final extension at 72° for 10 min with transcript specific 
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primers.  Negative controls included a no enzyme control as well as a no template 
control.   
 
RNA-Seq  
RNA-Seq analysis was performed on amplified mRNA from a pool of 10 bulls with 
fertility scores ranging from -2.9 to 3.5.  This pooled sample was run on the Illumina 
HiSeq 2000 to generate paired-end 100 bp reads (Tufts University; Boston, MA).  All 
read processing, alignment, and transcript expression analysis was performed using 
Galaxy (Giardine et al., 2005; Blankenberg et al., 2010; Goecks et al., 2010).  Reads were 
aligned to the bovine genome (UMD 3.1/bosTau6) was performed using Tophat 
(Langmead et al., 2009; Trapnell et al., 2012).  The maximum number of mismatches 
allowed during alignment was two.  Read and post-alignment statistics were obtained 
using analysis from RSeQC (Wang et al., 2012).  Cufflinks analysis was performed on 
aligned reads to determine transcripts present and their respective expression levels, 
denoted as Fragments Per Kilobase of exon per Million fragments mapped (FPKM) 
(Giardine et al., 2005).  
 
Gene ontology analysis 
Gene ontology analysis was performed using the DAVID Bioinformatics Database 
(http://david.abcc.ncifcrf.gov/) using three main categories: Biological Processes (BP), 
Molecular Function (MF), and Cellular Component (CC).    
 
 
 155 
Results 
RNA quality 
 Bull spermatozoal RNA isolated with the column-based method was devoid of 
contamination from germ cells and leukocytes as demonstrated by the lack of 
amplification for C-KIT and CD45 respectively (Figure 1).  Bioanalyzer analysis reveals 
a lack of 18S and 28S peaks compared to the control testis as expected (Figure 2).  The 
amplified mRNA sperm sample showed a broad peak for its RNA profile with a greater 
presence of smaller RNAs (Figure 2).  Nanodrop analysis results showed 260/280 ratios 
that ranged from 1.83 to 1.87.    
 
Illumina Sequencing 
 Using the Illumina HiSeq 2000, a total of 126,797,470 x 2 paired-end reads were 
generated that were all 100 bp in length.  When mapping the reads to the UMD 
3.1/bosTau6  version of the bovine genome, 17.75% of the reads mapped to the bovine 
genome and 37% of these were uniquely mapped to a single transcript.  Mapping 
statistics show that almost all fragments assigned to genes fell within coding exons and 
there was slightly more saturation at the 3’ end over the 5’ end with 107.43 reads/kb 
versus 80.74 reads/kb respectively.  Very few reads mapped to intronic regions at just 
0.82 reads/kb.   
 
Cryopreserved bovine spermatozoal transcript profile 
 A total of 8,311 transcripts were identified as expressed, FPKM>0, in the pool of 
10 bulls.  This population includes nuclear-encoded transcripts as well as 4 
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mitochondrial-encoded transcripts.  The top 10 transcripts, excluding transcripts coding 
for ribosomal proteins, based on FPKM expression levels are listed in Table 1.  A number 
of transcripts from this profile were unable to be validated through PCR as their presence 
was not found in similarly isolated samples, including: ACTINB, EIF1, EIF4A, GAPDH, 
and DBY.   
 Despite the inability to validate the spermatozoal RNA isolated with the column 
based method, there are several similarities between the transcript profile of RNA 
isolated with Method 1 and Method 2 (TRIzol isolation) reported in Chapter 2 of this 
dissertation. This profile contained a total of 8,311 transcripts while the RNA isolation 
Method 2 contained 6,166 transcripts.  When comparing the two populations a total of 
4,126 transcripts were common between the two populations.  Also, 2,040 transcripts 
were found unique to the Method 2 population while 4,206 were unique to this 
population (Figure 3).   
 
Gene ontology analysis 
 When examining all expressed transcripts (FPKM>0) a total of 762 BP categories 
were present with each being represented by a range of 6 to 669 transcripts (Table 2).  A 
total of 213 CC categories were found to be relevant with 7 to 786 transcripts 
representing each category.  The final category, MF, had 191 represented categories with 
each including anywhere from 6 to 1226 transcripts.  The top three BP represented by the 
dataset include regulation of transcription, regulation of RNA metabolic processes, and 
regulation of transcription (DNA-dependent).  
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 Gene ontology analysis was also performed on the population of spermatozoal 
transcripts common between the profiles sequenced with the two RNA isolation methods.  
The top 3 BP categories in this common population are regulation of transcription, 
protein localization, and transcription (Table 3).  For the transcript population unique to 
Method 1, the top 3 BP categories are regulation of transcription, regulation of RNA 
metabolic process, and regulation of transcription (DNA-dependent) while the unique to 
RNA isolation Method 2 had a top three BP category list of proteolysis, oxidation 
reduction, and translation.  
 
Discussion 
 High-throughput sequencing of spermatozoal RNA isolated with a column-based 
procedure (Method #1) identified 8,311 transcripts.  The isolated bovine spermatozoal 
RNA isolated with this method was devoid of somatic cell and testicular germ cell 
contamination, consistent with porcine spermatozoal RNA isolated with the same method 
(Yang et al, 2009).  Bioanalyzer analysis of this isolated spermatozoal RNA showed a 
population of small RNAs that was comparable to previous literature showing a low 
concentration of RNA with a broad peak that is at its highest where smaller sized RNAs 
would be present (Das et al, 2010).  This RNA profile differed from the profile of 
spermatozoal RNA isolated with a phenol-based method (Method #2) as it includes larger 
RNAs than those profiles (Gilbert et al, 2007; Card and Anderson et al, 2013).  Isolation 
Method #1 also yielded higher RNA amounts per spermatozoa (600-1000 fg per 
spermatozoa) than was reported in other studies using a TRIzol RNA isolation (Method 
#2) method (5-400 fg RNA per spermatozoa; Boerke et al, 2007; Das et al, 2010; 
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Hamatani 2012).  The increase RNA yield may represent the true amount of RNA in 
sperm or could include contamination from other sources that were not tested for.  
Though high quality RNA can be isolated through a variety of methods, the isolation 
method should be chosen to yield the desired subset of RNA.  For example, the total 
spermatozoal RNA population contains mostly smaller RNAs, in which a phenol-based 
isolation method such as Method #2 would an optimal choice to efficiently isolate this 
segment of RNA populations as phenol based isolation methods generally yield more 
smaller sized RNAs than column based methods (Eldh et al, 2012).    
 Despite the high quality of the RNA isolated and the number of transcripts 
sequenced, we were unable to validate the sperm transcript profile by PCR amplification 
of individual transcripts in an aliquot of RNA from sequenced population or in RNA 
from other individuals that were isolated in the same manner.  Several spermatozoal 
transcripts were identified from previous publications but were not identified in this 
transcript profile.  Anticipated transcripts that were not present in the sperm transcript 
profile, including TNP1, TNP2, PGK2, AKAP4, RPS4Y, PRM2, PLCZ1, CSN2, and 
CRISP2 (Swann et al, 2006; Gilbert et al, 2007; Feugang et al, 2010; Yao et al, 2010; 
Arangasamy et al, 2007; Ganguly et al, 2012).  Only the PRM1 and CLU transcripts were 
amplified, although inconsistently, in a similar sperm RNA population isolated via 
isolation Method #1.  PRM1 and TNP1 were not identified in the sequenced sperm 
transcript profile.  PRM1 is one of the most studied sperm RNAs and has been reported in 
bovine spermatozoa in numerous studies, as well as TNP1 (Gilbert et al, 2007; Feugang 
et al, 2010; Hecht et al, 2011).  The absence of these transcripts in the spermatozoal RNA 
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population lead us to question the validity of the isolation Method #1, and the biological 
representation of the resulting spermatozoal transcript profile.  
 Due to the inability to validate the spermatozoal transcript profile sequenced from 
sperm RNA isolated with Method #1, a TRIzol RNA isolation method (Method #2) for 
bovine spermatozoal was developed and validated from a horse spermatozoal RNA 
protocol (Card and Anderson et al, 2013 and Das et al., 2010).  The RNA from the 
TRIzol isolation (Method #2) had lower A260/A280 ratios (around 1.60) but was more 
consistent with previously published data.  Though the ratios were lower in RNA isolated 
with this method, the resulting sperm RNA population was treated with a DNAse and 
cDNA amplified then sequenced and successfully validated (Card and Anderson et al., 
2013).  
 There were many similarities between the sequences transcript profile for Method 
#1 with the transcript profile from Method #2.  The percent of reads aligned to the 
genome was similar (at 16% from Method #1 versus the 14% in Method #2). Also, 4,126 
transcripts are common between the two populations.  There were also just over 2,000 
transcripts unique to the isolation Method #2 population with just over 4,000 unique to 
this population from Method #1.  A total of 8,311 transcripts were expressed in 
population from isolation Method #1, which is comparable to the 6,166 from isolation 
Method #2 (Card and Anderson et al, 2013).  These differences must be due to not only 
sample preparation differences but also due to some different individual bulls used for the 
sequenced population.   
 Another reason for the difference in transcripts expressed is due to the data 
processing method.  The number of transcripts expressed and similar/unique to 
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populations was based on accession numbers.  A number of transcripts are represented by 
multiple accession numbers, in which there is potential that one transcript is represented 
by one accession number in a dataset, and then the other dataset contains that accession 
number but an additional accession number for the same transcript.  This would result in 
the same transcript being represented by a common transcript and a unique transcript to 
one population.  A number of transcripts in both populations were found expressed at 
very low levels, with only a few reads hitting on a transcript within the genome.  These 
transcripts are likely insignificant to the datasets but were included in analysis.  Although 
the fertility ranges were the same, individual variance has been seen in many species 
when comparing transcript profiles and is likely a large contributor to difference in the 
two transcript profiles (Ostermeier et al, 2002).   
 Some of the common transcripts that have been found between the RNA-Seq 
populations isolated using Method #1 and Method #2 include many found in previous 
literature such as CHMP5, CLGN, H2AFZ, CLU, MYCBP, PEBP1, CCT8, DDX3Y, 
PPIH, STRBP, and FLOT1.  Two transcripts expressed in this population, PEBPI and 
CCT8, have already shown to be correlated with fertility in bulls (Arangasamy et al, 
2011).  PEBP1 is known to have function associated with capacitation as it causes 
alterations in the plasma membrane located both in the tail and head of sperm.  CCT8 has 
been localized in centrioles and microtubules but appears to get discarded when the 
residual body is shed.  This transcript has been negatively correlated with fertility; 
meaning that its presence indicates that residual bodies were not shed and the sperm is 
potentially immature (Arangasamy et al, 2011).    
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 Some transcripts that were found in both populations had very different 
expression levels.  For example, H2AFZ is expressed at 6,200 FPKM (one of the highest 
transcripts; Method #1) when the Method #2 population had an expression level of 166 
FPKM.  Another example is that of CHMP5 in which this population, Method #1, had a 
low FPKM at 32 while it was one of the highest expression levels in the Method #2 
population at 2,778.  As the fertility range of the bulls was the same between populations, 
with many of the same bulls being used, this would be most likely attributed to sample 
preparation and sequencing differences.  
 Amongst the common transcript population gene ontology analysis showed a 
prevalence of transcripts involved in transcription, metabolic processes, and translation.  
Many of these transcripts are probably remnants of spermatogenesis and could be useful 
diagnostic tools for fertility.  Some of the transcription and translation associated genes 
could also be interesting candidates for full-length examination as they could be crucial 
post-fertilization before the embryonic genome takes over, which occurs around the 8-
cell stage in the cow (Boerke et al, 2007).   
 Some differences that remain concerns for this data set were also apparent in post-
sequencing analysis.  There were only 3 mitochondrial-encoded transcripts present in this 
population while 33 mitochondrial-encoded transcripts were identified in the 
spermatozoal transcript from RNA isolation Method #2.  This number is lower than 
expected, as there is a high level of mitochondrial activity in the mid-piece of 
spermatozoa that provides energy for sperm motility.  Only 37% of the aligned sequence 
was uniquely aligned to the genome, a much lower percentage than that of data from 
isolation Method #2, which was up at 80%.    
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  The spermatozoal RNA profile obtained by RNA-Seq of spermatozoal RNA 
isolated with the column-based method (Method #1) resulted in a transcript profile that 
could not be validated.  A TRIzol spermatozoal RNA isolation method was developed 
(Method #2) for bovine and that transcript profile was validated (Card and Anderson et 
al., 2013, Chapter 2 of this dissertation).  Although many similarities are noted in the two 
transcript profiles from the different isolation method, differences apparent in the 
column-based profile (presented in this appendix) may demonstrate contamination of the 
RNA. These experiments highlight the variation that can occur with different RNA 
isolation methods.  
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Figure 1. Spermatozoal RNA isolated with a column based method (Method 1) lacks 
contamination from germ cells (C-KIT) and leukocytes (CD45).  Three different sperm 
isolations were tested (Sp1-3).  Testis (T) positive control and negative controls (-RT) 
containing no enzyme and no template respectively.     
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Figure 2. Bioanalyzer electropherograms for testis and amplified sperm mRNA (Method 
1 isolation) samples.  M = Marker; 18S = 18S ribosomal RNA peak; 28S = 28S 
ribosomal RNA peak.   
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Figure 3. Common and unique spermatozoal transcripts between data from RNA isolated 
with the column based method (A) and the TRIzol method (B: Card and Anderson et al., 
2013, Chapter 2 of this dissertation).
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Table 1. Top 10 bovine spermatozoal transcripts based on FPKM 
Gene Symbol Gene Name Accession no. FPKM 
HRAS similar to GTPase Hras AJ437020 43728.7 
YWHAE tyrosine 3-monooxygenase activation protein BC102928 6290.88 
H2AFZ H2A histone family, member Z BC109743 6200.32 
LOC782052 basic transcription factor 3 AB098942 4144.2 
PTGES3 prostaglandin E synthase 3 (cytosolic) AY692440 4050.95 
PCBP2 poly(rC) binding protein 2 BC103397 3681.9 
HMGN2 high-mobility group nucleosomal binding domain 2 BC142241 3447.87 
HNRNPC heterogenous nuclear ribonucleoprotein C (C1/C2) BC104494 3378.44 
LOC789867 eukaryotic translation elongation factor 1 alpha 1 AF013213 3348.21 
PRDX1 peroxiredoxin 1 AB098940 3235.42 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 169 
Table 2. Top 10 gene ontology categories 
 
Transcripts 
% of Total 
Transcripts 
Biological Process 
  Reg. of Transcription 669 9.06 
Reg. of RNA Metabolic Process 451 6.11 
Reg. of Transcription, DNA-dependent 439 5.94 
Transcription 398 5.39 
Phosophorous Metabolic Process 372 5.04 
Phosphate Metabolic Process 372 5.04 
Protein Localization 351 4.75 
Est. of Protein Localization 323 4.37 
Intracellular Signaling Cascade 323 4.37 
Protein Transport 322 4.36 
   Cellular Component 
  Non-membrane-bounded Organelle 786 10.64 
Intracellular Non-membrane-bounded Organelle 786 10.64 
Mitochondrion 557 7.54 
Membrane-enclosed Lumen 518 7.01 
Intracellular Organelle Lumen 499 6.76 
Organelle Lumen 499 6.76 
Organelle Membrane 420 5.69 
Nuclear Lumen 371 5.02 
Cytoskeleton 369 4.99 
Endoplasmic Reticulum 333 4.51 
   Molecular Function 
  Ion Binding 1226 16.59 
Cation Binding 1214 16.44 
Metal Ion Binding 1202 16.27 
Nucleotide Binding 973 13.17 
Transition Metal Ion Binding 864 11.69 
Purine Nucleotide Binding 805 10.89 
Purine Ribonucleotide Binding 775 10.49 
Ribonucleotide Binding 775 10.49 
Zinc Ion Binding 681 9.22 
Nucleoside Binding 624 8.45 
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Table 3. Top 10 gene ontology categories for common transcripts 
 
Transcripts 
% of Total 
Transcripts 
Biological Process 
  regulation of transcription 319 8.21 
protein localization 203 5.22 
transcription 200 5.15 
phosphorus metabolic process 190 4.89 
phosphate metabolic process 190 4.89 
protein transport 188 4.83 
establishment of protein localization 188 4.84 
proteolysis 185 4.76 
macromolecule catabolic process 168 4.32 
cellular macromolecule catabolic process 160 4.12 
   Cellular Component 
  non-membrane-bounded organelle 493 12.68 
intracellular non-membrane-bounded organelle 493 12.68 
mitochondrion 331 8.52 
membrane-enclosed lumen 322 8.28 
intracellular organelle lumen 311 8.01 
organelle lumen 311 8.01 
nuclear lumen 236 6.07 
organelle membrane 231 5.94 
cytoskeleton 221 5.69 
ribonucleoprotein complex 208 5.35 
   Molecular Function 
  metal ion binding 615 15.82 
nucleotide binding 545 14.02 
transition metal ion binding 442 11.37 
purine nucleotide binding 434 11.17 
purine ribonucleotide binding 421 10.83 
ribonucleotide binding 421 10.83 
nucleoside binding 338 8.69 
purine nucleoside binding 336 8.64 
adenyl nucleotide binding 333 8.57 
adenyl ribonucleotide binding 320 8.23 
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APPENDIX 3: PROTOCOLS 
 
 
Percoll Separation and TRIzol Sperm Isolation 
 
Sperm-TALP media (Parrish et al., 1998) 
 
                                   Final concentration           FW          g per 100 mls  
NaCl                               100 mM                          58.4              0.584 
KCl                                 3.1 mM                          74.55             0.023 
NaHCO3                          25 mM                          84.01               0.21 
NaH2PO4                        0.3 mM                         120                0.0036 
HEPES                            10 mM                          238.3                0.238 
*Add CaCl2 and MgCl2 after all other powders are in solution 
CaCl2.2H20                        2 mM                          111                0.022 
MgCl2.6H20                     0.4 mM                      95.21               0.003 
Lactate (sodium salt)    21.6 mM                          112                0.308 ml   (fridge) 
 
Combine all chemical powders and solutions in 100 mls of dH2O.  
Sterile filter and store at 4°C in glass bottle.  
Good for 1 month 
On day of isolation: Supplement with pyruvate (1 mM). Be sure to adjust pH (7.3-7.4). 
Then add BSA.  
 
10X Tyrode’s: 
For 100 ml, mix the following in in 80 mls of dH20: 
                                      Final concentration         FW          100 mls 
KCl                                       31 mM                      74.55         0.230 g 
NaCl                                    800 mM                      58.4          4.675 g 
NaH2PO4                               3 mM                        142             0.04 g 
HEPES                                100 mM                      238.3          2.09 g 
Bring volume to 100 mls with dH20 
pH to 7.3 
Sterile filter and store in glass bottle in refrigerator indefinitely 
Re-adjust pH as needed 
 
90% isotonic Percoll            Conc.             FW 
Percoll                                                                               9 mls 
10X Tyrode’s                                                                    1 ml 
NaHCO3                                 25 mM             84            0.021 g 
Lactic acid (sodium salt)     21.6 mM           112               37 ul             (fridge) 
CaCl2 .2H20                              2 mM             111             20 ul  
      Stock = Add 0.735 g CaCl2.2H20 to 5 ml dH20 
                   Sterile filter, aliquot and freeze at -20°C 
MgCl2                                    0.4 mM          95.21            39 ul 
       Stock = Add 0.02 g MgCl2.6H20 to 10 ml of dH20      
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 Sterile filter, aliquot and freeze at -20°C 
 Mix in a sterile 15 ml conical tube.   
 Add ingredients in order listed.   
 Cap and vortex to mix.  Lactic acid may sink to bottom of tube. Be sure it is mixed in 
solution.  
 DO NOT FILTER.  Store at 4°C for up to 2 weeks. 
 
Percoll Washing Sperm Protocol for RNA and protein isolation from fresh sperm 
This protocol will separate a population of motile viable sperm from dead sperm and 
extender and/or seminal fluid. 
 
Need:  
38.5°C water bath 
Sperm-TALP with pyruvate and BSA 
90% Percoll 
 
Sperm-TALP Day of:  
- Add pyruvate (0.0012g/10 mls sperm-TALP) (fridge) 
- Check pH (7.3-7.4) and adjust if needed with acid or base. Add 10 to 20 uL at a time. 
- Add BSA (0.06 g/10 ml sperm-TALP) (fridge) 
- Sterile filter 
- Warm sperm-TALP in 38.5°C water bath 
 
Preparation for one Percoll gradient:  
 Add 100 ul of 90% Percoll to a 15 ml tube.  Mark this fluid level on the tube with a 
sharpie.   
 Add another 200 ul and mark this level also.   
 Add 1.7 ml more Percoll to bring to a total volume of 2 mls.   
 In another 5 ml tube, dilute 1 ml 90% Percoll with 1 ml sperm-TALP (with pyruvate and 
BSA) to make 2 ml 45 % Percoll (*Always make fresh 45% Percoll day of separation).  
 Leave these tubes at room temperature until used.  
 
Layering Percoll gradient:  
 Layer 2 mls of 45% Percoll onto the 2 mls 90% Percoll in the 15 ml tube by slowly 
pipetting using glass pipette with plastic bulb. Minimize splashing as much as possible. 
Make sure the two layers do not mix! 
 Cut 2 straws of sperm so contents flow into 1.5 mL centrifuge tube. If there is semen left 
in tip of straw, use pipette with tip at opposite end to push out into tube by pipetting up 
and down. Once straw contents are in centrifuge tube, pipette onto Percoll gradient.  
 
Centrifugation and washing:  
 Centrifuge for 30 minutes at 340 x g  
 Remove supernatant from the live layer and discard.   
 Add 4 mL of warmed sperm-TALP to live and dead samples in separate conical tubes. 
 Centrifuge at 800 x g for 10 minutes. 
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Microscope Work:   
 Remove supernatant down to 300 uL mark on conical tube.  
 Reconstitute pellet in 300 uL of solution. 
 If doing more than one Percoll gradient then pool all of the 300ul solutions together in 
one 15ml conical tube and reconstitute 
 Set 5 uL aside on slide (warmed to 30oC) for motility.  
 Remove another 3 uL of sample and put into 1.5 mL centrifuge tube with 27 uL water. 
Mix well and put 10 uL of sample on each side of hemocytometer.  
  
 MICROSCOPE: 
 Hemocytometer: Count 5 squares (each square consists of 15 small squares), 
diagonally. Record numbers and save for later calculations. 
 Motility: Starting at 50%, determine if motility is over or under. From that, 
determine if motility is over or under half-way point of remaining percentile. 
Continue until accurate motility can be determined at a multiple of 5.  
  
Use average hemocytometer count to dilute sample to 30,000,000 sperm cells/ul 
See Capacitation Protocol 
 
 TRIzol Isolation  
1. Add 1 mL TRIzol (or 750 uL TRIzol LS) reagent to sperm pellet + 3 µL Glycogen 
AFTER sperm has been washed twice for 10 minutes at 800 x g in sperm-TALP.  
3. Lyse sample with 26 ga, 6cc needle 20 times and incubate for 30 minutes at room 
temp. 
4. Add 200 µL chloroform per 1 mL TRIzol (or 750 uL TRIzol LS) reagent to sample. 
Shake for 20 seconds then let sit at room temperature for 10 minutes. 
5. Centrifuge at 12,000x g (11,400 RPM) for 15 minutes at 4o C. 
6. Remove clear aqueous layer at top (contains RNA) and put in new tube. Use a smaller 
sized pipette when closer to the division between the pink and clear layer.  
7. Add 500 µL ice cold isoproanol and let sit for 10 minutes on ice. 
Keep on ice for the remainder of isolation protocol. 
8. Centrifuge at 12,000x g for 10 minutes at 4o C. 
9. Remove and discard supernatant and add 1 mL 75% ethanol to pellet. 
Vortex briefly, then centrifuge at 12,000x g for 5 minutes at 4o C. 
10. Remove supernatant and air dry pellet on ice for 5 - 10 minutes. 
After 5 minutes on ice, remove any accumulated supernatant again. 
11. Add 60 µL of Nuclease-Free water to pellet. 
Vortex until RNA pellet is dissolved in solution. 
12. Nanodrop and store sample at -80o C. 
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Sperm Wash and RNA Isolation (RNeasy Kit) 
 
Sperm Wash 
1. Thaw frozen semen straws in water bath  
 
2. Add 100 ml sperm-TALP to thin conical tube and mark line at 100ul mark and then 
add semen sample to tube 
 
3. Add 4 ml of prepared/warmed sperm-TALP to sample and centrifuge for 10 minutes at  
600 x g(RCF) in swinging bucket centrifuge 
 
4. Remove supernatant from sperm pellet, add 4 ml of sperm-TALP and centrifuge again 
for 10 minutes at 600 x g(RCF)  
 
5. Remove supernatant down to 100 ul mark and reconstitute pellet into remaining sperm-
TALP 
 
6. Put 5 ul of sample onto warmed slide and use microscope to determine motility 
 
7. Dilute 3 ul of sample into 27 ul water and use this mixture on hemocytometer to 
determine sperm concentration (see hemocytometer protocol) 
 
 
 
RNA Isolation 
-All steps should be done at room temperature 
-Use RNA microcentrifuge and keep temperature between 20-25°C, making sure it does 
not cool below 20°C. 
 
Before Starting: 
- β-Mercaptoethanol (β-ME) must be added to the Buffer RLT before use.  Add 10ul β-
ME per 1ml Buffer RLT.  Dispense in a fume hood and set aside for use during isolation 
steps. 
 
-Make sure Buffer RPE has had ethanol added via kit instructions in RNeasy Kit before 
use.   
 
Procedure: 
1. Add 700ul of buffer RLT(with β-ME) to 10 million sperm cells worth of sample from 
wash and let sit for 10 minutes. 
 
2. Suck sample in and out of 26 ½ gauge needle 3x using weighing boat to hold sample.  
After 3rd run through the needle, dispense sample into 1.5ml centrifuge tube.   
 
3. Centrifuge the lysate for 3 minutes at 13,000 rpm.   
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4. Add 700ul of 70% ethanol to the cleared lysate and mix immediately by pipetting.  DO 
NOT CENTRIFUGE.  Proceed immediately to step 5.   
 
5. Transfer up to 700ul of the sample, including any precipitate that may have formed to 
an RNeasy spin column placed in a 2ml collection tube from the kit.  Close the lid gently 
and centrifuge for 15 seconds at 13,000 rpm.  Discard the flow-through from the 
collection tube.  Reuse the collection tube and repeat this process until the entire sample 
has been run through the column.  Discard the flow-through each time and use the same 
collection tube for the next step. 
 
6. Add 700ul of Buffer RW1 to the RNeasy spin column.  Close the lid gently and 
centrifuge for 15 seconds at 13,000 rpm to wash the spin column membrane.  Discard the 
flow-through and reuse the collection tube in the next step.   
 
7. Add 500ul of Buffer RPE to the RNeasy spin column.  Close the lid gently and 
centrifuge for 15 seconds at 13,000 rpm to wash the spin column.  Discard the flow-
through and reuse the collection tube in the next step.   
 
8. Add 500ul of Buffer RPE to the RNeasy spin column.  Close the lid gently and 
centrifuge for 2 minutes at 13,000 rpm to wash the spin column.  Discard the flow-
through.   
 
9. Place the RNeasy spin column into a new 2ml collection tube and discard the old 
collection tube.  Centrifuge for 1 minute at 13,000 rpm.   
 
11. Place the RNeasy spin column into a new 1.5ml microcentrifuge tube.  Add 55ul of 
RNase-free water (heated to 37.5°C) directly onto the spin column membrane.  Let the 
water sit on the column 8 minutes and then close the lid gently and centrifuge for 1 
minute at 13,000 rpm to elute the RNA.   
 
12. Take the 55ul of sample from the collection tube and reapply it to the RNeasy spin 
column.  Let the sample once again sit for 8 minutes and then centrifuge for 1 minute at 
13,000 rpm to elute the RNA.   
 
13. Put the RNA sample on ice and bring to Nanodrop to determine the concentration of 
the RNA (see Nanodrop protocol).   
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RNA Quality Gel 
 
To check the integrity of your RNA sample and for Northern analysis 
 
After RNA isolation: 
Retreive aqueous RNA sample from -80°C 
OR 
Do ethanol precipitation of RNA sample that was stored at -20°C 
Check concentration on Nanodrop 
Make aqueous solution sample in RNAase free water  
         To check RNA sample 5 ug in 5 ul H20 
         For Northern analysis 15 ug in 5 ul H20 
***KEEP SAMPLE ON ICE AT ALL TIMES UNLESS NOTED****** 
 
10X MOPS  
41.8 g MOPS 
in 700 ml of DEPC-treated H20 
Adjust pH to 7.0 with 2 N NaOH 
Add 20 ml of DEPC-treated 1 M sodium acetate 
Add 20 ml of DEPC-treated 0.5 M EDTA (pH 8.0) 
Adjust the volume to 1 liter with DEPC-treated H20 
 
Gel preparation:  
Use only DEPC-treated solutions and baked glassware to analyze RNA 
Bake glassware: 200°C for 4 hours 
Clean gel box, gel bed and comb with RNase away and wipe dry 
Position gel box with rubber gaskets at wall of gel box  
 
For 50 ml gel:  
Weigh out 0.5 g agarose (Fisher BP1356-100 Northerns) (for a 1% gel)  
Place agarose in a RNase-free 125 ml flask 
Add 44 ml DEPC H20 and swirl to mix 
Cover flask with double layer of plastic wrap  
Heat in microwave for 1 minute on high power.   
Open microwave and swirl flask  **Flask is hot** Tilt flask away from your face*** 
Heat in microwave for another 30sec to 1 minute until agarose is completely melted (no  
                  bubbles or “little contact lenses”) 
Remove from microwave and cool solution until you can touch the bottom with your 
hand 
After solution has cooled, add 5 ml of 10X MOPS, pH 7.0 
Add 0.885 ml 12.3M formaldehyde (final concentration in gel is 0.22M) 
Pour gel, pop any air bubbles with a RNase-free pipet tip, ADD COMB and let gel 
polymerize 
 
Running buffer:  
55 ml of 10 X MOPS, pH 7.0 + 9.8 ml formaldhyde (final 0.22 M) + 485.2 ml DEPC H20 
 177 
 
After gel has set, remove comb and turn gel 
Pour tank buffer to just cover gel 
Replace gel box cover until ready to use to prevent formaldehyde fumes from coming 
 
Sample preparation: Add 5 ul RNA loading buffer (stored in -20°C freezer) to 5 ul 
aqueous RNA sample.  Heat to 65C for 10 minutes then chill on ice for 5 minutes.  Load 
into wells of gel and note sample loading in lab notebook. 
 
Plug in red and black leads to power supply (make sure these are in the correct position!) 
and run get at  80 V for approximately 45 minutes or until the sample is 2/3 the length of 
the gel. Look for bubbles to make sure you have current.   
 
TURN OFF THE POWER!!!! AND UNPLUG THE UNIT FROM THE POWER 
SUPPLY!!!!! 
With gloves, remove the gel bed onto a piece of saran wrap.  The sample lane contains 
Ethidium Bromide so avoid touching the gel.  Analyze the gel with the UV box and 
check the ratio of the 28S to 18S ribosomal RNA.  Save an image of your gel.  
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SMARTer Pico ds-cDNA Synthesis (Amplification Kit) 
 
First-strand cDNA synthesis 
1. For each sample and Control Mouse Liver Total RNA, combine the following 
reagents in separate 0.5 ml reaction tubes: 
1–50 µl  RNA (1-1,000 ng of total RNA)* 
7 µl  3’ SMART CDS Primer II A (12 µM) 
x µl  Deionized H2O    
57 µl  Total Volume 
 
*For the control synthesis, add 10 ng of Control Mouse Liver Total RNA. PCR-
Select users should start with >10 ng of total RNA. 
2. Mix contents and spin the tubes briefly in a microcentrifuge. 
3. Incubate the tubes at 72°C in a hot-lid thermal cycler for 3 min, and then cool the 
tubes to 42°C. 
NOTE: The initial reaction steps (Step 4-6) are critical for first-strand synthesis 
and should not be delayed after Step 3. You can prepare your master mix (for Step 
4) while your tubes are incubating (Step 3) in order to jump starts the cDNA 
synthesis. 
4. Prepare a Master Mix for all reaction tubes at room temperature by combining the 
following reagents in the order shown: 
20 µl  5X First-Strand Buffer 
2 µl  DTT (100 mM) 
10 µl  dNTP Mix (10 mM) 
7 µl  SMARTer II A Oligonucleotide (12 µM) 
5 µl  RNase Inhibitor 
5 µl  SMARTScribe™ Reverse Transcriptase (100 U)* 
49 µl  Total Volume added per reaction 
 
* Add the reverse transcriptase to the master mix just prior to use. Mix well by 
vortexing and 
spin the tube briefly in a microcentrifuge. 
5. Aliquot 49 µl of the Master Mix into each reaction tube. Mix the contents of the tubes 
by gently 
pipetting, and spin the tubes briefly to collect the contents at the bottom. 
6. Incubate the tubes at 42°C for 1 hour. 
NOTE: If you plan to use a downstream application that requires long transcripts, 
extend the incubation time to 90 min. 
7. Terminate the reaction by heating the tubes at 70°C for 10 min. 
8. If necessary, cDNA samples can be stored at –20°C (for up to three months) until you 
are ready to proceed with spin-column purification. 
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Column purification of cDNA using NucleoSpin gel and PCR clean-up 
 
1. Add 350 µl of Buffer NT to each cDNA synthesis reaction; mix well by pipetting. 
2. Place a NucleoSpin Gel and PCR Clean-Up Column into a 2 ml collection tube. 
Pipette the sample into the column. Centrifuge at 8,000 rpm for 1 min. Discard the 
flowthrough. 
3. Return the column to the collection tube. Add 600 µl of Wash Buffer NT3 to the 
column. Centrifuge at 14,000 rpm for 1 min. Discard the flowthrough. 
4. Return the column to the collection tube. Add 250 µl of Wash Buffer NT3 to the 
column. Centrifuge at 14,000 rpm for 1 min. Discard the flowthrough. 
5. Place the column back into the collection tube. Centrifuge at 14,000 rpm for 2 min to 
remove any residual Wash Buffer NT3. 
6. Transfer the NucleoSpin Columns into a fresh 1.5 ml microcentrifuge tube. Add 50 µl 
of sterile Milli-Q H2O to the column. Allow the column to stand for 2 min with the 
caps open. 
7. Close the tube and centrifuge at 14,000 rpm for 1 min to elute the sample. 
8. Repeat elution with 35 µl of sterile Milli-Q H2O in the same 1.5 ml microcentrifuge 
tube. The recovered elution volume should be 80–85 µl per sample. If necessary, add 
sterile Milli-Q H2O to bring the total volume up to 80 µl. 
9. For PCR-Select cDNA subtraction, proceed with the protocols provided in Appendix 
A of this User Manual. For all other applications, proceed with Section D. Samples 
can be stored at –20°C (for up to three months) until you are ready to proceed with 
cDNA amplification by LD PCR. 
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cDNA amplification by LD PCR 
 
1. Preheat the PCR thermal cycler to 95°C. 
2. For each reaction, aliquot the appropriate volume (see T able II) of each diluted first-
strand cDNA into a labeled 0.5 ml reaction tube. If necessary, add deionized H2O to 
adjust the volume to 80 µl. 
 
Table II: Guidelines for Setting Up PCR Reactions 
Total RNA 
(ng) 
Volume of 
Diluted ss 
cDNA for PCR 
(uL) 
Volume of 
H20 (uL) 
Typical 
Optimal No. of 
PCR Cycles* 
1000 2.5 77.5 18-20 
250 10 70 18-20 
100 25 55 18-20 
50 40 40 18-20 
20 80 none 19-21 
5 80 none 21-23 
1 80 none 24-27 
 
3. Prepare a Master Mix for all reactions, plus one additional reaction. Combine the 
following reagents in the order shown: 
4 µl  Deionized H2O 
10 µl  10X Advantage 2 PCR Buffer 
2 µl  50X dNTP Mix (10 mM) 
2 µl  5’ PCR Primer II A (12 µM) 
2 µl  50X Advantage 2 Polymerase Mix 
20 µl  Total Volume per reaction 
 
4. Mix well by vortexing and spin the tube briefly in a microcentrifuge. 
5. Aliquot 20 µl of the PCR Master Mix into each tube from Step 2. 
6. Cap the tube, and place it in the preheated thermal cycler. If you are NOT using a hot-
lid thermal cycler, overlay the reaction mixture with two drops of mineral oil. 
 
Table III: Cycling Guidelines Based on Starting Material 
No. of Cells (e.g. HeLa) 
Typical Yield of Total RNA 
(ng) Typical No. of PCR Cycles 
~10 0.15 27 
~100 1.5 24 
~1,000 15 20 
~10,000 150* 18 
 
7. Commence thermal cycling using the following program: 
• 95°C 1 min 
• X cycles at: 
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95°C 15 sec 
65°C 30 sec 
68°C 3 min 
a) Consult Tables II & III for guidelines. Subject all tubes to 15 cycles. Then, 
divide the PCR reaction mix between the “Experimental” and “Optimization” 
tubes, using the Optimization tube for each reaction to determine the optimal 
number of PCR cycles, as described in Step 8. 
b) For applications requiring longer cDNA transcripts, increase to 6 min. 
8. Subject each reaction tube to 15 cycles, then pause the program. Transfer 30 µl from 
each tube to a second reaction tube labeled “Optimization”. Store the “Experimental” 
tubes at 4°C. Using the Tester PCR tube, determine the optimal number of PCR 
cycles (see Figure 3): 
a) Transfer 5 µl from the 15 cycle PCR reaction tube to a clean microcentrifuge tube 
(for agarose/EtBr gel analysis). 
b)  Return the Optimization tubes to the thermal cycler. Run three additional cycles 
(for a total of 18) with the remaining 25 µl of PCR mixture. 
c) Transfer 5 µl from the 18 cycle PCR reaction tube to a clean microcentrifuge tube 
(for agarose/EtBr gel analysis). 
d) Run three additional cycles (for a total of 21) with the remaining 20 µl of PCR 
mixture. 
e) Transfer 5 µl from the 21 cycle PCR to a clean microcentrifuge tube (for 
agarose/EtBr gel analysis). 
f) Run three additional cycles (for a total of 24) with the remaining 15 µl of PCR 
mixture. 
g) Transfer 5 µl from the 24 cycle PCR to a clean microcentrifuge tube (for 
agarose/EtBr gel analysis). 
h) Run three additional cycles (for a total of 27) with the remaining 10 µl of PCR 
mixture. 
i) Transfer 5 µl from the 27 cycle PCR to a clean microcentrifuge tube (for 
agarose/EtBr gel analysis). 
j) Run three additional cycles (for a total of 30) with the remaining 5 µl of PCR 
mixture. 
9. Electrophorese each 5 µl aliquot of the PCR reaction alongside 0.1 µg of 1 kb DNA 
size markers on a 1.2% agarose/EtBr gel in 1X TAE buffer. Determine the optimal 
number of cycles required for each experimental and control sample (see Figure 4, 
Section VI). 
10. Retrieve the 15 cycle Experimental PCR tubes from 4°C, return them to the thermal 
cycler, and subject them to additional cycles, if necessary, until you reach the optimal 
number. 
11. When the cycling 11. is completed, analyze a 5 µl sample of each PCR product 
alongside 0.1 µg of 1 kb DNA size markers on a 1.2% agarose/EtBr gel in 1X TAE 
buffer. Compare your results to Figure 4 to confirm that your reactions were 
successful. 
12. Add 2 µl of 0.5 M EDTA to each tube to terminate the reaction. 
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Column purification of PCR products using NucleoSpin gel and PCR clean-up 
 
1. Add 300 µl Binding NT Buffer to each 70 µl PCR reaction. Mix well by pipetting. 
2. Place a NucleoSpin column into a 2 ml Collection Tube, and pipette the sample 
onto the filter. Centrifuge at 8,000 rpm for 1 min. Discard the Collection Tube 
and flowthrough. 
3. Insert the NucleoSpin column into a fresh 2 ml Collection Tube. Add 600 µl 
Wash Buffer NT3 to the column. Centrifuge at 14,000 rpm for 1 min. Discard the 
flowthrough. 
4. Return the column to the Collection Tube. Add 250 µl Wash Buffer NT3 to the 
column. Centrifuge at 14,000 rpm for 1 min. Discard the flowthrough. 
5. Discard the flowthrough and spin again at 14,000 rpm for 1 min to remove the 
final traces of ethanol to dry the filter. 
6. Transfer the NucleoSpin column to a clean 1.5 ml microcentrifuge tube. Pipette 
50 µl Elution Buffer NE directly onto the filter, being careful not to touch the 
surface of the filter with the tip of the pipette. Allow the filter to soak for 2 min 
with the lid open. 
7. Close the tube and centrifuge at 14,000 rpm for 1 min to elute PCR product. Save 
the column. 
8. Determine the yield of each PCR product by measuring the A260. For each 
reaction, we usually obtain 1–2 µg of SMARTer cDNA after purification. 
9. If no product is detected, perform elution (Steps 6 and 7) a second time, using a 
fresh 1.5 ml microcentrifuge tube. 
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Qiagen Reverse Transcriptase (RT) 
 
1. Thaw gDNA wipeout buffer, Quantiscript reverse transcriptase, Quantiscript RT 
buffer, RT primer mix, and RNase-free water at room temperature. Thaw RNA in ice.  
 
2. Prepare the genomic DNA elimination reaction on ice, making an extra tube without 
template RNA as a control, just gDNA wipeout buffer and water:  
 
• gDNA wipeout buffer    2µl 
• Template RNA   up to 2µg 
•  RNase-free water  up to 14 ul total volume 
• TOTAL VOLUME:   14µl  
 
3. Incubate for 2 minutes at 42°C. Place immediately back on ice. Do not exceed an 
incubation time of 10 minutes.  
 
4. Add the remaining reagents to each tube. Add RNase-free water to the tube that is 
meant to be enzyme free:  
 
• Quantiscript reverse transcriptase    1µl  
• Quantiscript RT buffer     4µl 
• RT primer mix      1µl  
• TOTAL VOLUME:    20 µl  
 
5. Incubate for 15 minutes at 42°C 
• May run for 30 minutes if RT-PCR product is greater than 200 bp or to increase 
cDNA yields.  
 
6. Incubate for 3 minutes at 95°C  
 
7. Add 1 µl of each sample to corresponding PCR mix. Store at -20°C long term.  
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Diluting Primers from IDT 
 
To make freezer stock:  
1.  Spin down tubes 
2.  Add dH20 water to 50 µM (50 pmoles/ul) 
• Divide amount of oligo in nMoles by 50 µM 
• Typical volumes range from 300- 800 µl 
3. Vortex well 
4. Store at -20°C  
5. Note primer location on Primer Inventory Sheet 
 
 
To make 10 µM PCR Stock:  
100 µl  of 50 µM primer  
400 µl  of dH20 
Store at -20°C 
 
 
To make 2.5 µM working PCR stock 
125 µl  of 10 µM primer  
375 µl  of dH20 
Store at -20°C 
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Polymerase Chain Reaction: PCR 
 
• Wear gloves 
• Make aliquots of kit components for own use – except for Taq 
• Make sure to vortex MgCl2 well 
• Make master mix for number of samples + 1 
 
Sample Types: 
1.) cDNA from RT reaction 
2.) RT negative control: no enzyme  
3.) RT negative control: no template RNA 
4.) PCR negative control: no template RT added 
 
 
PCR Reaction Master Mix: 
 
 
• Mix well and centrifuge 
• Make sure no bubbles are present before PCR reaction 
 
PCR conditions: 
• 1 cycle: 94°C for 3 min 
• 35 cycles: 94°C for 30 sec, ____°C for 30 sec, 72°C for 30 sec 
• 1 cycle: 72°C for 10 min 
• Hold at 4°C 
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Store at -20°C until analysis 
 
MgCl2 Gradient Option: 
Reagents x1 x2 x3 x4 x5 x6 
Std Taq Buffer 5 10 15 20 25 30 
Forward GSP 4 8 12 16 20 24 
Reverse GSP 4 8 12 16 20 24 
MgCl2 1 2 3 4 5 6 
dNTPs 1 2 3 4 5 6 
Taq 0.5 1 1.5 2 2.5 3 
Water 33.5 32.5 31.5 30.5 29.5 28.5 
Total Per Tube 49 49 49 49 49 49 
Template Per Tube 1 1 1 1 1 1 
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DNA Agarose Gel 
 
During electrophoresis, water is electrolyzed, which generates protons at the anode, and 
hydroxyl ions at the cathode.  The cathode end of the electrophoresis chamber then 
becomes basic and the anodal end acidic.  The use of a buffering system therefore 
required when charged molecules are electrophoresed through a separation medium. The 
pH of the buffers is basic and the phosphate backbone of DNA has a net negative charge 
and migrates towards the anode. 
 
Make certain to wear gloves.  Ethidium Bromide is a known mutagen 
 
Need –  
Distilled water  
Clean gel box, casting tray and comb with dH20 
Ethidium bromide solution  
   Stock: 10 mg/ml dH20 
                0.1 g to 10 ml dH20 
                Store at 4°C 
   Working solution: 2.5 ug/ul  (4X dilution of stock) 
               (125 ul into 375 ul dH20) 
 
Running buffer:  
50X TAE   
242g Tris base 
57.1 ml glacial acetic acid 
100 ml 0.5 M EDTA  pH 8.0  (FW 372 = 18.6 g) 
dH20 to 1 Liter 
 
1X TAE 
20 ml 50X TAE 
980 ml dH20 
 
Gel preparation: (Agarose PCR grade BP 2410-100) 
Agarose (%)          Effective range of resolution of               Amount in 50 mls 1X TAE 
buffer (g) 
                                linear DNA fragments (kb) 
0.5                                         30 to 1                                                         0.25 
0.7                                         12 to 0.8                                                      0.35 
1.0                                         10 to 0.5                                                      0.5 
1.2                                         7 to 0.4                                                        0.6 
1.5                                         3 to 0.2                                                        0.75 
2.0                                                                                                             1.0 
 
For 50 ml gel, place agarose in a 125 ml flask  
(choose a flask that is 2-4 times that size of the gel volume) 
Add 50 ml 1X TAE buffer and swirl to mix 
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Cover flask with double layer of plastic wrap  
Heat in microwave for 1 minute on high power.   
Open microwave and swirl flask  **Flask is hot** Tilt flask away from your face*** 
Heat in microwave for another 30sec to 1 minute until agarose is completely melted (no  
                  bubbles or “little contact lenses”) 
Remove from microwave and cool solution until you can touch the bottom with your 
hand 
After solution has cooled, add 10  ul of 2.5 ug/ul ethidium bromide solution  
(Final gel concentration is 0.5 ug/ml) 
Pour gel into casting tray with comb, pop any air bubbles with a pipet tip, and let gel 
polymerize 
 
After gel has set, remove comb and turn gel 
Pour tank buffer 1X TAE to just cover gel 
 
Sample preparation: 
Agarose gel loading dye is 6X.  Add to samples so concentration is 1X 
Run 12 ul of PCR reaction + 2 ul of gel loading dye = 14 ul total volume 
 
Running gel:  
Add 10 ul of ready made DNA ladder to first well to assist in determining the size of the 
DNA fragments observed. 
Load samples into wells of gel 
Note sample loading in lab notebook. 
 
Plug in red and black leads to power supply (make sure these are in the correct position!) 
and run get at 80 V for approximately 45 minutes or until the dye front is near the bottom 
of the gel. Look for bubbles to make sure you have current.   
 
TURN OFF THE POWER!!!! AND UNPLUG THE UNIT FROM THE POWER 
SUPPLY!!!!! 
With gloves, remove the gel bed onto a piece of saran wrap. Observe stained gel on UV 
gel documentation system and save an image of your gel. Make certain to wear gloves 
when handling gel due to ethidium bromide. 
 
WASTE: Gel is placed in ethidium bromide waste container and running buffer is poured 
down the sink 
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QIAquick Gel Extraction Kit Protocol 
 
1.) Excise the DNA fragment from the agarose gel with a clean, sharp scalpel.  Minimize 
the size of the gel slice by removing extra agarose. 
 
2.) Weigh the gel slice in a colorless tube.  Add 3 volumes of Buffer QG to 1 volume of 
gel (100mg ~100 ul). 
 
3.) Incubate at 50°C for 10 min (or until the gel slice has completely dissolved).  Vortex 
the tube every 2-3 min during the incubation to mix. 
 
4.) After the gel slice has dissolved completely, check that the color of the mixture is 
yellow. 
 
5.) Add 1 gel volume of isopropanol to the sample and mix. 
 
6.) Place a QIAquick spin column in a provided 2 ml collection tube (already done). 
 
7.) To bind DNA, apply the sample to the QIAquick column, and centrifuge for 1 
min.  The maximum volume of the column reservoir is 800 ul.  For sample volumes 
of more than 800 ul, simply load and spin again. 
 
8.) Discard flow-through and place QIAquick column back in the same collection tube. 
 
9.) Add 500ul of Buffer QG to QIAquick column and centrifuge for 1 min.  This step 
will remove all traces of agarose. 
 
10.) To wash, add 750ul of Buffer PE to QIAquick column and centrifuge for 1 min. 
 
11.) Discard flow-through and centrifuge the QIAquick column for an extra 1 min   
       at ≥10,000 X g (~13,000 rpm). 
 
12.) Place a QIAquick column into a clean 1.5 ml microcentrifuge tube. 
 
13.) To elute DNA, add 50 ul autoclaved H2O to the center of the QIAquick  
       membrane and centrifuge the column for 1 min at maximum speed.  Reapply the  
       flow-through and centrifuge again for 1 min.  
 
14.) Check concentration of samples by nanodrop or running a 2% agarose gel 
 
**Store samples at -20°C** 
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Sequencing Gel Cutouts 
Following URI GSC Instructions: 
Target amounts for dsDNA templates: 
PCR products: 2.5 ng DNA per 100 bases per reaction 
Plasmids: 300-500 ng DNA per reaction 
Primer amount: 
Use one primer only; either forward or reverse, but not both! 
5 pmol per reaction (Note: 5 pmol = 2.0 µl of a 2.5 µM stock) 
Single sample volume: 
12 µl per reaction; add template plus one primer in the amounts above to MB grade 
water. 
To facilitate pipetting, submit your sample in duplicate with a total volume of 24 µl. 
Submit your template and primer combined in a 0.5 or 1.5ml tube. DO NOT submit 
samples in individual 0.2 ml (200µl) tubes. When submitting 16 or more samples, please 
submit them in 8-tube strip-tube(s) (capped) or a 96-well plate (capped or sealed). 
 
 
 
 
 
 
 
 
 
 
 
 191 
qPCR: Standard Curve Protocol 
 
1. Run your primers that will be used in QPCR on sperm/testis samples using standard 
PCR protocol.  Whichever sample type gives you the darkest/best product band should be 
used regardless of what sample type you want to investigate using QPCR.  (Example: 
testis bands can be used to generate standard curve even if you are only going to be 
running sperm samples on QPCR for your critical data). 
 
2. Run DNA agarose gel of your PCR and cut out product band for your gene of interest. 
 
3. Use the gel extraction kit to purify the gel cut out. 
 
4. Bring the purified DNA product to Nanodrop and get a concentration for you DNA 
solution, which is purified DNA of your gene of interest. 
 
5. Enter your concentration (ng/ul) from the Nanodrop and the size of your product into 
the DNA copy calculator on the URI Genomics and Sequencing Center website 
(http://www.uri.edu/research/gsc/resources/cndna.html).  This will give you the number 
of copies of your gene/ul of sample. 
 
6. Once you have found the # of copies/ul of your sample, you must dilute this sample 
out to get 1X108 copies/ul which will become your highest standard for the QPCR 
standard curve.  Note: this dilution is usually a very large dilution factor so splitting it up 
into 2 separate dilutions may help pipetting accuracy. 
 
7. From your 1X108 copies/ul sample you need to do a serial dilution down to 1X101 
copies/ul, which will become your final standard in the curve. 
 
 Example: 20ul 1X108 copies/ul sample +180 ul H2O => 200 ul of 1X107  
 copies/ul 
Repeat this dilution starting with 20ul of the 1X107 copies/ul sample and add the 
180ul of water, which will result in 200ul of your 1X106 copies/ul standard 
   
- This should be done until you have 8 standards made, 1X108 down to 
1X101 copies/ul 
 
8. Once you have all standards diluted out put aside for use in QPCR runs.  Standards are 
in solution with a concentration based on one ul of sample therefore all standards will 
only have 1ul added to tubes for QPCR samples as opposed to unknowns which have 
2.5ul of sample added to each tube.  This just requires adjusting water between unknowns 
and standards when running QPCR sample. 
 
*Proceed to QPCR protocols once standard curve is diluted out accordingly.* 
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qPCR (Stratagene MX3005P Machine) 
 
1.  Dilute ROX reference dye 1:500 using nuclease-free PCR grade water.  *Keep all 
solutions containing reference dye away from light. 
 
2.  Prepare the experimental reaction by combining components IN ORDER.  Combine 
reagents to form a master mix in the amount of number of samples + one to facilitate 
pipetting. 
 
Reagent Standards Unknown 
PCR water 9.125 µl 7.625 µl 
SYBR master mix 12.5 µl 12.5 µl 
Forward primer 1 µl 1 µl 
Reverse primer 1 µl 1 µl 
Diluted reference dye 
 
0.375 µl 0.375 µl 
Total volume (per sample) 24 µl 22.5 µl 
 
3.  Gently mix without creating bubbles (do not vortex), then distribute mixture to each 
reaction tube. 
 
4.  Add template cDNA to each sample. (1 µl to standards, 2.5 µl to unknowns) 
 
5.  Gently mix without creating bubbles (do not vortex) 
 
6.  Centrifuge briefly. 
 
7.  Place reactions in instrument (Mx 3005) and run qPCR program. 
 
qPCR cycling conditions 
Cycles Duration Temperature (°C) 
1 10 min 95  
40 30 sec 
1 min 
95  
59.0 (Annealing) 
1 (Dissociation curve) 1 min 
30 sec 
30 sec 
95  
55  
95  
 
Samples can be run on a 2% agarose gel afterward to check products. 
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qPCR (Roche LightCycler 480 Machine) 
 
Important notes before starting: 
- work with lab lights off if others don’t mind 
- wrap all master mix tubes with aluminum foil to block light 
 
1. Prepare the experimental reaction by combining components in order.  Combine 
reagents to form a master mix in the amount of number of samples + one additional 
sample for every 8 samples to facilitate pipetting (for example: 40 samples run on qPCR 
= 45x master mix).  
 
Reagent Amount/Sample 
PCR water 5 µl 
SYBR master mix 10 µl 
Forward primer 2 µl 
Reverse primer 2 µl 
Total volume (per sample) 19 µl 
 
2. Gently mix without creating bubbles (pulse vortex), and then distribute 19 µl of master 
mix to each well of qPCR plate (white) that will be used for samples. 
 
3. Add 1 µl of sample (standard or unknown) to appropriate wells.   
 
4. Cover plate with plate sealing film and firmly seal sticky cover onto plate with plastic 
sealing applicator.   
 
5. Bring plate up to plate centrifuge in GSC and spin plate at 1500 rcf for 2 minutes 
(make sure plate is balanced with balance plate from drawer below centrifuge).   
 
6.  Cycling conditions are to be set as follows within the LightCycler 480 software: 
 
Pre-incubation 
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Amplification (60 degree temperature is annealing and could vary pending primers used) 
 
 
 
 
Melting Curve 
 
 
 
 
Cooling 
 
 
 
 
Analysis Notes: 
- perfect standard curve has efficiency of 2.00 
- standard curve error should remain under 0.20 
- melting curve should show one distinct peak per sample for each primer set 
 - small peak at lower temperature usually indicates primer dimers 
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qPCR Troubleshooting: 
Primer Matrix 
 
Purpose: 
The primer matrix is done to find the best primer concentrations that offer optimal results 
on QPCR runs.  The idea of the primer matrix is to combine different amounts of the 
Forward and Reverse primers to find the best combo which could be one in which the 
primers differ in concentration with each other.   
 
Why: 
The SYBR Green dye we use in QPCR binds to any double stranded DNA products and 
emits fluorescence.  This makes it critical that when doing QPCR you are only 
amplifying your target product and no non-specific secondary products or primer dimers 
(forward and reverse primers sticking to each other).  These other products will have 
SYBR bind to them and emit fluorescence thus throwing off your final data.   
 
Procedure: 
The standard QPCR protocol is followed when doing a primer matrix.  The only 
variations are altering the amount of primer added between tubes.  You must use the 
same sample(template) for all tubes so that they only thing that is altered across the run 
are primer concentrations.  A standard primer matrix that should be sufficient is a 4x4 
primer matrix which is represented below.  
 
 F 50nM 
(.5ul) 
F 100nM 
(1ul) 
F 300nM 
(3ul) 
F 600nM 
(6ul) 
R 50nM 
(.5ul) 
F 50nM 
(.5ul) 
R 50nM 
(.5ul) 
F 100nM 
(1ul) 
R 50nM 
(.5ul) 
F 300nM 
(3ul) 
R 50nM 
(.5ul) 
F 600nM 
(6ul) 
R 50nM 
(.5ul) 
R 100nM 
(1ul) 
F 50nM 
(.5ul) 
R 100nM 
(1ul) 
F 100nM 
(1ul) 
R 100nM 
(1ul) 
F 300nM 
(3ul) 
R 100nM 
(1ul) 
F 600nM 
(6ul) 
R 100nM 
(1ul) 
R 300nM 
(3ul) 
F 50nM 
(.5ul) 
R 300nM 
(3ul) 
F 100nM 
(1ul) 
R 300nM 
(3ul) 
F 300nM 
(3ul) 
R 300nM 
(3ul) 
F 600nM 
(6ul) 
R 300nM 
(3ul) 
R 600nM 
(6ul) 
F 50nM 
(.5ul) 
R 600nM 
(6ul) 
F 100nM 
(1ul) 
R 600nM 
(6ul) 
F 300nM 
(3ul) 
R 600nM 
(6ul) 
F 600nM 
(6ul) 
R 600nM 
(6ul) 
 
- All amounts listed in the primer matrix are amount of 2.5uM primer stock that needs to 
be added.  This calculation is based on the final volume of each QPCR tube being 25ul.   
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- After adding various amounts of primer to the solutions the H2O amounts will need to 
be altered accordingly to maintain a final volume of 25ul in each QPCR tube.   
 
 
Analysis: 
A dissociation curve(melting curve) should be done during all QPCR reactions with the 
primer matrix being no exception.  There are a few criteria that must be looked at to be 
able to pick the best primer pair to move forward with in your QPCR assay.  Based on 
analyzing the amplification plots and dissociation curve you can choose the best pair 
based on the following criteria: 
 
1. There must be only one product being amplified.  
 - Only one peak in the dissociation curve around 85-88° usually 
 - Primer dimers will produce a small peak around 10° lower than your main 
product  (unacceptable) 
 - Secondary non-specific products can produce second higher temperature peaks 
or a  “shoulder” off of your main product peak (unacceptable) 
 - Samples can be run on DNA Agarose gels after QPCR to check for single 
product  amplification as well as do sequence analysis 
 
2. The lower the Ct the better when comparing combinations. 
 - If multiple primer pairs show single product amplification you should choose the 
one  with the lowest Ct(cycle where the amplification plot crosses the threshold line). 
 
3. Amplification must of course be present on the amplification plot 
 - Sometimes primers that are too low in concentration (example: Forward 50nM, 
Reverse  50nM combination) do not amplify due to insufficient primer amounts 
 
**Once a usable primer pair has been determined you can move ahead with your QPCR 
assay** 
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RNA-Seq Analaysis via Galaxy (usegalaxy.org) 
 
Notes before using Galaxy: 
 - Galaxy is very user friendly and will only let you choose files that are in   
 correct format for any analysis you are trying to do.   
 - Analysis takes much longer on Galaxy server than through command   
 line 
 - All output files get named with generic names; renaming after running   
 them is beneficial 
 - Making new histories for different sample analysis is helpful for    
 organizational  purposes 
 - For the most part you can leave all parameters as default unless you start   
 doing detailed analysis and become very familiar with advanced   
 options 
 
Files you will need to upload to galaxy server: 
 - Raw Illumina sequencing files (file 1 and file 2 for paired-end reads;   
 fasta/fastq) 
 - Annotated transcript file (igenomes; .gtf format) 
 - You do not need to upload bovine genome as galaxy has genomes   
 already on it 
 
From raw reads => Cufflinks/Cuffdiff analysis 
 
Uploading Files 
 
Left Tools Panel: Get Data => Upload File 
 
 
 
Browse for file(s) you want to upload and submit the job. 
 
FASTQ Groomer 
 
Left Tools Panel: NGS:QC and manipulation => FASTQ Groomer 
 
What it does: Changes format of raw sequence files into usable format for downstream 
applications 
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File to groom is your raw data sequence file.  Choose Sanger for input type and no need 
to adjust any advanced options.   
 
 
Draw Quality Score Boxplot 
 
Left Tools Panel: NGS: QC and manipulation => Draw quality score boxplot 
 
What it does: Scores each base of your reads across entire dataset with quality score to 
see if your read accuracy is consistent throughout all bases of sequencing.   
 
 
 
Your input file is any FASTQ groomed file that you want to check read quality on.   
 
Results look like this:  
 
 
 
The higher the score, the better.  A huge drop off on one end of the sequence could point 
to 3’ bias with the 5’ end not sequencing very accurately.   
Clipping adapter sequences 
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Left Tools Panel: NGS: QC and manipulation => Clip 
 
What it does: Removes adapters from ends of reads; removes reads with Ns; removes 
reads that are too short. 
 
 
 
Library to clip input file is your FASTQ groomed file.  You must change the source to 
“enter custom sequence” and then type in the sequencing adapter that you want clipped 
(example here is just random bases typed in).  You want to change output options to 
“output both clipped and non-clipped sequences” so that you keep reads that the adapter 
was not maintained on as well as those you clip.   
 
 
Manipulate Reads (Delete reads overrepresented from contamination; concatemers) 
 
Left Tools Panel: NGS: QC and manipulation => Manipulate FASTQ 
 
What it does: You can remove reads that contain a certain sequence that is due to some 
form of contamination.   
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You must match reads by “sequence content” and type in the sequence you are looking 
for in contaminated reads.  For the manipulation section you go to manipulate reads on 
“miscellaneous actions” and for manipulation type choose “remove read”.   
 
 
 
Tophat 
 
Left Tools Panel: NGS: RNA Analysis => Tophat for Illumina 
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What it does: Aligns your reads to the bovine (or species you are studying) genome.   
 
 
 
Galaxy has a large selection of built in genomes so they likely have what you need; in 
this example bosTau6.  This prevents you from having to upload your own genome file. 
 
If you have paired-end reads you want to change the library mate-paired section to 
paired-end.  This will cause a second RNA-Seq FASTQ file section to pop up.  Put your 
first groomed/clipped/manipulated file in the first section and the second file of the 
paired-end sequencing in the second section.  If you know mean inner distance between 
pairs you can change this but if not leave it as default.   
 
Results: You can use the accepted hits file that is one of the output files for subsequent 
cufflinks or cuffdiff analysis.  This file can also be downloaded and used for subsequent 
sequencing statistic/quality measures through other analysis packages such as ever-seq. 
 
Cufflinks 
 
Left Tools Panel: NGS: RNA Analysis => Cufflinks 
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What it does: Takes your alignment file from tophat and tells you what transcripts on the 
genome that reads aligned to as well as quantifies them.   
 
 
The SAM or BAM input aligned RNA-Seq reads file you need to use is the accepted hits 
file from your tophat analysis.  
 
The only change you need to make to default parameters is that you want to “use 
reference annotation” in the use reference annotation setting.  Then you have to choose 
which file in your galaxy history to use in the reference annotation pulldown that now 
appears.  This will be the igenomes .gtf file that you uploaded originally along with your 
raw sequence files.   
 
Results: You can download the transcript expression file and open it through excel to sort 
by FPKM and that is your list of expressed transcripts. 
Cuffdiff 
 
Left Tools Panel: NGS: RNA Analysis => Cuffdiff 
 
What it does: Compares alignment files of two different samples (for example: low and 
high fertility) and determines differentially expressed transcripts. 
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For the transcripts file you can use the igenomes .gtf file that you would likewise use in 
cufflinks analysis.   
 
Each condition is your different sample types (for example: low and high fertility).  You 
must use the accepted hits files from tophat for each sample type.   
 
Results: You can download the differential expression file and sort through it in excel to 
determine what transcripts were significantly differentially expressed.  This output will 
also give you FPKM of these transcripts in each sample but they will slightly differ from 
cufflinks FPKMs.   
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Command Line RNA-Seq Analysis 
 
Notes: 
 
Installation of various software packages for command line use can differ depending on 
the package but most instructions can be found online.    
 
For example, instructions for installation of cufflinks package on new can be found in the  
user manual online at: http://cufflinks.cbcb.umd.edu/tutorial.html#inst 
 
You can drag and drop analysis/input files from their folders on the computer and it will 
automatically fill in the path to the file so that it can be used in your analysis 
 
To just type in a file name you must be in the correct directory within the command line 
which can be accessed through the “cd” command (this is not necessary if you drag and 
drop each file you are using in the appropriate place within the command as it will fill in 
the pathing for you) 
 For example: cd ~/desktop will change the command directory to the desktop in 
 which case you could type in a file or folder name from the desktop without 
 having to drag and drop or write in the entire path to that folder 
 
 
 
For almost all command line analysis you can direct where the output goes by using the 
command –o   
 For example: -o /Users/chriscard/Desktop/seqoutput on the end of   
 command will send output to the folder named “seqoutput” on the   
 desktop (after  –o you can just drag the folder from the desktop and  
 it automatically fills in the rest of the pathing to that folder) 
  This will change the heading for the command line from the home   
 directory to the desktop as you can see in the following screenshot  
   
 
 
Cufflinks from command line 
 
Helpful information can be found online in the cufflinks user manual at: 
http://cufflinks.cbcb.umd.edu/manual.html  
 
Input files you will need: alignment file (accepted hits tophat file; .bam format); 
annotated transcript file (igenomes; .gtf format) 
 
First change directory to location where your input files are located: 
cd ~/Desktop/Card_LowHigh_Files  
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then you are ready for the cufflinks command which consists of the aligned .bam 
accepted hits file from tophat, an annotated transcript file, and an output location: 
 
cufflinks lowfertacchits.bam –G igenomegenes.gtf –o 
/Users/oystercow/Desktop/cufflinks_test  (all one continuous line just didn’t fit here) 
 
If done properly cufflinks should start to run in the command line.  Below are screenshots 
showing the command line window and then the resulting files in the “cufflinks_test” 
folder on the desktop that you specified the output to be sent to 
 
 
 
and the resulting files: 
 
 
 
 
 
Cuffdiff from command line 
 
Additional helpful information can be found in the cufflinks user manual linked above. 
 
Cuffdiff is installed when the cufflinks package is installed so if cufflinks is working you 
are ready to go with cuffdiff. 
 
Input files you will need include: annotated transcript file (igenomes; .gtf format); 
alignment file (low fertility accepted hits from tophat; .bam format); second condition 
alignment file (high fertility accepted hits from tophat; .bam format) 
 
Stay in the same directory as cufflinks as the files you will use are in the same location. 
 
The command order for cuffdiff is annotated transcript reference file, alignment file #1, 
alignment file #2, and output location. 
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Cuffdiff igenomegenes.gtf lowfertacchits.bam highfertacchits.bam –o 
/Users/oystercow/Desktop/cuffdiff_test (all one continuous line again) 
 
The final commands are as follows: 
 
 
 
The resulting files are in the “cuffdiff_test” folder they were directed to: 
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Determining % reads mapped via Everseq v.1.0.7 (read_distribution.py) 
 
Everseq commands are not formatted as shortcuts so unlike typing “cufflinks” as your 
first command line text and cufflinks running properly, you must drag and drop the 
location of the everseq script you want run.  Go into finder > press command+shift+h 
(brings you to base directory for entire system) > go to scripts folder and find everseq 
folder (which contains a scripts folder of its own with all applications in it) 
 
Files you will need to run read_distribution.py: alignment file (accepted hits from tophat; 
.sam format); bovine genome reference (btau6; .bed format) 
 
 
 
Take the total reads output # at top of output (1,336,844 in example) and divide by total 
number of reads that you input into tophat via galaxy to determine % reads aligned to 
genome.   
 
If reads/Kb in chart shows much higher value for 3’UTR exons it is indicative of 3’ bias 
which is a common pitfall of RNA-Seq.   
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DAVID Gene Ontology (GO) Analysis 
• Logon to the DAVID database ( http://david.abcc.ncifcrf.gov/) 
• Select “Start Analysis” from top menu 
• Copy transcript list of interest into the “Paste a list” box 
! Use Genbank IDs from RNA-Seq study 
o For the “Select Identifier” box, choose appropriate type of sample 
accession submitted 
! Use “GENBANK_ACCESSION” for RNA-Seq study 
o List Type: “Gene List” 
o Hit “Submit List” 
• Select species “Bos taurus” 
• On right, choose “Functional Annotation Tool” 
• Click “Gene_Ontology” 
o Should automatically have “GOTERM_BP_FAT,” 
“GOTERM_CC_FAT ,” “GOTERM_MF_FAT ” selected 
• Click “Chart” next to each checked box 
• Click “Download File” in top right corner 
• Copy entire window into a .txt file and save 
• Open the .txt file with excel, which should automatically insert tab delimiters 
o Can sort file according to target information 
  
 
Getting official gene symbols & long names from accession numbers 
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• Logon to the DAVID database ( http://david.abcc.ncifcrf.gov/) 
• Select “Start Analysis” from top menu 
• Copy transcript list of interest into the “Paste a list” box 
! Use Genbank IDs from RNA-Seq study 
o For the “Select Identifier” box, choose appropriate type of sample 
accession submitted 
! Use “GENBANK_ACCESSION” for RNA-Seq study 
o List Type: “Gene List” 
o Hit “Submit List” 
• On top menu, click “Shortcut to DAVID Tools” 
• Click “Gene ID Conversion” 
• Select “OFFICIAL_GENE_SYMBOL” from drop down menu 
• Click “Submit to Conversion Tool” 
• Click “Download File” in top right corner 
• Copy entire window into a .txt file and save 
• Open the .txt file with excel, which should automatically insert tab delimiters 
o Can sort file according to target information 
Pairing gene symbols & long names with known accessions 
• Open file that you’re annotating these names onto, referred to here as “FILE 1” 
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• Open file with accessions/official gene IDs/long names in it, referred to here as 
“FILE 2” 
 
• Temporarily copy all the information from “FILE 2” into blank columns to the 
right of the data in “FILE 1” 
• In “FILE 1,” add two additional columns to the right of the Genbank ID column 
o Title one “Gene ID” and the other “Long Name” 
 
 
• One cell to the right of the first accession number (B2), type  
“=VLOOKUP(A2,$E$1:$H$9, 2, FALSE)” 
 
o A1    the cell that contains what you’re searching for 
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o $E$1:$H$100   highlighting the entire table you’re taking 
information 
    from, with $ signs added to lock the entire thing in 
place  
    for when you start dragging it 
o 2   column number in the table you’re searching in 
containing  
    the information you’re looking for 
o FALSE  to tell it to search for a perfect match to the 
accession only 
• Copy this EXACT formula into cell under “Long Name”, but change column 2 to 
column 4, in this example. 
 
• Drag down to fill in the remainder of the accessions from column A 
 
• Select all cells, then copy and “Paste Special” into same cells after clicking 
“Values” on the pop-up menu 
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• Delete reference table, leaving just the annotated original file.  
 
 
  
